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Background: The present thesis sought to explore the relationship between sleep 
and paranoia, and investigate what factors mediate this relationship. The 
research was conducted at different levels, and in different groups including 
healthy members of the general population, people with a diagnosis of psychosis 
and clinicians. Method: in chapter 3, a cross-sectional study was conducted 
online to examine the relationships between sleep and paranoia in a non-clinical 
sample. Following this, chapter 4 outlines a systematic review that aimed to 
further understand how sleep has been investigated in clinical samples of people 
with psychosis. Next, chapter 5 examined the relationship between sleep 
disturbance and paranoia in a clinical sample using novel experience sampling 
methodologies. Finally, chapter 6 explored clinician perceptions of sleep 
problems in people with psychosis. Results: chapter 3 found evidence for a 
mediation model whereby sleep predicted paranoia, and this relationship was 
mediated by negative emotions, alexithymia and perceptual anomalies. Chapter 
4 revealed that there is a range of methodologies used to assess and measure 
sleep and identified areas of bias. Chapter 5 found no relationship between 
sleep and paranoia in a clinical sample of people with psychosis. Finally, chapter 
6 found that clinicians are fully aware of the range and types of sleep problems 
in people with psychosis but lack the training and skills to treat sleep problems. 
Discussion: Overall, the relationship between sleep and paranoia is inconsistent. 
Sleep disturbances are common and should be treated in people with psychosis. 
More work is required to develop effective intervention strategies to address the 
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1 An introduction to Psychosis and the Psychosis 
Continuum 
This opening chapter aims to 1) define and provide an historical overview of 
psychosis 2) define alternative models of psychosis including the continuum and 
single symptom approach and 3) give an introduction to paranoia.  
1.1 What is psychosis? 
Psychosis is defined as a loss of contact with reality and loss of ego boundaries 
(Arciniegas, 2015). Psychosis is normally defined on the presence of positive 
symptoms (e.g. hallucinations and delusions). In addition to positive symptoms, 
those with psychosis may also experience negative symptoms such as anhedonia 
and alogia (Kay, Fiszbein, & Opler, 1987). Schizophrenia is the most well-known 
example of a condition where someone experiences psychosis and the two terms 
are often used interchangeably. However, it is important to note that psychosis 
is not limited to schizophrenia, and can be found in other conditions and medical 
disorders (Arciniegas, 2015). In the first section I will outline and describe the 
phenomenology of positive and negative symptoms. 
1.2 Positive symptoms 
Positive symptoms are unusual thoughts and perceptions, associated with loss of 
contact with reality. Positive symptoms can be seen as exaggerations of normal 
sensations, feelings and behaviours. (Kay et al., 1987).  
1.2.1  Hallucinations 
Hallucinations are defined as sensory perceptions that occur in the absence of 
external stimuli (Arciniegas, 2015). Hallucinations can occur in all 5 senses, and 
can be tactile, auditory, visual, to do with taste or smell. For example, 
experiencing smells that others cannot detect would be an example of an 
olfactory hallucination (Kopala, Good, & Honer, 1994). It has been estimated 
that around 70% of people diagnosed with schizophrenia experience 
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hallucinations (Sartorius et al., 1986). Typically, the most prevalent 
hallucinations are auditory in nature, followed by visual with the others being 
reported much less frequently (Bauer et al., 2011).  A more recent study 
highlighted that multi-modal hallucinations are more common than uni-modal 
hallucinations. In other words, people with psychosis are more likely to 
experience more than one type of hallucination simultaneously than just 
experience one (A. Lim, Hoek, Deen, & Blom, 2016).  
1.2.2  Delusions  
Delusions are beliefs that are held with conviction, even if there is evidence that 
contradicts the belief (Bentall, Corcoran, Howard, Blackwood, & Kinderman, 
2001). Delusions vary greatly in content and fall on a continuum from mis-
interpretations of experiences, to bizarre, distressing delusions that are often 
associated with emotional distress (Arciniegas, 2015; Freeman, Garety, & 
Kuipers, 2001). One of the most common delusional beliefs is persecutory or 
paranoid in nature. Other types of delusions include delusions of grandeur (false 
impression of one’s importance), delusions of reference (where neutral or 
unrelated events start having personal significance) and somatic delusions 
(where the person feels their body/appearance is grossly abnormal). In terms of 
prevalence, a study reported that in a sample of 1,136 patients with a 
psychiatric diagnosis, persecutory delusions were most common, and that those 
with schizophrenia reported the most intense delusions (Appelbaum, Robbins, & 
Roth, 1999). Another study reported that more than 70% of people with a 
diagnosis for first episode psychosis experience delusions of persecution (Coid et 
al., 2013).  
1.3 Negative Symptoms  
Negative symptoms are those that are associated with reductions or deficits in 
normal behaviour(Andreasen, 1982). Negative symptoms can occur in various 
domains of functioning including speech or social behaviours (Aleman et al., 
2017). Examples of negative symptoms include flat affect (lack of emotional 
expression), alogia (poverty of speech), anhedonia (inability to experience 
pleasure), social withdrawal and avolition (decrease in motivation). In terms of 
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prevalence, negative symptoms are common. One study in a sample of 
outpatients with schizophrenia spectrum disorders reported 60% experienced at 
least one negative symptom (Bobes, Arango, Garcia-Garcia, & Rejas, 2010). This 
study also reported that the most common negative symptom was social 
withdrawal. Negative symptoms have been linked to a range of areas of 
functioning including cognitive impairment, intellectual impairments, poor 
outcome, response to neuroleptic treatment and lowered quality of life 
(Andreasen, 1982; M. F. Green, Kern, Braff, & Mintz, 2000; Myin-Germeys & van 
Os, 2007).  
1.4 Schizophrenia, psychosis: a historical overview  
A historical overview of the evolution of psychosis and the term schizophrenia is 
presented next.  
1.4.1  History  
French Physician Philippe Pinel, is credited as one of the founding fathers of 
Psychiatry. One of his case studies presented in 1809 is regarded as one of the 
earliest descriptions of schizophrenia (Kyziridis, 2005). A student of Pinel, Jean 
Etienne Esquirol is credited with defining hallucinations, and distinguishing them 
from illusions. He also defined a condition called “monomania” which is similar 
to concepts of paranoia schizophrenia (Choong, Hunter, & Woodruff, 2007; 
Kyziridis, 2005). Bénédict Augustin Morel, a French psychiatrist can be credited 
with the identification of the term schizophrenia. In his 1860 textbook “Traite 
des Maladies Mentales” (Treatise on Mental Illness) he was to first describe the 
concept of “Dementia Praecox” (which later came to be known as 
schizophrenia). He used this term to refer to states of cognitive decline in young 
people (Berrios, Luque, & Villagrán, 2003).   
1.4.2  Emil Kraepelin  
The term “Dementia Praecox” was advanced by German psychiatrist Emil 
Kraepelin (1856-1926). Kraepelin’s pioneering work was based on his 
observations and clinical notes of patients in hospitals he worked in. He defined 
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“Dementia Praecox” as a disorder with poor prognosis, early onset and a number 
of symptoms associated with it (Mueser & Jeste, 2011). His well-known work also 
includes the taxonomy he created for classifying and categorizing mental 
disorders. He viewed mental illnesses as biological diseases and asserted that 
specific clusters of symptoms were characteristic of specific conditions (Greene, 
2007).  He also believed that there was a clear divide between normal and 
abnormal (Bentall, 2006). Through the years and in his revisions of his Textbook 
of Psychiatry he also argued for a distinction between manic depression and 
‘dementia praecox’ (now known as schizophrenia). ‘Dementia praecox’ was seen 
as a progressive neurodegenerative disease with poor recovery, defined on the 
basis of symptoms of psychosis, whereas manic depression was defined on the 
presence of neurosis (depression, anxiety), seen as episodic and a disease with 
better prognosis (Ebert & Bär, 2010). This division between affective and non- 
affective psychosis is still present today and encapsulated within diagnostic 
systems (Bentall, 2006).   
1.4.3  Eugen Bleuler 
Eugen Bleuler was a Swiss psychiatrist, who revised some of the ideas Emil 
Kraepelin put forward. Unlike Kraepelin, Bleuler did not believe that the 
prognosis of ‘dementia praecox’ was as bleak as proposed and is credited for a 
change in the terminology and understanding of the term ‘dementia praecox’. 
(Mueser & Jeste, 2011). In 1911 he coined the term “Schizophrenia”, which 
come from the Greek root “schizo” (split) and “phrene” (mind). He used this 
term to refer to fragmented thinking, not a split personality as it is sometimes 
known (Kyziridis, 2005; Mueser & Jeste, 2011). He defined schizophrenia in 
terms of the 4’A’s that he believed were fundamental symptoms characteristic 
of psychosis: Affect (inability to display appropriate emotions), Autism (social 
withdrawal), Ambivalence (depersonalisation) and Associations (loosening of 
thoughts/thought disorder). Furthermore, loosening of associations was also 
proposed to be a primary (core deficit) that underlies schizophrenia (Moskowitz 
& Heim, 2011).  
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1.4.4  Kurt Schneider  
Schneider was a German Psychiatrist who attempted to further advance and 
refine schizophrenia by defining symptoms he saw as integral to its diagnosis. 
These are now known as First Rank Symptoms. These include audible thoughts; 
arguing or commenting voices; feeling controlled or influenced by an external 
force; thought withdrawal; diffusion of thought; and delusions (Mueser & Jeste, 
2011). Second rank symptoms included other forms of hallucinations, depressive 
or euphoric mood changes, emotional blunting, perplexity, and sudden 
delusional ideas (Lake, 2012).  
1.5 Diagnostic criteria: DSM and ICD- evolution and 
changes  
There are two main classification manuals used to diagnose mental disorders, 
the Diagnostic and Statistical Manual of Mental Disorders (DSM; American 
Psychiatric Association, 2013) and the International Classification of Mental and 
Behavioral Disorders (ICD; World Health Organization, 1992). The DSM is in its 5th 
version which was released in 2013, while the ICD is currently in its 10th version. 
The ICD 11 is under development, and a draft version was released in June 2018 
to allow translation to other languages. By 2022, ICD 11 will fully replace ICD10 
(World Health Organization, 1992). The taxonomy and classification system 
developed by Emil Kraepelin formed the basis for these manuals. The criteria 
and diagnosis for schizophrenia and related conditions have all been influenced 
heavily by the work of aforementioned psychiatrists.  
1.5.1  ICD V DSM 
Table 1 and 2 presents the diagnostic criteria for diagnosis of schizophrenia 
based on DSM and ICD classification systems. In the DSM-V, schizophrenia comes 
under the category “Schizophrenia Spectrum and Other Psychotic Disorders” 
which also includes delusional disorder, schizophreniform disorder and 
schizoaffective disorder (APA, 2013). In the ICD 10 schizophrenia comes under 
the class of “Schizophrenia, schizotypal and delusional disorders.” Looking at 
tables 1 and 2, there are some similarities between the two classifications. For 
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example, both propose that the time frame for symptoms to be present is one 
month. Likewise, in both manuals, the diagnosis of schizophrenia cannot be 
attributable to substance mis-use. There are some key differences between the 
two manuals. Firstly, the ICD places more emphasis on Schneiderian first rank 
symptoms such as delusions of control, whereas the DSM does not. The DSM 
places more emphasis on the impact of psychosis on social /occupational 
dysfunction. This is not included in the ICD.  Finally, the ICD includes sub-types 
of schizophrenia including paranoid and catatonic types. The DSM-V has no sub-
types of schizophrenia.   
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Table 1: DSM criteria for schizophrenia  
DSM-V (APA, 2013): Diagnostic criteria for Schizophrenia  
A: Characteristic symptoms: Two or more for the following, each present for 





B: Social/occupational dysfunction: For a significant portion of the time since 
the onset of the disturbance, one or more major areas of functioning, such as 
work, interpersonal relations, or self-care, are markedly below the level 
achieved prior to the onset (or when the onset is in childhood or adolescence, 
failure to achieve expected level of interpersonal, academic, or occupational 
achievement). 
C: Duration: Continuous signs of the disturbance persist for at least 6 months. 
This 6-month period must include at least 1 month of symptoms (or less if 
successfully treated) that meet Criterion A (i.e., active-phase symptoms) and 
may include periods of prodromal or residual symptoms. During these 
prodromal or residual periods, the signs of the disturbance may be manifested 
by only negative symptoms or by two or more symptoms listed in Criterion A 
present in an attenuated form (e.g., odd beliefs, unusual perceptual 
experiences). 
D:  Schizoaffective and major mood disorder exclusion Schizoaffective disorder 
and depressive or bipolar disorder with psychotic features have been ruled out 
because either (1) no major depressive or manic episodes have occurred 
concurrently with the active phase symptoms; or (2) if mood episodes have 
occurred during active-phase symptoms, their total duration has been brief 
relative to the duration of the active and residual periods. 
 E. Substance/general mood condition exclusion Substance/general medical 
condition exclusion: The disturbance is not attributed to the direct 
physiological effects of a substance (e.g., a drug of abuse, a medication) or 
another medical condition. 
F. Relationship to Global Developmental Delay or Autism Spectrum Disorder: If 
there is a history of autism spectrum disorder, or other communication 
childhood disorder, the additional diagnosis of schizophrenia is made only if 
prominent delusions or hallucinations are also present for at least 1 month (or 
less if successfully treated). 
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Table 2: ICD criteria for schizophrenia  
ICD- 10- 1993: Diagnostic Criteria for Schizophrenia  
Either at least one of the syndromes, symptoms, and sign listed below under 
(1), or at least two of the symptoms and signs listed under (2), Should be 
present for most of the time during an episode of psychotic illness lasting for 
at least one month (Or at some time during most of the days):  
1) At least one of the following must be present:  
 a) Thought echo, thought insertion or withdrawal, or thought broadcasting.  
 b) Delusions of control, influence or passivity, clearly referred to body or limb 
Movements or specific thoughts, actions or sensations; delusional perception.  
 c) Hallucinatory voices giving a running commentary on the patient’s 
behavior, or discussing the patient among themselves, or other types of 
hallucinatory voices coming from some part of the body.  
 d) Persistent delusions of other kinds that are culturally inappropriate and 
completely impossible (ex: Being able to control the weather). 
 
2) Or at least two of the following:  
a) Persistent hallucinations in any modality, when occurring every day for at 
least one month, when accompanied by delusions without clear affective 
content, or by persistent over-valued ideas.  
b) Neologisms, breaks or interpolations in the train of thought, resulting in 
incoherence or irrelevant speech.  
 c) Catatonic behavior, such as marked apathy, paucity of speech, and blunting 
or incongruity of emotional responses.  
 
3) Most Commonly Used Exclusion Criteria:  
 1) If the patient also meets criteria for manic episode or depressive episode, 
the criteria listed under I (1) and I (2) above must have been met before the 
disturbance of mood developed.  
 2) The disorder is not attributable to organic brain disease, or to alcohol or 





1.6 Epidemiology of Psychosis 
The frequency of a psychosis can be presented in terms of incidence or 
prevalence rates. The incidence is the rate of new cases of a condition within a 
period of time e.g. per year. It may be measured as a frequency count, a rate, 
or a proportion (Saha, Chant, Welham, & McGrath, 2005).  On the other hand, 
prevalence is the proportion of people who have a condition at a particular 
time.  Prevalence can be reported in a number of different ways. Period 
prevalence is the proportion of people who have the condition during a 
particular period e.g. annual, point prevalence is the proportion of people who 
manifest the disorder at a particular point e.g. day. Lifetime prevalence is the 
proportion of people who have had the diagnosis at some point in their lives 
(Saha et al., 2005).  
1.6.1  Prevalence  
A systematic review based on 188 studies reported a point prevalence of 
4.6/1000, period prevalence of 3.3/1000 and lifetime prevalence of 4.0/1000 for 
schizophrenia (Saha et al., 2005). These rates were similar to an older study that 
reported an overall prevalence rate of 4.6/ 1000 (Torrey, 1987). One study 
screened members of the general population (N=8,028) for bipolar and psychotic 
disorders (including schizophrenia). The lifetime prevalence for non-affective 
psychotic disorders was 1.94%, whereas for schizophrenia alone it was 0.87% 
(Perälä et al., 2007). Another study that provided a concise overview of 
prevalence (as well as incidence rates) reported that about 7 people per 1000 
will be affected by schizophrenia during their lifetime (McGrath, Saha, Chant, & 
Welham, 2008).  
1.6.2  Incidence  
A study conducted in the UK reported that the incidence of both affective and 
non-affective psychosis was 32 per 100,000 (Kirkbride et al., 2012). A highly 
cited review reported a median incidence rate for schizophrenia being 15.2 per 
100,000 (McGrath et al., 2008). Several environmental and biological factors 
have been linked to increased incidence of psychosis. Stress – vulnerability 
models propose that psychotic symptoms emerge when the threshold of stress, 
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exceeds the persons vulnerability levels (Myin-Germeys, Krabbendam, Delespaul, 
& Van Os, 2003). Moreover, it has also been proposed that increased emotional 
reactivity (increased negative affect) to stressors is the core mechanism that 
predisposes a person to psychosis (Myin-Germeys et al., 2003). This heightened 
affective response to stress can make individuals sensitive to biological and 
environmental risk factors (Read, van Os, Morrison, & Ross, 2005; van Os, Kenis, 
& Rutten, 2010). A number of these environmental and biological factors will be 
discussed next. 
1.6.2.1 Cannabis use 
The use of cannabis has long been associated with psychosis (Moore et al., 
2007). In a longitudinal population study of 1923 individuals from the general 
population (ages 14-24), it was found that incident cannabis use predicted the 
risk of later psychotic symptoms (Kuepper et al., 2011). Furthermore, this was 
independent of a number of confounding variables such as age, childhood 
trauma and gender. A comprehensive and systematic review on this topic 
concluded that there was enough evidence to inform young people that cannabis 
use may increase their risk of psychosis later in life (Moore et al., 2007). 
Although the exact mechanisms by which cannabis use may increase risk for 
psychosis is not yet known, some research suggests that polymorphisms in the 
COMT gene are associated with greater risk of psychosis if cannabis is used 
(Caspi et al., 2005).  
1.6.2.2 Trauma  
Traumatic experiences such as child sexual and physical abuse have been 
causally linked to psychosis especially symptoms such as hallucinations (Read et 
al., 2005). This finding has been replicated in a more recent review, which also 
included a greater range of traumas as well as childhood adversities such as 
bullying (Varese et al., 2012). Potential pathways that may link trauma to 
psychosis include negative emotions, dysfunctional beliefs about the self, as well 
as biological factors such as increased reactivity to stress (Schäfer & Fisher, 
2011).  
23 
1.6.2.3  Ethnicity  
Elevated rates of psychosis have been consistently reported in people of ethnic 
minorities, especially those from African- Caribbean or African origin (Wessely, 
Castle, Der, & Murray, 1991). It has also been shown that the incidence of 
schizophrenia in non-white ethnic minorities is higher when the minority group 
form a smaller percentage of the local population (Boydell et al., 2001). This 
finding has been found in both first and second generation migrants, as well as 
those in minority groups who haven’t migrated (Bresnahan et al., 2007; Cantor-
Graae & Selten, 2005). Potential mechanisms and explanations for these findings 
are partly due to the social adversity and marginalisation that may be 
experienced by these ethnic groups (Morgan, Charalambides, Hutchinson, & 
Murray, 2010; van Os et al., 2010).  
1.6.2.4 Urbanicity  
A large number of studies have now shown that rates of psychosis are higher in 
urban areas (Kirkbride, Jones, Ullrich, & Coid, 2014). For example, in a 
longitudinal study of 4.4 million people in Sweden it was found that people living 
in the most densely populated area had a 68-77% greater risk of developing 
psychosis than those in less densely populated areas (Sundquist, Frank, & 
Sundquist, 2004).  It has also been shown that moving from an urban to a rural 
environment brings about a decrease in risk for psychosis (Pedersen & 
Mortensen, 2001). It has been suggested that this effect may be moderated by 
social factors such as marital status or single parent families (van Os et al., 
2010).   
1.6.2.5  Early biological factors  
A wide range of early prenatal factors including birth complications, maternal 
stress, viral and bacterial infections have been linked to incidence of psychosis 
(Buka et al., 2001; Hultman, Sparén, Takei, Murray, & Cnattingius, 1999). The 
evidence for these factors is not as strong as previously mentioned ones (van Os 
et al., 2010).  
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1.7 Rethinking psychosis 
Psychosis has traditionally been viewed as a categorical diagnosis- an individual 
is given a diagnosis for a psychotic disorder based on the presence or absence of 
criteria as set out in a diagnostic manual (Bentall, 2006). This is rooted in the 
early classification systems developed by Emil Kraepelin. Diagnostic manuals 
provide useful tools and guidelines for both clinical and research use, and it can 
be the route by which an individual seeks treatment for the distress they are 
experiencing. Furthermore, to some people, a diagnosis may serve as useful 
explanation for distressing, confusing or emotional experiences. However, this 
approach does not come without its criticisms and intense debate regarding 
classification is ongoing.  
The fundamental concepts of the categorical approach to defining mental illness 
include that there is a clear boundary between sick and normal, that there are 
discrete mental disorders and that these disorders have a biological basis and 
can be viewed in the same way as physical disorders (Bentall, Jackson, & 
Pilgrim, 1988). However, emerging evidence suggests that each of these 
assumptions can be challenged and cast doubts on the categorical classification 
systems.   
1.7.1 Affective v non-affective psychosis  
There has always been a divide between affective and non-affective psychoses, 
embedded within classification systems. This divide assumes that affective 
disorders (e.g. bipolar) and psychotic disorders (e.g. schizophrenia) are 
qualitatively distinct, and separate disorders (Freeman & Garety, 2003). One 
argument against a clear distinction between affective and non- affective 
psychosis is the co-morbidity across the two classes. For example, having one 
disorder e.g. schizophrenia, should mean there is an elevated risk for 
schizophrenia in the person’s family as it is a biological disease with a genetic 
basis. However, relatives of people who have schizophrenia also have elevated 
risk for other disorders such as bipolar, and the same argument holds for bipolar 
disorder (Farmer, McGuffin, & Gottesman, 1987; Greene, 2007). This has led 
some to suggest that rather than distinct, or discrete, unrelated disorders, 
25 
perhaps affective and non-affective psychosis exist on a continuum (Crow, 
1990). This distinction is also blurred by the presence of disorders characterized 
by both affective and psychotic symptoms, such as schizo-affective disorder and 
by the observations that diagnoses can change over time, and cut across the 
divide (e.g. depression developing into a psychotic disorder)(Angst, 2002). 
Furthermore, the role of emotion in psychosis has been undermined. Indeed, 
individuals with psychosis do experience affective symptoms such as depression 
and anxiety, and that these emotional experiences can be linked to their 
symptoms (Freeman, Garety, Kuipers, Fowler, & Bebbington, 2002). This has 
been long recognized and was central to Bleuler’s concepts of schizophrenia. In 
his book he argued the case that emotion is important and that the affective 
experiences of people with schizophrenia are transformed into symptoms such as 
delusions and hallucinations (Moskowitz & Heim, 2011). It has been shown that 
the presence of affective symptoms such as anxiety can precede the 
development of psychotic symptoms (Tien & Eaton, 1992) and affective 
disturbances are early symptoms reported by people who go onto develop 
psychosis (Freeman & Garety, 2003). It is interesting to also note that Kraepelin 
himself, towards the end of his career questioned the divide between neurosis 
and psychosis (Greene, 2007).  
1.7.2 Symptom structure of psychosis  
One of the other debates centres on the symptom structure of psychosis. 
Traditionally, psychosis was split on the basis of positive and negative symptoms 
(Andreasen, Flaum, Swayze, Tyrrell, & Arndt, 1990). The diagnosis of 
schizophrenia is based on scores on the Positive and Negative Syndrome Scale 
(PANSS) (Kay et al., 1987). However, over the years there have been numerous 
studies finding evidence that a two factor structure is not sufficient (van der 
Gaag et al., 2006).  In fact, studies have found 3, 4, 5, 6 and even 7 factor 
models (Emsley, Rabinowitz, & Torreman, 2003; van der Gaag et al., 2006), 
suggesting that psychosis may be defined on a broader range of symptoms. The 
most common factor structure is a 5 factor one that includes affective symptoms 
(anxiety/depression), excitability/hostility and disorganisation/cognitive 
(Lehoux, Gobeil, Lefèbvre, Maziade, & Roy, 2009).   
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1.8 Alternative Approaches  
While the discrete, categorical approach to classifying mental disorders may be 
the predominant system, it is not the only one. Alternative approaches to 
classifying psychosis are presented next.  
1.8.1  Continuum approach to psychosis 
The continuum model of psychosis suggests that rather than viewing symptoms 
as present/absent, they can be viewed on a continuum. One of the classic 
studies supporting this view was conducted by Strauss in 1969 who interviewed a 
large number of inpatients on their symptom levels. Rather than symptoms being 
simply rated as absent or present (and distressing), an additional option was 
provided, where symptoms could be rated as present but not severe or 
distressing. When given this added flexibility, it was found that many symptoms 
did not fall into clear present or absent categories, and a gradient existed. Many 
patients experienced mild forms of delusions and hallucinations suggestive of a 
continuum (Strauss, 1969). This concept has been extended to the general 
population, where it has been shown that symptoms associated with psychosis 
such as delusions, are endorsed by healthy members of the population (van Os, 
Hanssen, Bijl, & Ravelli, 2000). This model suggests that symptoms associated 
with psychotic illness lies at the extreme end of a continuum, whilst milder 
experiences can be found in people who do not have a diagnosis (van Os, 
Linscott, Myin-Germeys, Delespaul, & Krabbendam, 2009). There is considerable 
evidence for the utility of this model.  
1.8.1.1  Evidence for a psychosis continuum in the general population  
A body of evidence for the psychosis continuum comes from epidemiological 
studies. In these studies, individuals from the general population are questioned 
on their experience of Psychotic like experiences (PLE’s) through self-reported 
questionnaires, or clinician rated measures. For example, as part of the National 
Comorbidity Survey, over 5,000 members of the general population were 
screened for psychotic symptoms. Results found that 28.4% of individuals 
endorsed a PLE but only 1% were rated as having a diagnosis of schizophrenia, 
highlighting that endorsing such symptoms does not mean presence of disorder 
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(Kendler, Gallagher, Abelson, & Kessler, 1996). Another study reported that in a 
sample of 875 students, a significant proportion reported PLE’s. For example, 
28% reported hearing voices, whilst 26% reported feeling that their thoughts 
were being taken away or not their own (Yung et al., 2009). In a comprehensive 
meta-analysis a median prevalence of PLE’s was reported to be 5% (van Os et 
al., 2009). Prevalence rates can differ based on the instrument used to measure 
PLE’s, the definitions and types of samples used. It has also been shown that the 
majority of PLE’s are transitory and cause no distress to the individual, but that 
the persistence of these experiences can predict the development of psychosis 
(Poulton et al., 2000; van Os et al., 2009). Another form of evidence that 
supports the continuum approach is that PLE’s measured in such populations 
share the same risk factors as in those with psychosis. For example, a higher 
prevalence of PLE’s are reported in males, ethnic minorities and in people who 
experience stressful life events (L. C. Johns et al., 2004; van Os et al., 2009). 
Also, exposure of cannabis and other psychoactive drugs predict a higher 
prevalence of PLE’s (van Os et al., 2009). For these reasons, researchers have 
argued that individuals who report PLE’s are a valuable population to study, as it 
is likely to further knowledge about the causes and mechanisms underlying 
psychosis (Linscott & van Os, 2013).   
1.8.2 Single symptom approach 
Another alternative approach to studying psychosis is the single symptom 
approach, which is related to the continuum approach. The single symptom 
approach proposes that rather than study clusters of symptoms e.g. positive 
symptoms, single experiences should be studied. This is termed the single 
symptom or complaint orientated approach (Bentall, 2006). Evidence for this 
approach comes from factor analysis studies conducted on positive symptoms. 
These studies find positive symptoms are best represented by a number of 
underlying dimensions including paranoia and hallucinations (Armando et al., 
2010; Wigman et al., 2011). The single symptom approach emphasizes studying 
single symptoms as they are complex in nature. For example, the factors that 
underlie hallucinations may be different from grandiose ideas and what causes 
and maintains paranoia is likely to be different to the factors that cause and 
maintain a visual hallucination (Bentall, 2006), although they may share some 
28 
common mechanisms (Bentall, 2006). It has been argued that symptom specific 
models can further advance theory and treatment development (Freeman et al., 
2002). The next section is now going to narrow focus onto the most widely 
studied PLE: paranoia.  
1.9 Paranoia 
Paranoia is defined as the unfounded fear that others intend to cause the person 
psychological, physical or social harm (Freeman & Garety, 2000). Paranoid 
delusions are one of the most common delusional beliefs in people with 
psychosis (Freeman, 2007) and paranoia has been widely studied in the general 
population. Over the past few decades great gains have been made in 
understanding the nature, structure, prevalence of paranoia, and cognitive 
models have been developed (Freeman, 2007).   
1.9.1  Frequency and structure of paranoia  
Paranoid thoughts are very common in healthy members of the population. One 
study reported that 47% of a sample 324 college students reported an episode of 
paranoid thinking that involved a clear belief that someone intended to cause 
harm to them (Ellett, Lopes, & Chadwick, 2003). In a large scale epidemiological 
study in over 8,000 people, the paranoia item “Have there been times when you 
felt that people were deliberately acting to harm you or your interests?” was 
endorsed by 9% (L. C. Johns et al., 2004). In 1202 healthy individuals who 
completed an online survey about paranoid thoughts it was found that one third 
of individuals endorsed paranoid thoughts (Freeman et al., 2005). This study 
went one step further than just assessing prevalence- it also looked at the 
structure of paranoid thoughts. Paranoia was found to be arranged on a 
hierarchy with more common paranoid items being endorsed more frequently 
(e.g. concerns about social rejection) and rarer more severe paranoid thoughts 
(e.g. there is a conspiracy against me) being endorsed less frequently.  These 
infrequent and more bizarre suspicions are characteristic of people who 
experience psychosis and seem to occur in line with more common and plausible 
experiences. In other words, more serious paranoid thoughts are built upon more 
frequent suspicions and emotional concerns (Freeman et al., 2005).   
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1.9.2  Occurrence and persistence of paranoia  
A number of psychological processes have been linked to the development and 
persistence of paranoid thoughts in the general population, as well as in clinical 
samples. Emotion factors appear to play an important role, with depression, 
anxiety and worry predicting both the development and maintenance of 
paranoid thoughts (Freeman, 2007; Freeman et al., 2012). Anxiety in particular, 
shows a strong and consistent association with paranoia. This is not surprising as 
paranoia concerns anticipation of threat- a state that would cause anxiety 
(Freeman, 2007). Perceptual anomalies are also linked to paranoia. The 
presence of puzzling, odd internal experiences often precede development of 
paranoid thoughts. Examples of odd experiences may be subtle hearing changes, 
such as noises being louder than usual (Freeman, 2007). This route to paranoid 
thoughts has received little attention however, partly because it is difficult to 
measure and lack of a clear definition (Freeman, 2007). Cognitive factors have 
also been linked to paranoia. Within this domain, the most well studied factor 
has been the jumping to conclusions reasoning bias. Initially, this was 
investigated in people with psychosis who experience delusions (rather than 
paranoia specifically). Typically, in this task, individuals have to decide from 
which two jars beads have been drawn from. Both jars will contain beads of two 
colours, but in different proportions. For example, one jar will have 85 red 
beads and 15 green beads, and the other jar will have 85 green beads and 15 red 
beads. A bead is drawn one at a time and individuals can request a certain 
number before they decide which jar the beads are from. People with delusions 
request to see fewer beads and hence “jump to conclusions”(Garety & Freeman, 
1999). These findings have been extended to paranoid delusions (Moritz, Van 
Quaquebeke, & Lincoln, 2012; Startup, Freeman, & Garety, 2008). In recent 
years, sleep disturbances have also been linked to paranoia, particularly 
insomnia (Freeman et al., 2012) and it has been hypothesized that this 
relationship is mediated by negative emotion (Freeman et al., 2010).   
1.9.3  Psychological models of paranoia  
There are two main models of paranoia. The model developed by Bentall et al., 
(1994), argues that paranoid beliefs are a defence against negative emotional 
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experiences. For example, they argue that individuals, who are paranoid, have 
latent negative beliefs about themselves, which are activated by negative 
experiences. By trying to avoid this negative activation, people with paranoia 
develop external- personal attributions to prevent negative beliefs about the 
self from emerging. For example, a negative experience may be attributed to 
being planned by another person who is malicious and out to get them (Bentall, 
Kinderman, & Kaney, 1994). A key prediction from this model is that self-esteem 
levels should be normal in people with psychosis, as paranoia serves as a 
defensive function against low self-esteem. However, research has found 
inconsistent results regarding self-esteem and a trend towards lower self-esteem 
(Freeman, 2007). In contrast, the model put forth by Freeman and colleagues 
(2002) gives a direct role of emotion in paranoia. In this model, paranoid 
thoughts are conceptualised as threat beliefs, which arise as explanations for 
anomalous, unusual or puzzling experiences that the person experiences. The 
search for meaning, is influenced by both cognitive and emotional factors, and 
within the model, there are cognitive and emotional pathways to paranoid 
thoughts. In the emotional pathway, it is proposed that individuals who 
experience more negative affect, such as anxiety or depression will be more 
likely to develop paranoid interpretations of anomalous experiences (Freeman et 
al., 2002). The paranoid thoughts therefore are negatively charged and are a 
direct reflection of the person’s affective state. The cognitive pathway to 
paranoia occurs via reasoning biases such as jumping to conclusions which may 
limit the amount of information used to develop explanations. Furthermore, it is 
also proposed that cognitive and affective pathways to paranoia interact 
(Freeman et al., 2002). The strong relationship between affective states such as 
anxiety and paranoia provide support for direct relationships between emotion 
and paranoia, consistent with the Freeman model (Freeman, 2007).  
1.10 Summary of chapter 
This chapter defined and gave a historical context into psychosis. It also covered 
controversies around classification of psychosis and described alternative models 
of psychosis including the continuum and single symptom approach. These 
alternative models were applied to paranoia, which is the main symptom I focus 
on in my thesis.  
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2 An introduction to Sleep 
Sleep and wakefulness are behavioural and neurobiological states experienced 
by all human beings and mammals. Typically, humans sleep in one consolidated 
bout for around 7 hours every night. Humans spend a third of their lives asleep, 
and it is now well established that a good night’s sleep is essential for adequate 
health and wellbeing (Lockley & Foster, 2012).  
2.1 What happens during sleep? 
Sleep is not a simple passive process, it is a complex neurobiological state and a 
number of intricate changes occur when we sleep and between the transitions of 
sleep and wake. Our sleep at night is split into two main stages: non-rapid eye 
movement sleep (NREM) and rapid eye movement sleep (REM). These two stages 
alternate to form a NREM-REM cycle roughly every 90 minutes, 4-5 times a night 
(McCarley, 2007).  The proportion of NREM and REM sleep in each cycle changes, 
with higher levels of NREM during the first few cycles and an increasing amount 
of REM in the later cycles (Fuller, Gooley, & Saper, 2006). The sleep stages are 
characterised by distinct electroencephalography (EEG) patterns.  
2.1.1 Scoring of sleep  
The stages of sleep have normally been classified and scored on the manual 
developed by Rechtschaffen and Kales (Rechtschaffen & Kales 1968). This 
manual classed sleep into specific stages: wake, stage 1, stage 2, stage 3, stage 
4, REM sleep and movement time. Furthermore, stages 1, 2, 3, and 4 form NREM 
sleep, while stage 4 is classed as REM sleep. Moreover, stages 3 and 4 together 
are called slow wave sleep, which is the stage associated with deep sleep (Moser 
et al., 2009). In 2004, the American Academy of Sleep Medicine (AASM) revised 
the sleep stage scoring and this manual was published in 2007. Under the new 
guidelines, sleep stages can be scored as N1, N2, N3 (with N3 reflecting SWS, 
which were classically stages 3 and 4 under R and K scoring) or stage R for REM 
sleep (Moser et al., 2009).  
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2.1.2 NREM sleep 
Stage N1 is characterised by theta waves, and this stage is similar to being in a 
state of relaxed wakefulness. Stage N2 sleep is characterised by short bursts of 
spindle activity called sleep spindles and high amplitude and low frequency 
events known as k complexes. During this stage our conscious awareness of the 
external environment fades but we can be awoken easily. Stage N3 is referred to 
as deep sleep or slow wave sleep (SWS) and is characterised by delta waves. The 
more sleep deprived an individual is, the more time they spend in SWS (Fuller et 
al., 2006). Therefore, NREM sleep can be seen as the stage of sleep associated 
with a slowing of an individual’s body, as the breathing, heart rate and blood 
pressure falls and the sleeper becomes unaware of the external environment. 
NREM sleep takes up 75% of our sleep. Dreams from NREM sleep  tend to be 
brief, fragmented and lacking emotion (McCarley, 2007).  
2.1.3 REM sleep  
Stage R sleep is defined by the presence of desynchronised, low voltage, mixed 
frequency beta brain waves. It is also characterized by bursts of rapid eye 
movements and paralysis of the body (McCarley, 2007). REM sleep is commonly 
referred to as paradoxical sleep because the brain is highly active, but the body 
is paralysed. REM sleep comprises 25% of our total sleep time (McCarley, 2007). 
The first REM period of the night is short, but these periods become longer as 
the night goes on. REM sleep is the stage of sleep associated with vivid, bizarre 
and emotionally salient dreams.  
2.2 How is sleep/wake cycle governed?  The two process 
model of sleep/wake regulation 
The two process model of sleep/wake regulation was proposed in 1982, and it 
provides a useful framework by which to understand how the depth and timing 
of our sleep/wake cycle is controlled (Borbély, 1982). The model suggests that 
our sleep/wake cycle is governed by two mechanisms acting either in synchrony 
or in opposition to each other along the 24-hr cycle: the homeostatic process 
and the circadian process.  
33 
2.2.1  The sleep homeostat 
The homeostatic process is also called process S or our level of sleep pressure. 
Our homeostatic drive is like an hourglass, the longer we are awake, the greater 
the homeostatic drive (or sleep pressure) and the greater the likelihood of 
falling asleep. This process coincides with a decreases in cognitive performance, 
alertness and an increase in sleepiness.  Likewise, the longer we have been 
asleep, the lower the pressure to sleep and the likelihood of waking increases 
(Borbely, Achermann, Trachsel, & Tobler, 1989). One of the substrates linked to 
homeostatic control is adenosine. Increased adenosine is associated with an 
increased need to sleep, suggesting that adenosine, may be involved in the 
homeostatic control of sleep (Schwartz & Roth, 2008). The alerting effects of 
caffeine work by antagonizing adenosine receptors (Schwartz & Roth, 2008).  
2.2.2 The circadian process 
On the other hand, the circadian process, (also known as the circadian 
pacemaker or ‘master clock’) governs the timing and temporal organization of 
our sleep/wake cycle. The master clock is aptly located just above the optic 
chiasm, in a tiny region of the anterior hypothalamus called the suprachiasmatic 
nucleus (SCN). The location of our circadian clock allows it to keep track of the 
time of day based on light information via the retino-hypothalamic tract, which 
is then used to govern the timing of numerous physiological processes such as 
body temperature and the hormone melatonin, which promotes sleep. Humans 
are a diurnal species, and the circadian process promotes wakefulness by 
generating an arousal signal that increases in strength throughout the day and 
declines during the night (Dijk & Lockley, 2002). For example, when darkness 
falls our clock starts to prepare the body for sleep by increasing levels of 
melatonin and lowering body temperature which promotes sleep. As morning 
approaches, the light suppresses melatonin, body temperature rises, cortisol 
levels increase and waking occurs (Saper, Cano, & Scammell, 2005).   
2.2.3  How the model works 
The two process model states that at any given time, the degree of sleepiness 
and alertness is determined by the interacting influences of the two processes. 
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For example, in the evening it is the low circadian pressure to sleep that stops 
us from falling asleep when the homeostatic sleep drive is high. In this case, the 
two processes work against each other, which in turn ensure a consolidated bout 
of sleep or wakefulness. When the two processes work in synchrony, for example 
roughly 15 hours after wakefulness we fall asleep as both the circadian and 
homeostatic sleep drive for sleep is high (Borbely et al., 1989). More recently, 
the model has been reviewed and updated. One of these developments includes 
the emphasis on the continuous interaction between process S and C, rather 
than these two processes only interacting at sleep and wake. Another revision 
includes viewing the circadian clock as a maintainer of temporal integrity rather 
than the generator of circadian rhythms. Finally, the description highlights the 
role of energy metabolism, such that metabolic processes are modulated by the 
light/dark cycle (Borbely, Daan, Wirz-Justice, & Deboer, 2016). The 
neuroanatomical basis for the sleep wake cycle is located in the hypothalamus, 
with neurons in the ventro-lateral pre optic nucleus (VLPO) being active during 
sleep (homeostatic sleep pressure). In contrast the lateral hypothalamus 
contains populations of wake promoting ‘orexinergic neurons’ containing 
glutamate that project to arousal centres in the brain such as the brainstem 
promoting wakefulness (circadian) (Saper et al., 2005).  The two process model 
is depicted in figure 1 which depicts how process S and process C interact and 
govern our sleep/wake cycle.  
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The previous sections aimed to provide a short overview on sleep/wake 
processes, and highlight the complexity of our sleep/wake rhythm and how it is 
governed. Sleep disturbance is a broad term that can be used to describe the 
range of sleep/wake difficulties that a person may experience. Sleep 
disturbance may come in the form of symptoms such as lack of sleep, trouble 
getting to sleep or issues with the timing of sleep and wake. Sometimes 
symptoms, if severe or persistent enough can lead to the development of a sleep 
disorder. According to the International Classification of sleep disorders (ICSD, 
2014), sleep disorders can be categorised into 6 types. The categories include 
insomnia (e.g. difficulties falling asleep), parasomnias (e.g. nightmares, 
sleepwalking), circadian sleep/wake disorders (e.g. delayed sleep phase 
syndrome), disorders of hypersomnolence (e.g. narcolepsy), sleep related 
breathing disorders (e.g. sleep apnoea) and sleep related movement disorders 
(e.g. restless legs). 
2.2.5  Sleep disorders 
One of the most common sleep disorders is insomnia disorder which is 
characterised by the presence of difficulties initiating or maintaining sleep, or 
Figure 1 is taken from (Borbely and Achermann 1999). 
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reports of non-refreshing sleep that impact on daytime functioning (APA, 2013). 
Importantly, within the DSM -5 insomnia is viewed as a disorder in its own right 
that needs to be treated independently, regardless of any other co-morbid 
condition. Another common class of sleep disorders are those related to 
circadian rhythm disturbance. These disorders are characterised by a mismatch 
between a personals internal sleep/wake cycle and the external environment. 
For example, in delayed sleep wake syndrome (DSPS), individuals go to sleep and 
wake much later than they would like and this then begins to interfere with 
daily routines and commitments. Insomnia can be common symptom of DSPS as 
individuals may try to go to sleep early in order to get up for commitments such 
as word, but this goes against their internal cycle, causing difficulties getting to 
sleep (APA, 2013). Insomnia symptoms can be a common feature of other sleep 
disorders and it is important to adequately assess the nature of the sleep 
disturbance so as to provide the correct mode of treatment.   
2.2.6  Impact of sleep disturbance: survey evidence 
Sleep disturbance in general is associated with poor health and mental 
wellbeing. Indeed, a good night’s sleep is becoming rare due to the 24-hour 
society we now live in. Advances in technology mean people are constantly on 
some form of screen including phones, IPAD’s, laptops and TV’s, all of which 
have negative effects on sleep. Furthermore, businesses open later, more people 
work through the night, and these all present new challenges and pressures to 
our sleep/wake rhythm (Lockley & Foster, 2012).  Surveys conducted in the 
British public reveal some interesting insights into the sleep of Britons. The 
Understanding Society is a UK based longitudinal study  funded by the Economic 
and Social Research Council (ESRC) which is following 40,000 individuals over 
time until March, 2018 collecting a wide range of data annually on economic and 
social circumstances as well as health information 
(http://www.esrc.ac.uk/research/our-research/understanding-society-the-uk-
household-longitudinal-study/ ). Subsets of individuals have completed questions 
on sleep which is summarized in the Better of Sleep Better report (2011). 
Analysis of data from 14,000 UK households revealed that one in 10 people 
report taking sleeping medication on three or more nights a week and that 
women are more likely to report sleep difficulties. It was also found that across 
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gender and age, poor sleep was associated with poorer health 
(https://www.understandingsociety.ac.uk/research/publications/findings/early)
. The Great British Sleep Survey which started in 2012, is another similar survey, 
which is solely focused on the sleep of over 20,000 Britons.  Things that are 
keeping Britons up at night include physical features of the environment such as 
light, as well as cognitive factors such as thoughts about the future (Great 
British Sleep Survey, 2012). The survey also revealed that poor sleepers in 
comparison to good sleepers experience more fatigue, low mood, feel more 
alone and struggle to be productive.  
2.2.7 Impact of sleep disturbance: experimental evidence 
In line with subjective surveys, research has shown that sleep disruption at 
different levels has been associated with a range of adverse outcomes including 
cognitive impairment and emotion dysfunction.   
2.2.7.1  Sleep disturbances and cognition 
It has been shown that curtailment of sleep is associated with a range of 
cognitive impairments. In a meta-analysis it was concluded that sleep loss 
impairs accuracy and speed on a range of cognitive domains including attention, 
reasoning, short term memory and processing speed (J. Lim & Dinges, 2010) . 
Furthermore, sleep is actively involved in memory processing with evidence that 
the different sleep stages are linked to the processing of different types of 
memories. For example, NREM sleep has been linked to declarative memory, 
whilst REM sleep appears to have an important role in the consolidation of 
emotional memories, especially those that are negatively charged (Wagner, 
Kashyap, Diekelmann, & Born, 2007).  These findings have real world 
implications as lapses in attention and memory can be responsible for fatal 
accidents, as well as errors made my physicians (Horne & Reyner, 1995; Lockley 
et al., 2004). Some of the effects of poor sleep can be remediated by normal 
sleep, highlighting the importance of a good night’s sleep (Waters & Bucks, 
2011).  
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2.2.7.2  Sleep disturbances and emotion 
There is an intimate relationship between sleep and emotion. Consecutive nights 
of poor sleep is associated with feeling down and more easily irritated 
(Vandekerckhove & Cluydts, 2010). Under conditions of sleep loss, there is an 
increased reaction to negative stimuli (Franzen & Buysse, 2008). In a study on 
medical students it was shown that sleep loss amplified the negative emotional 
effects of a disruptive events, and decreased the positive effects of goal 
enhancing events (Zohar, Tzischinsky, Epstein, & Lavie, 2005). These findings 
also extend to the domain of emotion perception, with sleep disruption being 
linked to impaired ability to accurately rate emotions of others (Huck, McBride, 
Kendall, Grugle, & Killgore, 2008). Circadian disruption of sleep such as when 
timing of our sleep becomes disrupted is also linked to emotion.  Intuitive 
examples of this include shift work and jetlag, which most of us experience as 
some point in our lives.  But circadian disruption can also become apparent at a 
more day to day level, when our social and work/school commitments result in 
periods of sleep deprivation and light exposure at the wrong times (e.g. light at 
night). This can affect us all and is termed “social jetlag” (Roenneberg, Wirz-
Justice, & Merrow, 2003). Social jetlag and misalignment of sleep timing is 
linked to increased depression, mood fluctuations, anxiety and anger 
(Levandovski et al., 2011; Pritchett et al., 2012).  
2.3  Sleep and mental health 
So far, we have seen that the sleep-wake cycle is a complex behavioural state 
regulated in numerous aspects of the brain, and that sleep disruption is 
associated with negative outcomes. The next section will focus on sleep in 
relation to mental health.  
2.3.1  Sleep disruption in mental health disorders 
Sleep disturbance is common in a wide range of mental health conditions. The 
classic meta-analysis by Benca et al., (1992) combined the results of 177 studies, 
including 7151 patients. Across all mental health conditions there was reduced 
sleep time and poor sleep efficiency compared to controls. Sleep disruption is 
becoming recognised as an important and potential mechanism that may be 
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linked to the symptoms associated with mental health disorders (Harvey, Murray, 
Chandler, & Soehner, 2011). The strongest support so far for sleep disruption is 
in affective disorders, but sleep disruption cuts across a broad range of mental 
health conditions including psychosis (Baglioni et al., 2016; Benca, Obermeyer, 
Thisted, & Gillin, 1992).   
2.3.2  How is sleep linked to mental health disorders: the role of 
emotion? 
The mechanism that may link together sleep and its presence in mental health 
disorders is emotion, as both sleep and emotion share some common 
neurobiology. It has been shown that sleep loss leads to decreased medial-
prefrontal cortical activity and increased amygdala activation, suggesting that 
under conditions of poor sleep, our ability to regulate emotion is reduced (Yoo, 
Gujar, Hu, Jolesz, & Walker, 2007). The sleep wake cycle is governed in an 
intricate manner. During sleep neurons in the VLPO fire twice as fast, and they 
inhibit the wake promoting arousal systems through inhibitory neurotransmitters 
such as GABA and galanin (Saper et al., 2005). During wake, the ascending 
arousal system promotes wakefulness starting in the upper brainstem. The 
arousal system has multiple pathways and cell pathways that fire during wake 
and inhibit the sleep promoting VLPO including noradrenergic, serotoninergic, 
dopaminergic neurons (Saper et al., 2005). Emotion is also regulated by some of 
the same systems. For example, the amygdala is located in the forebrain and is 
involved in emotion processing and has connections with areas governing sleep 
and wakefulness. Through its connections, the amygdala not only has a role in 
emotion processing but also is involved in regulating brainstem neural 
mechanisms effecting sleep and wakefulness (Vandekerckhove & Cluydts, 2010).   
2.4 Sleep in psychosis 
The previous sections outlined that sleep disruption has negative consequences 
on functioning including an increase in mood disturbance, and that sleep 
disruption is commonly reported in psychiatric disorders. Emotion may be one 
mechanism linking sleep and psychiatric disorders. Going back over 100 years, 
sleep was acknowledged to be disturbed in people with psychosis. Severe sleep 
deprivation has been associated with inducing hallucinations and delusional 
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thoughts (Luby, Frohman, Grisell, Lenzo, & Gottlieb, 1960; West, Janszen, 
Lester, Lester, & Cornelisoon, 1962). However, it is only over the last few 
decades that sleep has been systematically investigated and thoroughly 
explored. It has been shown that disturbances of sleep are very common and 
found through all stages of the disorder and has been linked to psychotic 
symptoms including paranoia (Cohrs, 2008; Reeve, Sheaves, & Freeman, 2015).  
2.5  Integration of chapters and aims of the thesis 
Psychosis is commonly defined on the presence of positive symptoms such as 
paranoia, and within psychosis, schizophrenia is the most well studied disorder. 
It has been shown that symptoms of psychosis such as paranoia exist on a 
continuum in the normal population, and that the study of individual 
experiences can inform us about more severe forms of the disorder. In this thesis 
I focus on paranoia, and its relationship to an important correlate: sleep 
disturbance. Furthermore, negative emotionality is linked to both sleep and 
paranoia, and will be explored as a potential mechanism that could link sleep 
and paranoia together. The relationship between sleep, paranoia and negative 
emotion will be studied in both non-clinical and clinical samples (chapters 3 and 
5). Chapter 4 will present a systematic review of literature investigating sleep in 
psychosis, with a specific focus on methodology. Finally, chapter 6 explores 
clinician perceptions of sleep in people with psychosis. This final chapter aims to 
identify gaps in treating sleep in psychosis and addresses how these can be 
overcome. 
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3 Sleep quality and paranoia: The role of 
alexithymia, negative emotions and perceptual 
anomalies 
3.1  Introduction 
Paranoia is defined as the unfounded fear that others intend to cause you harm, 
is a common and distressing experience reported by many individuals with 
psychosis (Freeman & Garety, 2000). Paranoid thinking is not confined to 
psychosis, and is reported by up to 30% the general population (Freeman, 2007; 
Freeman et al., 2005). Studying symptoms like paranoia at a sub-clinical level 
can further inform our knowledge about symptoms at a clinical level in line with 
psychosis continuum models and identify candidate variables for future clinical 
research (van Os et al., 2009).  
Recent research has identified a robust link between sleep disturbances and 
paranoia. At the non-clinical level, sleep deprivation in healthy individuals lead 
to an increase in paranoid thoughts (Kahn-Greene, Killgore, Kamimori, Balkin, & 
Killgore, 2007). Another study administered the Oxford Sleep Survey which 
includes questions on sleep and PLE’s to over 1000 students. Results found links 
between a number of sleep disorder symptoms such as insomnia, nightmare 
frequency and nightmare distress and PLE’S including paranoia (Sheaves et al., 
2016). In a large –scale general population study conducted of 8,580 people, 
there were strong relationships between insomnia and paranoia. Insomnia was 
associated with an approximately two to threefold increase in paranoid thinking 
(Freeman et al., 2010). Prospectively, insomnia was also a significant predictor 
of new incidence of paranoid thoughts, suggestive of insomnia having a causal 
role (Freeman et al., 2012).  
Furthermore, treating sleep disturbance with Cognitive Behavioural Therapy for 
Insomnia (CBTi) leads to improvements in sleep, paranoia, perceptual anomalies 
and emotional variables, in both clinical and non-clinical samples (Freeman et 
al., 2017; Freeman, Sheaves, et al., 2015; Myers, Startup, & Freeman, 2011).  
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With the link between sleep and paranoia being established, the next step turns 
to identifying how sleep and paranoia are related (Reeve et al., 2015). This 
question can be addressed by mediation analysis. Mediation is a regression based 
statistical approach that allows us to identify factors that significantly explain 
the variance between our independent (sleep) and dependant variable 
(paranoia) (Hayes, 2017). These factors are termed mediators and can be useful 
in helping us identify targets for treatments, as well as helping refine models of 
paranoid thinking. 
Negative emotions such as anxiety and depression are linked to both sleep and 
paranoia (Baglioni, Spiegelhalder, Lombardo, & Riemann, 2010; Freeman et al., 
2012) and have been identified as mediators. Indeed, research has shown that 
negative emotions account largely for the relationship between sleep and 
paranoia (Freeman, Pugh, Vorontsova, & Southgate, 2009; Mulligan, Haddock, 
Emsley, Neil, & Kyle, 2016). Along with negative emotions, another emotion 
related mediator that has been studied recently is emotion regulation. One 
study found that the effect of insomnia on paranoid ideation was mediated by a 
frequent use of ineffective strategies such as expressive suppression and an 
infrequent use of effective strategies such as reappraisal. This suggests there 
may be a number of emotional processes linking sleep to paranoia (Grezellschak, 
Lincoln, & Westermann, 2015) 
Along with emotional processes, non-emotional factors such as perceptual 
anomalies may also mediate the link between sleep and paranoia (Freeman et 
al., 2010). Sleep deprivation has been known to induce perceptual anomalies 
such as hallucinations (West et al., 1962). More recently, a study showed that 
insomnia was associated with perceptual anomalies (hallucinations), even after 
controlling for negative emotions (Sheaves et al., 2016). Furthermore, 
perceptual distortions are considered central to paranoia (Freeman et al., 2002). 
No direct test of this exists although cannabis use which can induce anomalous 
experiences partially mediates the relationship between insomnia and paranoia 
(Freeman et al., 2010).  
We sought to replicate and build on some of these findings. The main aim of our 
paper is to investigate the role of alexithymia as a potential mediator. 
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Alexithymia is an aspect of emotion that is concerned with an individual’s ability 
to recognise, and verbalise their emotions (Bagby, Parker, & Taylor, 1994). 
Individuals with high alexithymia experience difficulties in identifying their 
emotions, describing their feelings, and exhibit an externally orientated style of 
thinking which can be accompanied with arousal (Bagby et al., 1994). 
Alexithymia is a relevant candidate as it linked to both sleep and paranoia. One 
study reported that that those with low levels of emotional awareness (high 
alexithymia) reported higher suspiciousness (Boden & Berenbaum, 2007). Higher 
levels of alexithymia in people with psychosis have also been reported in 
comparison to controls (Kimhy et al., 2014; van 't Wout, Aleman, Bermond, & 
Kahn, 2007). Furthermore, alexithymia is linked to a range of sleep disturbances 
including insomnia, daytime sleepiness and nightmares (Bauermann, Parker, & 
Taylor, 2008). Under conditions of sleep deprivation there is a decrease in 
emotional intelligence- a trait similar to alexithymia (Killgore et al., 2008). More 
specifically, this study reported a decrease in the intrapersonal functioning 
component of emotional intelligence which is concerned with knowing and 
understanding our feelings (Killgore et al., 2008). 
Therefore, we predicted that alexithymia mediates the relationship between 
sleep quality and paranoia, in addition to negative emotional states such as 
anxiety and depression. 
A secondary aim of our study was to test whether perceptual anomalies 
mediates the relationship between sleep and paranoia. To do so, we included a 
comprehensive measure of perceptual anomalies- the Cardiff Anomalous 
Perceptions Scale (Bell, Halligan, & Ellis, 2006).  
In study 1 we hypothesised that 1) sleep quality, negative emotions, alexithymia 
and perceptual anomalies predict paranoid thoughts and 2) that the relationship 
between sleep quality and paranoia will be mediated by negative emotions, 
alexithymia and perceptual anomalies. Study 2 was conducted to try and 
replicate the mediation model we developed in study 1.  
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3.2 Study 1: Methods  
3.2.1 Participants and procedures 
In order to recruit a large sample, and provide a safe, environment for 
volunteers to disclose paranoid thoughts, an anonymous online survey was set up 
using Qualtrics (http://www.qualtrics.com/login/). The sample was recruited 
using the University of Glasgow’s School of Psychology’s online subject pool. 
Participants were excluded from the study if they reported a diagnosed 
psychiatric/physical condition, traumatic brain injury, recreational drug use and 
were aged under 16. The online survey was available online from 2012 to 2013.  
The study was approved by the University of Glasgow, School of Psychology 
Ethics committee. 
3.2.2  Measures  
3.2.2.1 Positive and Negative Affect Schedule (PANAS) (Watson, Clark, & 
Tellegen, 1988):  
The PANAS has two ten -item subscales of positive (PA) and negative (NA) affect. 
The questionnaire has been psychometrically evaluated in non-clinical groups 
(Watson et al., 1988). The range of scores for each sub-scale ranges from 10-50, 
with higher scores meaning higher negative or positive affect. The PANAS can be 
used to assess affect on various time scales by altering the instructions. For the 
present study ‘current moment’ assessment was used. Internal consistency (α = 
.84). 
3.2.2.2  Hospital Anxiety and Depression scale (HADS) (Zigmond & Snaith, 
1983):  
The HADS is a self-report rating scale designed to measure both anxiety and 
depression over the past week. It consists of two subscales, each containing 
seven items on a 4-point Likert scale (ranging from 0-3). It is scored by summing 
the ratings for the 7 items of each subscale to yield separate scores for anxiety 
and depression. The questionnaire has been psychometrically evaluated in non-
clinical groups(Crawford, Henry, Crombie, & Taylor, 2001). Internal consistency 
(α = .82). 
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3.2.2.3 Toronto Alexithymia Scale (TAS-20) (Bagby et al., 1994).  
Has a 3-factor structure. Factor 1 assesses difficulty in identifying feelings. 
Factor 2 assesses difficulty in describing feelings. Factor 3 assesses externally 
oriented thinking. Scores range from 20-100 with higher scores reflect higher 
alexithymia. There is no timescale for alexithymia as it is measured as a trait 
factor. The questionnaire has been psychometrically evaluated in non-clinical 
groups (Bagby et al., 1994). 
3.2.2.4 Pittsburgh Sleep Quality Index (PSQI) (Buysse, Reynolds, Monk, 
Berman, & Kupfer, 1989).  
The PSQI provides a reliable, valid, and standardized measure of sleep quality. 
Scores range from 0-21 with higher scores representing poorer sleep.  A PSQI 
global score > 5 indicates that a subject is having severe difficulty in at least two 
areas, or moderate difficulty in more than three areas of sleep quality in the 
past month.The questionnaire has been psychometrically evaluated in non-
clinical groups (Mollayeva et al., 2016)  
3.2.2.5 Green Paranoid Thoughts Scale Part B (GPTS) (C. E. Green et al., 
2008).  
The G-PTS is a 16-item measure of paranoia, assessing ideas of persecution over 
the past month. Scores range from 16-80 with higher scores indicating greater 
levels of paranoid thinking. The questionnaire includes subscales for conviction, 
preoccupation, and distress. The questionnaire has been psychometrically 
evaluated in clinical and non-clinical populations.  Internal consistency (α = .92). 
3.2.2.6 Cardiff Anomalous Perceptions Scale (CAPS) (Bell et al., 2006).  
The CAPS is a 32-item questionnaire, developed in both non-clinical and 
psychosis groups, and assesses perceptual anomalies such as changes in levels of 
sensory intensity, distortion of the external world, sensory flooding and 
hallucinations.  Scores range from 0-32, higher scores mean higher endorsement 
of perceptual anomalies. For the present study the time scale was changed to 
the ‘past month’ in order to provide a more current assessment of perceptual 
anomalies. Internal consistency (α = .88). The questionnaire has been 
psychometrically evaluated in non-clinical groups (Bell et al., 2006). 
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3.3 Data Analysis and preperation 
The GPTS showed high levels of skewness, which was expected as paranoia is 
thought to lie on a quasi- continuum, whereby ‘many endorse few paranoid 
thoughts and few endorse many paranoid thoughts’ (Freeman et al., 2005; 
Verdoux & van Os, 2002). To address this we dichotomised the variable. Subjects 
with paranoia scores at the 75th percentile or above were classed as the ‘high 
paranoid’ group and those below the 75th percentile as the ‘low-paranoid’ group 
(Stopa & Clark, 2001). 
Next, linear regression models were run to test which variables significantly 
predicted paranoid group membership. Our dependent variable was paranoid 
group (0 = low paranoia, 1 = high paranoia). Forced entry and backward stepwise 
models were run to ensure reliability of results. 
Mediation analysis was conducted using the SPSS macro PROCESS (model 4) 
which uses a bootstrapping approach to mediation (Hayes, 2012). Bootstrapping 
involves creating a repeated series of representations of the population by 
resampling from the current sample to replicate the original sampling 
procedure. For the current study, we chose to set the number of bootstrapping 
samples to 10,000. In turn, these 10,000 bootstrapping samples were used to 
generate a 95% confidence interval for the mediation effect. The mediation 
effect is statistically significant if the confidence interval does not contain the 
value of zero (Hayes, 2012). For ease of interpretation, standardised values are 
presented unless otherwise stated. 
3.4  Results 
3.4.1 Descriptive statistics and correlations 
Table 3 presents all the descriptive information for the sample. A total of 401 
individuals (n= 93 males, 308 females) completed the survey with a mean age of 
24 (SD= 8.1, range 16-70). The correlations between all the variables are shown 
in table 4. Age was correlated with several our predictors including sleep 
quality, alexithymia and perceptual anomalies, therefore we included it as a co-
variate in further analysis. A series of Mann- Whitney U tests revealed gender 
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was not related to any of our variables except anxiety and depression. Anxiety 
scores were significantly higher in females (Mdn = 8) than males (Mdn = 7), U = 
11985.5, p = 0.01 and depression scores were significantly higher in males (Mdn 
= 5) than females (Mdn = 4), U = 12340.5, p = 0.04. As these differences are 
small, we chose not to include gender as a co-variate in further analysis. 
3.4.2  Logistic regression  
We first tested hypothesis 1 that sleep quality, negative emotions, alexithymia 
and perceptual anomalies predict paranoia. Descriptive statistics of the low and 
high paranoid group are presented in table 5. Mann Whitney u tests were used to 
test the validity of our grouping. Validity of our grouping was confirmed as the 
high paranoid group reported higher levels of negative affect, anxiety, 
depression, alexithymia, perceptual anomalies and paranoia. There were no 
differences in positive affect or gender.  
Next, we ran logistic regressions with the predictors entered being age, negative 
affect, sleep quality, anxiety, depression, perceptual anomalies and 
alexithymia. Results of both logistic regressions are shown in table 6. A test of 
the full model against a constant only model (no predictors) was statistically 
significant, indicating that the predictors reliably distinguished between the 
paranoid and non-paranoid groups (c2 = 69.078, p <.0.001). The Wald test was 
used to determine what predictors are significant. Significant predictors of 
paranoid group membership included negative affect, sleep quality, alexithymia 
and perceptual anomalies. Age, anxiety and depression did not significantly 
predict paranoid group membership. The log odds (Exp B) column in table 4 is an 
indicator of the log odds of being in the paranoid group due to a one point 
increase in the predictor variable. For example, a one unit increase in negative 
affect increases the odds of being in the paranoid group by 1.05, 95%CI [1.00-
1.09]. Nagelkerke’s R2of .231 indicated that 23% of the variance was explained 
by the significant predictors. Similar results were obtained in the stepwise 
logistic regression which also found that negative affect, sleep quality, 
alexithymia and perceptual anomalies predicted paranoid group membership and 
this model explained 22% of the variance (Nagelkerke’s R2of .222). In sum, two 
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separate regression models showed that negative affect, alexithymia, perceptual 
anomalies and sleep quality predicted membership of the paranoid group.
49 
Table 3: Sample demographics for study 1 (N=401) 
 Mean SD Median Range 
Age 24.08 8.15 22.00 16-70 
PSQI 6.56 3.27 6.00 0-21 
PA 24.73 8.15 24.00 11-50 
NA 15.87 6.44 14.00 10-40 
HADS-A 8.15 3.91 8.00 0-20 
HADS-D 4.59 3.28 4.00 0-19 
TAS-20 48.08 11.55 48.00 23-79 
GPTS 20.03 8.43 17.00 16-70 
CAPS 3.73 4.73 2.00 0-28 
Abbreviations: PSQI- Pittsburgh Sleep Quality Index, PA and NA- Positive and Negative Affect, 
HADS-A and D Hospital Anxiety and Depression Scale respectively, TAS-20 – 20-item Toronto 
Alexithymia Scale, GPTS- paranoia subscale of the Green Paranoid Thoughts Scale, CAPS- 
Cardiff Anomalous Perceptions Scale. 
Table 4: Spearman rho correlations for study 1. 
Measure 1 2 3 4 5 6 7 8 
1. Age         
2. PA  0.13*        
3. NA -0.12* -0.02       
4. HADS- A  0.00 -0.11* 0.47*      
5. HADS-D  0.01 -0.29* 0.42*  0.46*     
6. PSQI -0.13* -0.23* 0.24*  0.36*  0.35*    
7. TAS -0.18* -0.28* 0.27*  0.43*  0.41*  0.33*   
8. GPTS -0.13*  0.09 0.28*  0.24*  0.20*  0.19*  0.30*  
9. CAPS -0.18* -0.05 0.21*  0.29*  0.25*  0.23* -0.29 0.39* 
Abbreviations: PSQI- Pittsburgh Sleep Quality Index, PA and NA- Positive and Negative Affect, 
HADS-A and D Hospital Anxiety and Depression Scale respectively, TAS-20 – 20-item Toronto 
Alexithymia Scale, GPTS- paranoia subscale of the Green Paranoid Thoughts Scale, CAPS- 
Cardiff Anomalous Perceptions Scale. *p <0.05
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Table 5: Descriptive information of the high and low paranoid groups for study 1. 













69:226 24:82 χ2 (1)=0.02    0.49 
Age 24.59(8.66) 22.67(6.37) U= 13569    0.04 
PSQI 6.11(3.04) 7.81(3.57) U=11073 <.001 
PA 24.84(8.08) 24.42(8.39) U=15039     0.56 
NA 14.86(5.72) 18.67(7.46) U=10768 <. 001 
HADS-A 7.65(3.81) 9.55(3.87) U=11334 <. 001 
HADS-D 4.30(3.16) 5.38(3.50) U=12642 <. 001 
TAS-20 46.23(11.56) 53.25(9.85) U=10092 <. 001 
GPTS 16.60(0.95) 29.60(11.95) U=000 <. 001 
CAPS 2.77(3.53) 6.40(6.37) U=9121 <. 001 
 
Abbreviations: PSQI- Pittsburgh Sleep Quality Index, PA and NA- Positive and Negative Affect, 
HADS-A and D Hospital Anxiety and Depression Scale respectively, TAS-20 – 20-item Toronto 
Alexithymia Scale, GPTS- paranoia subscale of the Green Paranoid Thoughts Scale, CAPS- 
Cardiff Anomalous Perceptions Scale. 
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Table 6: Logistic regression of variables that predict membership of being in the paranoid 
group in study 1 
Model B(SE)  Wald Sig Exp(B) 95% CI 
Lower        Upper 
Forced Entry model      
Constant -3.85(0.82)  21.81 0.00 n/a     
Age -0.22(0.01)  1.34 0.24 0.97  0.94   1.01 
NA  0.04(0.02)  4.91 0.02 1.05  1.00   1.09 
HADS-A  0.01(0.04)  0.10 0.74 1.01  0.93   1.09 
HADS-D -0.05(0.04)  0.72 0.27 0.95  0.86   1.04 
PSQI  0.08(0.04)  4.39 0.03 1.09  1.00   1.18 
TAS-20  0.03(0.01)  6.24 0.01 1.03  1.00   1.05 
CAPS  0.10(0.02)  14.00 0.00 1.11  1.05   1.17 
Stepwise model (Backward) 
Constant -4.31(0.64)  44.90 0.00 n/a   
NA  0.04(0.01)  5.30 0.02 1.04  1.00  1.08 
PSQI  0.07(0.04)  3.86 0.04 1.08  1.00  1.17 
TAS-20  0.03(0.01)  6.96 0.00 1.03  1 .00  1.05 
CAPS  0.10(0.02)  14.36 0.00 1.11  1.05  1.17 
 
Abbreviations: PSQI- Pittsburgh Sleep Quality Index, PA and NA- Positive and Negative Affect, 
HADS-A and D Hospital Anxiety and Depression Scale respectively, TAS-20 – 20-item Toronto 
Alexithymia Scale, GPTS- paranoia subscale of the Green Paranoid Thoughts Scale, CAPS- 
Cardiff Anomalous Perceptions Scale.   
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3.4.3  Main analysis: mediation  
We next tested hypothesis 2 that the relationship between sleep quality and 
paranoid thinking is mediated by negative emotion, by alexithymia and by levels 
of perceptual anomalies. As, anxiety and depression were not significant 
predictors of paranoia in the logistic regressions, we did not include these 
variables in mediation analysis. Paranoid group (high and low) was entered as 
the dependent variable, sleep quality as the predictor variable, age as a co-
variate and alexithymia, negative mood and perceptual anomalies were entered 
as mediators. This model was significant as revealed by the bootstrapped 
confidence intervals all being above 0. The indirect (mediation) pathway from 
PSQI to paranoia via negative affect was significant b= 0.06 95%CI [0.009-0.143], 
the indirect (mediation) pathway from sleep quality to paranoia via alexithymia 
was significant b= 0.11 95%CI [0.033-0.216], the indirect (mediation) pathway 
from sleep quality to paranoia via perceptual anomalies was significant, b= 0.13 
95%CI [0.03-0.21].  Finally, the direct pathway from sleep quality to paranoia 
was significant, b= 0.26 95%CI [0.009-0.527]. Together the results support our 
hypothesis and suggest that the relationship between sleep quality and paranoia 
is partially mediated by levels of negative affect, alexithymia and perceptual 
anomalies. This mediation model is depicted in figure 2.  
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3.5 Study 2: Introduction 
In study 2 we aimed to replicate the mediation model in a second, 
independently collected data set. We hypothesised that the relationship 
between sleep quality and paranoia would be partially mediated by levels of 
negative affect, perceptual anomalies and alexithymia. 
3.6 Participants, procedure and measures 
The recruitment procedures, questionnaires and data analytical techniques used 
were identical to study 1. A separate Qualtrics survey was available online 2013-
2015. Cronbach alphas were available for the following questionnaires: TAS-20 (α 
0.85), GPTS (α 0.95), PANAS (α 0.84), CAPS (α 0.86), HADS D (α 0.74) and HADS A 
(α 0.80). 
3.7 Results 
3.7.1 Descriptive statistics and correlations 
Table 7 presents all the descriptive information for the sample. A total of 402 
(n=114 males, 288 females) individuals completed the survey with a mean age of 
24 (SD = 10.8, range 16-77). Overall, the sample from study 2 was similar to the 
sample in study 1. This was confirmed by a series of Mann Whitney U tests, 
which revealed no significant differences between the samples in study 1 and 2 
on anxiety, depression, positive affect, negative affect, sleep quality, 
alexithymia or perceptual anomalies (p>0.05). However, sample 2 (Mdn=18) 
reported slightly higher levels of paranoia compared to sample 1 (Mdn=17), 
U=62283, p=<0.001 and sample 2 were slightly younger (Mdn=20) than sample 1 
(Mdn=22), U=70386, p=0.002. The correlations between all the variables are 
shown in table 8. Age was correlated with several our predictors including sleep 
quality, alexithymia and perceptual anomalies; therefore, we included it as a 
co-variate in further analysis. A series of Mann-Whitney U tests revealed that 
gender was not associated with any of the variables in this study, all p > 0.05. 
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Table 7: Sample demographics for study 2 (N=402) 
 Mea
n 
SD Median Range 
Age 24.7
5 
10.64 20.00 17-77 
PSQI 6.24 3.01 6.00 0-16 
PA 25.4
3 
7.80 25.00 10-49 
NA 15.0
9 
5.87 13.00 10-42 
HADS-A 7.96 3.83 8.00 0-20 
HADS-D 4.19 3.04 4.00 0-17 
TAS-20 48.2
0 
11.70 48.00 22-81 
GPTS 23.2
9 
11.70 18.00 16-80 
CAPS 3.56 4.50 2.00 0-24 
 
Abbreviations: PSQI- Pittsburgh Sleep Quality Index, PA and NA- Positive and Negative 
Affect, HADS-A and D Hospital Anxiety and Depression Scale respectively, TAS-20 – 20-item 
Toronto Alexithymia Scale, GPTS- paranoia subscale of the Green Paranoid Thoughts Scale, 
CAPS- Cardiff Anomalous Perceptions Scale. 
Table 8: Spearman rho correlations for study 2. 
 
Abbreviations: PSQI- Pittsburgh Sleep Quality Index, PA and NA- Positive and Negative 
Affect, HADS-A and D Hospital Anxiety and Depression Scale respectively, TAS-20 – 20-item 
Toronto Alexithymia Scale, GPTS- paranoia subscale of the Green Paranoid Thoughts Scale, 





Measure 1 2 3 4 5 6 7 8 
1. Age         
2. PA  0.17*        
3. NA -0.13* -0.09       
4. HADS- A -0.10* -0.17* 0.48*      
5. HADS-D  0.00 -0.33* 0.29*  0.47*     
6. PSQI -0.07 -0.16* 0.24*  0.38*  0.33*    
7. TAS -0.17* -0.22* 0.25*  0.45*  0.51*  0.29*   
8. GPTS -0.17*  0.04 0.31*  0.39*  0.26*  0.17*  0.41*  
9. CAPS -0.19* -0.02 0.18*  0.29*  0.27*  0.13* -0.26* 0.45* 
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3.7.2 Mediation analysis replication 
Paranoid group was entered as the dependent variable, sleep quality as the 
predictor variable, age as a co-variate and alexithymia, negative mood and 
perceptual anomalies were entered as mediators. This model was significant as 
revealed by the bootstrapped confidence intervals all being above 0. The 
indirect (mediation) pathway to paranoia via negative affect was significant b= 
0.06 95%CI [0.012-0.1450], the indirect (mediation) pathway from sleep quality 
to paranoia via alexithymia was significant b=0.0895%CI [0.012-0.200], the 
indirect (mediation) pathway from sleep quality to paranoia via perceptual 
anomalies was significant, b= 0.08 95%CI [0.012-0.200]. However, the direct 
pathway from sleep quality to paranoia was non- significant, b=0.10 95%CI [-
0.1630-0.3813]. In sum, the relationship between sleep quality and paranoia was 
fully mediated by levels of negative affect, alexithymia and perceptual 
anomalies. This contrasts with study 1 which found partial mediation. This 
mediation model is depicted in figure 3.  


















3.7.3  Post hoc analysis 
As the mediation models were different in study 1 and 2, we sought to explore 
the data in study 2 further by running post-hoc regression analyses to see 
whether we could replicate the regression results found in study 1. The 
predictors entered were age, negative affect, anxiety, depression, perceptual 
anomalies, sleep quality and alexithymia. A test of the full model against a 
constant only model (no predictors) was statistically significant, indicating that 
the predictors reliably distinguished between the paranoid and non-paranoid 
groups (χ2 = 94.331, p < 0.0.001). The Wald test was used to determine what 
predictors are significant. Significant predictors of paranoid group membership 
included anxiety, alexithymia and perceptual anomalies. Sleep quality, age, 
negative affect and depression did not significantly predict paranoid group 
membership. The log odds (Exp B) is an indicator of the log odds of being in the 
paranoid group due to a one point increase in the predictor variable. For 
example, a one unit increase in anxiety increases the odds of being in the 
paranoid group by 1.09, 95%CI [1.00, 1.19]. Nagelkerke's R2 of 0.314 indicated 
that 31% of the variance was explained by the significant predictors. Similar 
results were obtained in the stepwise logistic regression which also found that 
anxiety, alexithymia and perceptual anomalies predicted paranoid group 
membership and this model explained 30% of the variance (Nagelkerke's R2 of 
0.30). In sum, two separate regression models showed that anxiety, alexithymia 
and perceptual anomalies predicted membership of the paranoid group. Similar 
to the mediation results, we found sleep quality did not predict paranoia. 
However, we also found that anxiety predicted paranoia rather than negative 







Previous research has found that sleep is related to paranoia and that this 
relationship is mostly mediated by negative emotions (Freeman et al., 2010; 
Freeman et al., 2009). Non-emotional factors such as perceptual anomalies have 
also been proposed as potential mediators (Freeman et al., 2010). We sought to 
add to this previous work by testing whether alexithymia is related to paranoia 
and whether it mediates the relationship between sleep quality and paranoia. 
We also sought to test the role of perceptual anomalies as a mediating factor. 
3.8.1  Sleep quality and paranoia 
 Our hypothesised mediation model proposed that the relationship between 
sleep quality and paranoia is mediated by alexithymia, negative emotions and 
perceptual anomalies. While this mediation model was found in both studies, we 
found discrepant results such that there was partial mediation in study 1 and full 
mediation in study 2. The discrepancy can be ruled out due to sample 
differences between study 1 and 2 as they did not significantly differ in levels of 
sleep quality. Furthermore, both the low and high paranoid groups in study 1 and 
2 were similar and differed on the same variables. However, our answer may lie 
in the post-hoc regression analyses conducted in study 2 which found that sleep 
quality did not significantly predict paranoid group membership. This is 
surprising as several studies have reported links between a range of sleep 
disturbances and paranoia (Kahn-Greene et al., 2007; Sheaves et al., 2016).   
The discrepancy could be due to our chosen measure of sleep. Sleep quality is a 
broad term and the PSQI measures a wide range of sleep disturbances rather 
than focus on a specific disturbance (Buysse et al., 1989). Research suggests that 
the relationship between sleep and paranoia is strongest for insomnia. Insomnia 
has been found to predict paranoia in cross-sectional studies (Grezellschak et 
al., 2015) but also predict the development of paranoid thoughts in a 
longitudinal study (Freeman et al., 2012). We propose that while sleep quality 
scores did not differ between study 1 and 2, the nature of the sleep disturbance 
may have. The participants in sample 1 may have experienced more insomnia in 
comparison to sample 2. This may have resulted in significant results in study 1 
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but not in study 2. Future research would benefit from focusing on specific sleep 
disturbances.  
3.8.2 Alexithymia and paranoia  
A novel finding in our study is the link between alexithymia and paranoia. Across 
both studies regression analyses showed that alexithymia predicted paranoia, 
independently of negative emotions, perceptual anomalies and sleep. 
Furthermore, we found some preliminary evidence that alexithymia may 
mediate the relationship between sleep quality and paranoia. This suggests that 
along with negative emotions, alexithymia is an additional emotional facet to 
consider when studying paranoia. Our emotions provide us with information on 
how we are feeling at a given moment. These emotions then help guide and 
direct us to make sense of the world, to make judgements about others 
behaviours, intentions and emotions (Boden & Berenbaum, 2007; Clore & 
Huntsinger, 2007). In alexithymia, this ability is diminished and this may make 
such individuals prone to faulty judgements and beliefs about others (including 
paranoid beliefs). This fits with a study reporting that low levels of emotional 
awareness (high alexithymia) was linked to higher levels of suspiciousness 
(Boden & Berenbaum, 2007). Another line of evidence for our claim comes from 
research looking at alexithymia and social dysfunction. One study found that 
individuals with difficulties identifying and describing feelings had significantly 
lower levels of social contacts, fewer acquaintances, and were more often 
unmarried (Kauhanen, Kaplan, Julkunen, Wilson, & Salonen, 1993). Higher levels 
of alexithymia have been reported in people with psychosis (van 't Wout et al., 
2007) and alexithymia has been linked to poorer social functioning in such 
individuals (Kimhy et al., 2014).   
The relationship between alexithymia and paranoia may have clinical 
implications. Individuals with psychosis who also experience alexithymia may be 
at risk of experiencing greater paranoia but struggle to convey their concerns to 
others. They may also experience lower levels of trust towards their clinicians. 
As such, their responses to treatment may be poorer (Gumley, 2011). Assessing 
alexithymia may be useful in clinical practise to identify individuals who may 
require support to understand and regulate emotions. This could be achieved in 
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clinical practice by including an assessment of alexithymia by using 
questionnaires such as the Toronto Alexithymia Scale. When individuals with 
alexithymia are identified, a focus on their emotional experiences could be 
incorporated into their CBT approach to sleep. 
3.8.3  Negative emotions and paranoia 
Across both studies we found that negative emotions predicted paranoia and 
mediated the relationship between sleep quality and paranoia. Negative 
emotions have been linked to paranoia in both cross-sectional and longitudinal 
studies (Freeman et al., 2010; Freeman et al., 2012). In particular, anxiety has a 
strong association with paranoia as they share many features such as the 
anticipation of threat and a worry reasoning style. The presence of perceptual 
anomalies differentiates anxiety from paranoia (Freeman, 2007).   
However, we found discrepant results in regards to what negative emotion was 
significant, with study 1 finding that negative affect predicted paranoia whilst in 
study 2 it was anxiety. Depression did not predict paranoia in either study. One 
of the reasons for this may be because the samples in our studies had low levels 
of depression overall. 
The HADS provides scoring criteria, with scores of 0–7 being normal, 8–10, being 
borderline and more than 11 being clinically significant levels (Zigmond & 
Snaith, 1983). In both samples, the mean depression scores in the low and high 
paranoid groups fell in the normal range. This may be why depression was not a 
significant predictor in our regression analyses. In contrast, our measure of 
negative affect was measured with the PANAS, which was developed to measure 
a range of affective states (Watson et al., 1988). The negative affect component 
covers a range of states such as jittery, guilt and ashamed and is a measure of 
overall distress rather than a specific type of negative emotion (Watson et al., 
1988). These differences between measures may have contributed to the 
discrepant results. It is also worth noting that the timeframe of the 
questionnaires differed and may be another reason behind the different results. 
The HADS timeframe is the past two weeks, whereas the PANAS was measured at 
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the “current” level. The current timeframe captures momentary states which 
would experience more fluctuation than fortnightly levels. 
3.8.4 Perceptual anomalies and paranoia  
A consistent finding across both studies was that perceptual anomalies predicted 
paranoia and mediated the relationship between sleep quality and paranoia. It 
has been long proposed that delusions serve as explanations for odd or strange 
internal experiences (Maher, 1974). Furthermore, perceptual anomalies are 
incorporated within a cognitive model of paranoid delusions, where paranoid 
beliefs arise from an attempt to explain anomalous and odd internal experiences 
(Freeman et al., 2002). Indeed, research has shown that perceptual anomalies 
increase the risk for the development of delusional ideas (Krabbendam et al., 
2004) and anomalies of experience caused by illegal drug use have also been 
linked to delusional ideation (D’Souza et al., 2005). Our mediation model 
suggests that individuals experiencing sleep problems may also experience an 
increase in perceptual anomalies which then leads to the development of 
paranoid thoughts. 
3.8.5  Summary of findings 
Taking all the mediation and regression results together, we can conclude that 
alexithymia, perceptual anomalies and negative emotions predict paranoid 
thoughts. The role of sleep quality is not clear, and our mediation model 
requires replication. In regards to effect size, our results were significant but 
small. For example, our regression models explained between 22–31% of the 
variance and many of the mediation effects could be considered small as they lie 
between 0.10 and 0.20 (Cohen, 1992). Although small, we feel they are clinically 
significant. A recent trial has found that improving sleep disturbance with CBTi 
in a student sample was associated with medium to large, sustained 
improvements in paranoia (Freeman et al., 2017). Furthermore, another study 
has found that the relationship between sleep loss (as found in insomnia) is 
associated with moderate to large effect size increases in paranoia and negative 
emotions. This study also found that negative affect accounted for 90% of the 
increase in paranoia after sleep loss (Reeve, Emsley, Sheaves, & Freeman, 
2017). This highlights the usefulness of studying sleep and paranoia in non-
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clinical samples, and that effects can be detected in non-clinical samples. This is 
complemented by work in clinical samples where CBTi is associated with large 
effect size reductions in sleep disturbance (Freeman, Waite, et al., 2015) and in 
paranoia, perceptual anomalies and mood variables (Myers et al., 2011). One 
potential reason for our small effect sizes in comparison to these papers is that 
they focused on insomnia, whereas we looked at sleep quality. It may also be 
the case that the effects we found in our mediation analysis would be larger and 
more exaggerated in a clinical sample who experience more severe sleep and 
mood disturbance.   
3.8.6  Limitations 
Several limitations of our study should also be noted when considering the 
results. Our study was cross-sectional and it is highly likely that the mediation 
model pathways proposed are interacting and bi-directional over time. 
Furthermore, the timeframe of our questionnaires also differed. The PANAS was 
measured at the moment level, whilst sleep quality and paranoia at the monthly 
level. Therefore, hypothesised causal links between variables should be 
interpreted with caution. To tease out causal effects experimental and 
randomised control trials are called for. Another way to look at causal effects 
could be to conduct experience sampling studies (Myin-Germeys et al., 2009). 
This approach allows temporal mapping of relationships and questions of 
directionality can be addressed. A recent study using this methodology found 
that the relationship between a range of sleep parameters and paranoia was 
mediated by negative affect (Mulligan et al., 2016).  
The sample population was predominantly university students that may not be 
representative of the general population. However, students are one population 
that may experience higher levels of psychotic like experiences such as paranoia 
(Lincoln & Keller, 2008) suggesting that this is a useful population to study 
psychotic experiences in. The gender ratio of the sample was skewed with the 
majority of the sample being females. This is a finding that has been noted in 
other online survey studies of paranoia (Freeman et al., 2005). However, as 
there is some research to suggest that males may experience more alexithymia 
(Levant, Hall, Williams, & Hasan, 2009) future studies should aim for more 
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gender-balanced studies. All our variables were skewed which could have 
reduced power and the ability to detect certain relationships (Wilcox & 
Keselman, 2003). However, we dealt with the skewed data in a number of ways 
including bootstrapping making our results more reliable and robust. Another 
limitation is that all our measures were self-report and required the individual to 
accurately report their responses. The questionnaire assessment of paranoia has 
the additional limitation that it may capture paranoid thoughts that are justified 
suspicions to real threats. Nonetheless, laboratory based virtual reality 
experiments where unfounded paranoia can be tested have reached the same 
conclusions as questionnaire studies of paranoid thinking in non-clinical 
populations (Freeman et al., 2003). 
We used the same recruitment method in sample 1 and 2 and have no way to 
know whether some participants completed the survey in both study 1 and 2. 
However, given that there is no incentive to complete the survey and that the 
survey is long and extensive, we feel it is unlikely that someone would complete 
the survey twice. 
Finally, a concern may be whether the findings in non-clinical samples are 
generalizable to a clinical sample. However, it is now widely accepted that 
psychotic symptoms lie on a continuum with normal experience, that non-
clinical and clinical symptoms share the same risk factors and the presence of 
non-clinical experiences increase the risk of clinical disorder (L. C. Johns et al., 
2004; van Os et al., 2009).  
3.8.7  Conclusions 
In conclusion, we found inconclusive evidence for a link between sleep quality 
and paranoia. The current research also emphasises that alexithymia and 
paranoia are related. Alexithymia can easily be assessed and should be 




4 A systematic review of sleep in people with non-
affective psychosis: a methodological review 
4.1 Introduction 
Sleep is essential for adequate mental health and well-being, and occupies a 
third of the human lifespan (Baglioni et al., 2016). Sleep disturbances have long 
been associated with psychosis.  (Reeve et al., 2015). Depending on the severity 
of the illness, sleep disturbances are found in as many as 80% of patients (Cohrs, 
2008). One of the key findings is that regardless of illness stage, medication 
status or severity of illness, a range of sleep/wake disturbances are reported 
(Chouinard, Poulin, Stip, & Godbout, 2004; Mulligan et al., 2016; Reeve et al., 
2015). Importantly, sleep is recognised by individuals themselves as an important 
treatment target and an important part of recovery (Auslander & Jeste, 2002; 
Waite, Evans, et al., 2016).  
4.1.1  Sleep disruption 
Sleep disruption is a broad term, and can encompass aspects of sleep on many 
different levels. Within the context of our review we view sleep disruption as a 
term that includes abnormalities in subjective or objective sleep, in the form of 
symptoms or disorders.  
4.1.2  Sleep disorders 
Sleep/wake difficulties can be roughly classified into 6 types according to the 
International Classification of Sleep Disorders (American Academy of Sleep 
Medicine;AASM, 2005). The 6 categories include insomnia (e.g. difficulties falling 
asleep, maintaining sleep), parasomnias (e.g. nightmares, sleepwalking), 
circadian sleep/wake disorders (e.g. delayed sleep phase syndrome), disorders 
of hypersomnolence (e.g. narcolepsy), sleep related breathing disorders (e.g. 
sleep apnoea) and sleep related movement disorders (e.g. restless legs). There is 
evidence for elevated levels for a number of these sleep disorders in people 
diagnosed with non-affective psychosis (NAP). The most well studied sleep 




population (American Psychiatric Association; APA, 2013). In people with NAP 
the rates are more than double with estimates ranging from 27-52% of (Freeman 
et al., 2009; Palmese et al., 2011; Xiang et al., 2009b). Sleep apnoea is another 
sleep disorder with elevated rates estimated to range from 20-57% compared to 
psychiatric and healthy controls (Myles et al., 2018; Takahashi et al., 1998; 
Winkelman, 2001). There is also some evidence that nightmare disorder is 
reported in as many as 55% of patients (Sheaves, Onwumere, Keen, Stahl, & 
Kuipers, 2015). Clear prevalence estimates are not available for circadian 
rhythm disorders or hypersomnia. However, there is evidence that symptoms 
associated with these disorders are present in people with schizophrenia 
(Hawley, 2006; Hawley et al., 2010; Wulff, Dijk, Middleton, Foster, & Joyce, 
2012).  
4.1.3  Sleep disturbances 
Apart from sleep disorders, a range of other sleep difficulties have been 
reported in people with NAP. Disturbances of sleep continuity have been 
reported such as decreased total sleep time (TST), decreased sleep efficiency 
(SE), increased sleep onset latency (SOL) and increased wakefulness during the 
night (WASO)(Chouinard et al., 2004). Regarding sleep architecture, reductions 
in REM sleep latency, REM density and slow wave sleep have been reported by 
some authors (Poulin, Daoust, Forest, Stip, & Godbout, 2003; Yang & 
Winkelman, 2006), but not all (Chouinard et al., 2004; Lauer, Schreiber, 
Pollmacher, Holsboer, & Krieg, 1997). Some of the circadian disturbances 
reported in individuals include fragmented sleep/wake rhythms, irregular and 
delayed sleep patterns, increased daytime napping, delayed and blunted 
rhythms of melatonin (Bromundt et al., 2011; Monteleone, Maj, Fusco, Kemali, & 
Reiter, 1992; Monti et al., 2013; Wulff et al., 2012). Furthermore, there is also 
evidence that people with NAP reported subjectively poorer sleep quality, and 




4.1.4 The measurement of sleep 
Numerous methodologies exist to assess and quantify sleep disturbance. These 
methods can be broadly split into two categories: subjective (questionnaires and 
sleep diaries) and objective (polysomnography, actigraphy). Each method has its 
own advantages and disadvantages which are summarised in table 9. 
4.1.4.1 Objective assessment 
The gold standard assessment of sleep is polysomnography (PSG). PSG is most 
often conducted in a sleep lab, but ambulatory monitoring can be done (McCall, 
Erwin, Edinger, Krystal, & Marsh, 1992). PSG normally involves the simultaneous 
monitoring of electronic brain activity (EEG), muscle tone (EMG) and eye 
movements (EOG). Breathing flow and oxygen can also be recorded 
(oximetry)(Sadeh, 2011). A wide range of sleep parameters can be assessed and 
measured with PSG including sleep architecture, sleep stages, brain activity, eye 
movements and arousals. With the detailed information from PSG, sleep 
disorders can be accurately diagnosed (Sadeh, 2011). Recent advances in PSG 
include spectral analysis which looks at sleep microstructure (Poulin, Stip, & 
Godbout, 2008), and cyclic alternating pattern which looks at sleep instability 
(Ozone, Kuroda, Aoki, Manabe, & Itoh, 2013). When interpreting and assessing 
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sleeping in a unique environment such as in the sleep lab which is not 
representative of natural sleep environments. Furthermore, it is costly, and 
requires overnight (often multiple nights) in a sleep lab and requires a trained 
sleep technician to score the data. It is also unable to capture daytime sleep 
episodes or to capture the day to day and night to night variability of sleep 
(Sadeh, 2011).  
On the other hand, actigraphy is a method more suited to capture sleep and 
circadian rhythms. Actigraphy is a watch like device worn on the non-
dominant wrist, which uses an accelerometer to record movement (Ancoli-
Israel et al., 2003). These movement counts can be used to indirectly measure 
sleep/wake patterns. Actigraphy has the advantage of assessing both day and 
night time sleep across several days or weeks, and being worn in the 
participant’s natural environment. Often the participant can also press a 
button called an event marker which is pressed when the participant goes to 
bed and wakes up, to accurately record sleep/wake times. Data from the 
actiwatch are downloaded and scored with the manufacturer’s software and 
algorithms to score sleep and wake. Some actiwatches also incorporate light 
information to complement movement data. One of the limitations of 
actigraphy, and especially relevant to clinical samples is that it can be 
difficult to distinguish quiet rest from sleep, which may produce biased sleep 
estimates (Paquet, Kawinska, & Carrier, 2007). Often, sleep logs are also 
completed along with actigraphy to allow the researcher to score the data 
more accurately (Sadeh, 2011). Furthermore, actigraphy cannot be used to 
diagnose or screen for sleep disorders and it cannot provide information on 
sleep architecture (Sadeh, 2011).   
4.1.4.2  Subjective assessment 
Questionnaires are commonly used as they allow a quick assessment of sleep. 
A range of sleep questionnaires exist, each focused on specific aspects of 
sleep. The Pittsburgh Sleep Quality Index (PSQI) is the most widely used self-




month (Buysse et al., 1989). Other questionnaires include those to assess 
daytime sleepiness such as the Epworth Sleepiness Scale (M. W. Johns, 1991). 
Specific sleep disorders such as insomnia can be assessed with the Insomnia 
Severity Index (ISI) (Morin, Belleville, Bélanger, & Ivers, 2011) and assessment 
of chronotype by the Morning-Eveningness Questionnaire (MEQ) (Horne & 
Ostberg, 1976). Questionnaires have the advantage of being quick and easy to 
administer, as well as being cheap. However, questionnaires are retrospective 
and do not allow variability of sleep to be reliably measured. More in depth 
subjective sleep assessments include the sleep diary which allows evaluation 
of sleep over numerous days (Carney et al., 2012). As sleep diaries are 
prospective, they reduce memory biases (Carney et al., 2012). Furthermore, 
sleep diaries can allow the assessment of additional variables that provide 
rich, detailed information about sleep, such as napping, nightmare frequency 
and distress. However, they require a level of commitment from participants, 
who must remember to complete the sleep diary daily.  
4.1.5 The current review 
A number of reviews currently exist, that have examined the association of 
sleep disturbances and impact on functioning, including symptomology 
(Barton, Kyle, Varese, Jones, & Haddock, 2018; Davies, Haddock, Yung, 
Mulligan, & Kyle, 2017; Reeve et al., 2015). However, a methodological 
review is missing. In this review we intend to provide a clear overview and 
evaluation of the methods used to assess and measure sleep in non-affective 
psychosis (NAP). The key questions that we ask in this review are what 
methods have been used to assess sleep in people with NAP and what are 
some of the areas of bias within these methods? Furthermore, we also seek to 
evaluate what aspects of sleep are disrupted in NAP, but in the context of the 
various methods and their limitations. More specifically we focus on 4 main 
sleep outcomes: sleep onset latency, total sleep time, sleep efficiency and 
wake after sleep onset (sleep continuity measures). We focus on these 
measures as they can be calculated by all sleep methodologies; actigraphy, 




made across methods. Secondary outcomes that we consider include those 
specific to each sleep methodology. Tables (10 and 11) provide definitions of 
the common sleep outcomes used. Within this review we focus on NAP which 
includes conditions such as schizophrenia.  It is hoped that a comprehensive 
review and evaluation of the methods used to assess sleep will complement 
findings in other reviews, and guide future research and research agendas.  
Table 10 Sleep continuity outcomes 
Sleep variable Definition  
Sleep Onset Latency (SOL).  Time taken to fall asleep  
Total Sleep Time (TST). Total time spent asleep 
Sleep Efficiency (SE). Percentage of time in bed 
spent asleep  
Wake After Sleep Onset 
(WASO).  
The duration of wake during 
the night 
 
Table 11 Sleep architecture outcomes 
Sleep variable Definition  
Stage 1  Duration of stage 1 sleep presented in 
minutes or as a percentage of overall sleep. 
Stage 2  Duration of stage 2 sleep presented in 
minutes or as a percentage of overall sleep. 
Stage 3 Duration of stage 3 sleep presented in 
minutes or as a percentage of overall sleep. 
Stage 4 Duration of stage 4 sleep presented in 
minutes or as a percentage of overall sleep. 
Slow Wave Sleep Amount of non-REM sleep stages 3 and 4 (also 
known as delta sleep) 
REM sleep Duration of REM sleep presented in minutes or 
as a percentage of overall sleep. 
REM latency The interval between sleep onset and the 
onset of the first REM sleep period. 




The protocol and data extraction was conducted according to the 2009 





4.2.1  Search and selection of studies 
A search was carried out on Medline, Psychinfo and Web Of Science. Search 
terms included: Schizophrenia/Psychosis/psychotic disorder AND sleep or 
sleep disorders or circadian rhythms or actigraphy or polysomnography or 
sleep EEG. Appendix 2 contains the search terms in more detail. To enhance 
search sensitivity we conducted journal searches and examined the references 
of published articles for any additional references.  We also contacted authors 
about any studies they are currently conducting or writing up that could be 
eligible for the systematic review. 
Eligibility assessment for each study was conducted by AR, who screened each 
paper by examining the title and abstracts. After the initial screening of titles 
and abstracts, full texts were examined based on the exclusion 
criteria/inclusion criteria by AR. Where there was uncertainty, advice was 
sought from the co-authors (AG, SB) and a joint decision was made. After 
selection of studies based on inclusion/exclusion criteria, AR completed a risk 
of bias assessment of each study (see sections below). Bias assessment was 
also conducted by another person to check reliability of scoring and validate 
further the bias assessment tool. Disagreements were resolved with mutual 
agreement.  
4.2.2  Inclusion and exclusion criteria  
Inclusion criteria: (1) at least one of our primary sleep outcomes (sleep onset 
latency, wake after sleep onset, total sleep time and sleep efficiency), (2) 
study must report the sleep outcome values for the whole sample (3) 
participants who experience non-affective psychosis (4) studies published 
between 1953 (which is when REM sleep was discovered and polysomnography 
studies in sleep started) and 2017, and (5) studies written in English. Exclusion 
criteria: 1) non-clinical/analogue studies, (2) qualitative data, (3) single case 
studies, (4) at risk for psychosis studies, (5) studies in children, (6) conference 




If there were multiple papers published by the same research group using the 
same sample, we selected the most relevant paper for the review. Typically, 
this meant we selected the paper that included the most information about 
sleep. If it was unclear whether publications from a research group used the 
same sample, we emailed the authors to clarify independence of the samples. 
If the authors did not respond, we selected the one paper that was most 
suitable for the review, for example the paper with the most sleep 
information.  
4.2.3  Bias assessment  
In line with the guidelines in the PRISMA statement and in the Cochrane 
handbook for systematic reviews we assessed included studies on their risk of 
bias (Liberati et al., 2009). For the purpose of our review we chose to use a 
modified version of the QUADAS-2 tool(Whiting et al., 2006). The QUADAS-2 
includes a risk of bias judgement (high, low, or unclear) on 4 key domains: 
patient selection, index tests, reference standard and flow and timing. We 
refined the tool to fit with our systematic review, including a methodological 
component to rate each of the sleep methods used. A description of the 
development and piloting of the Risk of Bias tool is described in Appendix 1. 
Table 12, gives a brief overview of the components each study was rated on.  
Table 12  Brief overview of risk of bias components rated in studies 
Component 1: Patient Selection 
Component 2: Baseline characteristics  
Component 3: Actigraphy (Length of recording + distinguishing quiet 
rest from sleep)  





Component 5: Subjective sleep : ( Use of validated measures) 
Component 6: Power 
Component 7: Missing data 
Component 8: Completion rates  
Component 9: Data analysis  
 
4.2.4  Data extraction 
Information that was extracted from each study included: 1) characteristics of 
the participants, (sample size, age, gender, method of diagnosis, and 
medication status), 2) the study design, 3) country research was conducted, 
4) the methods used to assess sleep and 5) the tools used to diagnose 
psychosis. In studies that examine the influence of medications on sleep 
outcomes, we extracted the baseline sleep information, as our primary focus 
is on sleep, not changes in sleep with medications. 
4.3 Results 
A total of 2333 papers were identified through our search including databases 
and other sources. After removing duplicates 2215 papers were screened on 
the basis of their titles and abstracts. Of these, 1949 were excluded leaving 
266 papers to be evaluated based on the full article. Of these 266 papers, 209 
were excluded, leaving 57 studies included in our review. See figure 4 for a 




4.3.1  Sleep methodologies 
From the 57 papers included in the review 8 papers used actigraphy as their 
primary measure of sleep, 6 papers used subjective assessment as their 
primary measure of sleep and 39 papers used polysomnography as the primary 
measure of sleep assessment. Four papers  presented sleep data for more 
than one method: Bian et al (2016) used polysomnography and subjective 
assessment, Rotenberg et al., (2000) used polysomnography and subjective 
assessment, Wamsley et al., (2012) used polysomnography and actigraphy as 
sleep assessment measures and Mulligan et al., (2017) used actigraphy and 
sleep diary measures. For the purpose of this review the studies will be split 
into their method of assessment- subjective, actigraphy or polysomnography.   
4.3.1.1 Subjective assessment 




Figure 4 Flowchart of selection of studies  
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Additional records identified 
through other sources  
(n = 630) 
Records after duplicates removed  
(n= 2215) 
Records screened  
(n =2215) 
Records excluded 
n = 1949 
Full-text articles assessed 
for eligibility  
(n = 266) 
Full-text articles excluded (n=209)  
Didn’t have required sleep 
parameters (n = 79) 
Didn’t present data for whole 
sample (n=18) 
Not in non-affective psychosis (n=9) 
Overlapping sample (n=44) 
Conference abstract (n=27) 
Other (n=31) 
 
Studies included in 
qualitative synthesis  




In terms of design, all were cross-sectional, except for one randomised 
control trial (Bosch et al., 2016). All patient groups were medicated, 4 studies 
were conducted in inpatients, 4 in outpatients, and 1 did not clarify patient 
status. Five studies included a control group, while 4 studies only had a 
patient group. The average sample size in subjective studies was 150. The 
median age of the sample across the studies was 42.0. In terms of gender, 
there were more males in the sample with an average ratio of 87:68 (average 
% males = 55). Three studies used a validated measure to assess sleep, the 
PSQI (Bosch et al., 2016; Yamashita et al., 2004) or the Carney sleep diary 
(Mulligan et al., 2016). All other papers used their own questions/interview, 
which are outlined in table 13.  
4.3.1.2  Sleep continuity  
There was a surprising lack of data on our sleep continuity measures. Of the 9 
papers included in the subjective assessment, 1 study found an increased SOL 
compared to controls (Poulin et al., 2010), and one study found no difference 
compared to both healthy and psychiatric controls (Bosch et al., 2016) while 
the other 7 studies did  not report SOL. In terms of TST, one study reported 
increased TST compared to controls (Poulin et al., 2010) one study found no 
difference between psychiatric and healthy controls (Bosch et al., 2016), 
whilst the other studies did not report TST. WASO was not reported as an 
outcome in any of the studies except one, finding no difference between 
patients, psychiatric controls and healthy controls (Bosch et al., 2016). In 
regards to SE, only one study reported it, finding no difference between 
patients and healthy controls (Poulin et al., 2010). These findings are 
summarised in table 14.  
4.3.1.3 Other sleep outcomes 




Table 13: Overview of subjective studies included  
Study Country Design Sample Age 
Mean (SD) 
Gender 











Bian, 2016* China Cross-sectional N=148 
Schizophrenia 
inpatients 




1 What time 
did you go to 
bed last night? 
2 How long did 
it take you to 
fall asleep last 
night? 
3 What time 
did you wake 
up this 
morning? 
4 How long do 
you think that 












TST and SE but 
underestimate
d SOL.  


































sleep?” 5. “Did 
you feel 
exhausted?”, 



























Hou, 2016 China Cross-sectional N=623  
Schizophrenia 
outpatients 
47.7(10,3) 341:282 All medicated 
during study 
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43.5% as long 
sleepers.   
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37.4(10.4) 13:9 Medicated Carney Sleep  
Diary- 
measured  SE, 




















































































































DSM-IV In comparison 
to controls, 
the patients 
had a longer 
SOL, TIB, TST 






















Israel Cross-sectional N= 20 
Schizophrenia 
patients 























DSM-IV Patients had 
longer SOL 
than HC, but 
no diffs on 
TST, or SE.  
Yamashita,20
04 



















lower SOL and 
higher SE.  





Table 14: Sleep continuity in subjective studies 
 SOL TST WASO SE 
Bian, (2016) - - - - 
Bosch, (2016) n/s n/s n/s - 
Hou, (2016) - - - - 
Muller, (2016) - - - - 
Mulligan, (2017) - - - - 
Okruszek, (2014) - - - - 
Poulin, (2010) Longer in 
people with 
schizophrenia 






Rotenberg,(2000) - - - - 
Yamashita, 
*2004) 
- - - - 
 




















Bian, 2016        
Bosch, 2016        
Hou, 2016        
Muller, 2016        
Mulligan,2017        
Okruszek, 
2014 
       
Poulin,  2010        
Rotenberg, 
2000 
       
Yamashita,  
2004 




4.3.1.4  Bias assessment 
See table 15 for table that conveys the risk of bias for each of the studies. 
Red dots represent high risk of bias, green represent low risk of bias and 
amber represents unsure about risk of bias. Across the subjective studies the 
two components with most studies at risk of bias was subjective sleep 
assessment and baseline characteristics. Across the subjective studies there 
were two areas identified as risk of bias. In the subjective sleep component 
(6/9 studies, 67%) were rated at risk or bias or unsure because they did not 
include validated measures of sleep. In the component of baseline 
characteristics (6/9 studies, 67%) were rated as risk of bias or unclear due to 
not having a control group or there being differences between controls and 
patients (e.g. age) that are not controlled for in the analysis.   
4.3.2  Actigraphy assessment 
4.3.2.1 Description of studies 
In terms of design, all were cross-sectional. All patient groups were 
medicated. Eight studies were conducted in outpatients, 1 in inpatients and 1 
used a mixture. The average sample size across the studies was 39. The 
median age of the sample across the studies was 42. In terms of gender, there 
were more males in the sample with an average ratio of 25:13 (average % 
males = 70). Actigraphs by various manufacturers were used to assess sleep 
and circadian rhythms. In three studies, the actiwatches also included light 
sensors (Afonso, Figueira, & Paiva, 2014; Martin, Jeste, & Ancoli-Israel, 2005; 
Wulff et al., 2012). See table 16 for overview of all the studies.  
4.3.2.2  Sleep continuity  
Of the 10 papers included in the actigraphy assessment, 4 reported a longer 
SOL in comparison to healthy controls, 1 reported a shorter SOL compared to 
controls, whilst 5 did not report on SOL. In terms of TST, 6 studies reported a 
longer TST, compared to healthy controls, whilst 4 studies did not report TST. 




compared to healthy controls, and one finding no differences. In regards to 
SE, findings were mixed, one study reported lower SE compared to controls, 
and one study reporting higher SE. Three studies did not find significant 
differences between patients and healthy controls on SE, and 5 studies did 
not report SE. See table 17 for an overview of sleep continuity outcomes in 
actigraphy studies.  
4.3.2.3  Other sleep outcomes 
See table 16 for descriptions and additional outcomes of each study.  
4.3.2.4  Bias assessment 
See table 18 for table that conveys the risk of bias for each of the studies. 
Red dots represent high risk of bias, green represent low risk of bias and 
amber represents unsure about risk of bias. Across the actigraphy studies 
there were two areas identified as risk of bias. In the patient selection 
component (4/10 studies, 40%) were rated at risk or bias because they did not 
include enough information about patients e.g. inclusion/exclusion criteria 
not stated. In the component of actigraphy (4/10 studies, 40%) were rated as 
risk of bias due to not having multiple days or recording, or not including 
measures or criteria to distinguish between quiet rest and sleep.   
4.3.3  Polysomnography assessment 
4.3.3.1 Description of studies 
Overall, there were 42 studies included in our PSG section. The median age of 
the sample across the studies was 30.2. The average sample size across the 
studies was 19. In terms of gender, there were more males in the sample with 
an average ratio of 13:6 (average % males = 70).The vast majority (n=35) were 
cross-sectional designs, often comparing the patient group to a control group 
on sleep variables. There were 7 treatment studies, of which 6 looked at the 
effects of anti-psychotics on sleep. Three studies looked at clozapine (Hinze-




2001; Tsekou et al., 2015), 1 study looked at olanzapine (Salin-Pascual, 
Herrera-Estrella, Galicia-Polo, & Laurrabaquio, 1999), 1 study looked at 
chlorpromazine (Kaplan, Dawson, Vaughan, Green, & Wyatt, 1974) and 1 
study looked at  haloperidol vs thiothixene (Maixner et al., 1998). One study 
looked at the effects of bromocriptine, a dopamine agonist on sleep 
parameters (Brambilla et al., 1983). The medication status amongst the 




Table 16: Summary of actigraphy studies included in the review  
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All medicated Actigraphy- Model #24.000, 
Ambulatory Monitoring Inc 
21 days 
PSQI DSM-IV-TR Only 7 patients 
agreed to wear 
actigraphy. 
Patients had 
short TST than 
controls. 
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37.4(10.4) 13:9 Medicated Actigraphy (CamNtech) for 7 
days 
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SOL, more TST, 
more variation, 
and later wake 
time V NC. Two 
subgroups could 
be found, one 
group with 
earlier bed and 
wake time and 
hypersomnia 
and a second 
with delayed 
sleep pattern.  
 
Table 17: Sleep continuity outcomes for actigraphy 
 SOL TST WASO SE 
Afonso, (2013) Longer in SCZ Longer in SCZ - Lower in SCZ 
Bromunt,(2012) - - - - 
Fang, (2016) Longer in SCZ Longer in SCZ n/s Higher in SCZ 
Reshe, (2013) - - - - 
Hofstetter, 
(2005) 
Shorter in SCZ - - - 
Martin, (2005) - Longer in SCZ Higher in SCZ - 
Mulligan, 
(2017)* 
- - - - 
Wamsley, 
(2012) 




Waters, (2011) Longer in SCZ Longer in SCZ - n/s 
Wulff, (2012) Longer in SCZ Longer in SCZ - n/s 




















       
Bromunt, 
2012 
       
Fang, 2013        
Reshef, 
2013 
       
Hofstetter, 
2005  
       
Martin, 
2005  
       
Mulligan,* 
2017 
       
Wamsley, 
2012 
       
Waters, 
2011 
       




conducted in medication naïve patients, in those unmedicated for a set period 
of time, or those were medicated during the study. The majority of the 
studies were conducted in inpatients (n=29), 5 were conducted in outpatients, 
1 was conducted in a mixed in and outpatient sample and in 7 studies in/out 
patient status was unclear. See table 19 for an overview of PSG studies. 
4.3.3.2  Bias assessment 
See table 21 for table that conveys the risk of bias for each of the studies. 
Red dots represent high risk of bias, green represent low risk of bias and 
amber represents unsure about risk of bias. Across the polysomnography 
studies there were two areas identified as risk of bias. In the 
polysomnography component (37/42 studies, 89%) were rated at risk or bias or 
unsure because they did not include an adaptation night or minimise the use 
of caffeine and napping on recording days. In the component of power (36/42 
studies, 85%) were rated as risk of bias or unclear due to small samples and it 
being unclear whether non-significant results are related to small samples.  
4.3.3.3 How was sleep assessed?  
PSG was conducted either in the patients ward or at sleep centres. There was 
a great deal of variation in the number of nights of recording conducted, 
ranging from 1-11. Thirty studies scored the sleep data using Rechtschaffen 
and Kales criteria, whilst 6 studies used the more recent American Academy 
of Sleep Medicine scoring criteria (2015). In 5 studies the scoring criteria 
wasn’t clear and 1 study used criteria by (Dement & Kleitman, 1957).   
4.3.3.4  What aspects of sleep are disrupted? 
There were a great number of sleep variables reported within PSG studies. To 
try and narrow down and summarise the range of sleep variables, we split the 
variables into different categories. Furthermore, we report of the differences 




groups. For a comprehensive analysis of sleep in psychosis compared to other 
conditions see Baglioni et al., 2016.  
4.3.3.4.1 Sleep continuity  
There were 28 studies with a control group, or with comparison data available 
between groups. Each of our variables was reported at different levels.  For 
SOL, there were 23 studies that had data available. Of these 23, 13 reported a 
higher SOL, and 10 reported non-significant results. No studies reported a 
shorter SOL. For TST 22 studies had data available. Of these 22, 6 reported 
reduced TST, 2 reported increased TST and 14 reported non-significant 
findings. For WASO, there 9 studies of which 7 reported increased WASO and 2 
reported non-significant results. Finally, for SE, 21 studies had data. Of these 
21 studies, 11 reported a reduced SE and 10 reported non-significant findings. 
See table 20 for an overview of sleep continuity findings in PSG studies.  
4.3.3.4.2 Stage 1 and 2 sleep. 
Stage 1 and 2 sleep was presented in minutes or as percentage as overall 
sleep. There were no consistent findings. For stage 1 sleep, there were data 
available from 21 studies. Of these 21 studies, 5 reported an increase in S1, 
and 16 reported non-significant results. For Stage 2 sleep, there were data 
available from 22 studies. Of these 22 studies 6 reported a decrease in S2, 
and 2 reported an increase in S2, while 14 studies reported non-significant 
findings.  
4.3.3.4.3 Slow wave sleep (Stage 3 and 4). 
For stage 3 sleep, there were data available from 11 studies, of which 1 
reported reduced S3 and 10 reported non-significant results. For stage 4 
sleep, there were data available from 10 studies of which 3 studies reported 
reduced S4 and 7 reported non-significant results. For SWS (stage 3 and 4 
combined) data were available from 21 studies, of which 6 reported reduced 




4.3.3.4.4 REM variables (REM sleep, REM latency, REM density) 
The vast majority of the studies reported no differences in any of the REM 
parameters. For REM sleep, there were 27 studies, of which only 1 reported 
reduced REM sleep and 26 reported non-significant results. For REM-L, there 
were 18 studies of which 2 reported a reduced REM-L and 16 reported non-
significant results. Finally, for REM-density there were data available from 9 
studies, of which 1 reported increased REM-density, and 8 reported non-
significant results.  
4.3.3.4.5 Sleep microstructure: 
The previously reported variables are those that can be classed under sleep 
macrostructure, and done with classical scoring methods that focus on the 
temporal organisation of sleep. In recent years there has been an increase in 
techniques aimed to assess sleep at a deeper level, and study the dynamics of 
sleep in greater detail. Some of these methods include spectral analysis, 
cyclic alternating pattern, micro-arousal analysis as well as the study of 
spontaneous events such as sleep spindles and K complexes. The following 
section will summarise sleep micro-structure in schizophrenia that were found 
in our included papers.  
Eight studies included in our review focused on spindle analysis. The main 
finding was that people with schizophrenia report lower spindle amplitude, 
lower spindle duration and a reduced number of spindles (Ferrarelli et al., 
2010; Goder et al., 2015; Manoach et al., 2014; Sasidharan et al., 2017; 
Schilling et al., 2017; Wamsley et al., 2012). Of  note, two studies reported 
no differences on spindle density (Poulin et al., 2003; Van Cauter et al., 
1991). Furthermore, one study by Schilling et al., (2017) reports a deficit only 
in fast sleep spindle density.  
Ferralli 2010 looked at slow wave analysis, and variables that measure cortical 
synchronization during slow waves. There were no differences between 




looked at delta wave counts, finding that the group with schizophrenia 
reported lower delta wave sum counts and counts per minutes compared to 
controls (Ganguli, Reynolds, & Kupfer, 1987).  Keshavan et al., (1998) 
conducted period amplitude analysis and power spectral analysis. The period 
amplitude analysis revealed that patients had reduced average delta wave 
count in the first NREM period in the 1-2 HZ range. Spectral analysis showed 
that  patients had reduced spectral power in the delta and theta ranges and 
most prominent in the 1-2 Hz delta range compared to the 0.5-1 Hz range 
(Keshavan et al., 1998). Oh (2017) conducted spectral analysis and found that 
during N2 sleep 0.5-1Hz was lower in the schizophrenia group with higher 
theta and beta values. During N3 sleep alpha activity was higher in patients. 
Sasidharan (2017) conducted power spectral analysis and neuroloop gain 
analysis showing overall sleep instability in the schizophrenia group. For 
example, they had more awakenings in the first and third sleep cycles and 
unstable stage transitions. Sekimoto (2011) conducted delta half wave 
analysis and found that patients with schizophrenia showed lower total delta 
wave counts during all-night sleep than did control subjects in all regions. 
Finally, a study looked at high frequency activity and found that the 




Table 19: overview of PSG studies included in the review  





Medication status Sleep measure Psychosis 
measure 
Summary 






Drug free for one 
week before 
recordings 
2 nights PSG DSM-111 Interleukin levels 
correlated 
negatively with a 
range of sleep 
parameters.  
Bian, 2016 China Cross-sectional N=148 
Schizophrenia 
inpatients 
42(14.7) 77:71 All medicated 
during study 





and SE but 
underestimated SOL 




N= 6 Schizophrenia 
inpatients 
Not reported 3:7 Withdrawn meds 
3 weeks before 
study 
PSG- 3 nights 
before 
treatment, an 







effects of the 















Medicated 2 nights PSG DSM-IV-R Similar sleep 
continuity across 
groups. 





Not reported Not 
reported 
Not reported  4-5 nights PSG Not reported  Schizophrenia group 
took longer to fall 
asleep than the 
control group.  

















Medicated PSG- 1 night DSM-IV Schizophrenia 
patients had 
increased SOL in 





patients also had 
whole night deficits 
in other sleep 




spindle power and 
amplitude.  
Ganguli 1987 USA Cross-sectional N=8 Schizophrenia 
(Inpatients) 

































also had diminished 
delta counts and 
decreased total 
delta wave count 
 












Medicated 2 nights PSG DSM-IV, ICD-
10 
No diffs on sleep 
continuity 
Gillin, 1974 USA Cross-sectional N=8 Schizophrenia  
(Inpatients) 










3 weeks  prior 
study except 1 






less likely than 
control psychiatric 
patients to exhibit 
a normal REM 
rebound. No diffs 
on TST. 









Medicated 2 nights PSG ICD-10 Patients spent more 
TIB, Longer SOL, 
poorer SE, More 
awakening, more 
S1, Less SWS and 
longer latency to 
SWS and poorer 
sleep quality on 
PSQI. Reductions in 
SWS & SE correlated 
with poorer spatial 
recall. Same sleep 
findings remained 
in sub sample of 
patients who were 











Medicated 2 nights PSG ICD-10 Patients spent more 
TIB and slept longer 














6:7 Med free for at 
least 6 months 






Clozapine lead to 
an overall 
improvement of 
sleep including TST 
and SE.  
















weeks prior to 




2-4 nights PSG DSM-III-R. 
BPRS 
Patient groups all 
reported similar 
levels of sleep 
disturbance. There 
were no diffs across 
groups on SOL, 
stage 2, 3, and 








28.8 All male Drug free, and 
then given 
chlorpromazine 






TST,NREM time and 















All male Med free for 1 
month before 
study  
3 nights PSG RDC, SADS Schizophrenia group 
had longer SOL, and 
more stage 1 sleep 
than controls. They 
also had less stage 
3 sleep than 
depression group.  










19 Med- naïve 




2-3 nights [SG DSM-III-R Patients had 
reduced delta 
sleep. Also had 
longer SOL, shorter 
TST, lower SE and 
higher WASO than 
controls.  








Drug  naive 2 Nights PSG DSM-III-R, 
BPRS 
Patients had lower 
TST, lower SE, and 






30.7(6.7) 13:7 more awakenings 
and less S2 sleep 
than controls.  









All male Drug free for at 
least 7 days 
(ranged 16-31) 




DSM-III-R Patients had 
decreased SE, TST, 






there was an 
improvement of 
sleep after 3-4 days 
and this effect was 
stable weeks after.  
Lusignan, 2010 Canada Dream collection 
study- cross-
sectional 










Medicated  3 nights PSG DSM-IV-TR No diffs in sleep 
parameters 













27.7 12:2 2 weeks med free 
before study 
Pre and post 
medication PSG 
2 nights 
DSM-III-R Sleep improved 
with neuroleptic 
treatment including 
SOL, TST and SE. 






























































deficits were also 
























seems to be one 
night 
ICD-10 Patients had longer 
SOL and TIB 




also present.   
Ozone, 2013 Japan Cross-sectional N=7 Schizophrenia 34.6(14.5) 4:3 Medicated 1 night PSG ICD-10 Schizophrenia had 
poor sleep with 
score of 9 on PSQI, 
and all slept more 
than 7 hours with a 
high sleep 
efficiency. 















Neuroleptic naive 2 nights PSG DSM-IV Patients had higher 
SOL, decreased 
stage 4 duration, 
reduced rapid eye 
movement (REM) 
sleep latency, and 
normal sleep 











8:12 Medicated PSG- 1 night? DSM-IV Sleep parameters 
related to enhanced 
performance on 
cognitive tasks 
Reich,1975 USA Cross-sectional N=29 Schizophrenia 
(inpatients) 
24.0 (1.8) 12:17 At least two 
weeks med free 




effects of illness 




had less SWS, and 
less time spent 
asleep. Acute 
schizophrenia had 








Riemann, 1995 Germany Cross-sectional N=10 Schizophrenia 
(inpatients) 
 

















At least one week 
drug free, 2 were 
drug naïve 
3 nights PSG DSM-III-R Sleep continuity 
was impaired in 
schizophrenia.  
Roschke, 1995 Germany Cross-sectional N=13 Schizophrenia 
(inpatients) 
N=13 HC 
age and gender 
matched 
28(5) 11:2 Med free for 3 
months 
2 nights PSG DSM-III-R The only sleep 
parameter that 
differed between 
the two groups was 
REM –Latency. The 
patient group had a 











Medicated 3 nights PSG DSM-IV Patient group 





had longer duration 
of first rem period 
and higher eye 


















improved a range of 
sleep parameters 
including less wake 
time, less stage 1 
sleep, more stage 2 
sleep, more slow 
wave sleep, longer 
TST and increased 
REM density.  
Sarkar, 2010 India Cross-sectional N=20 Schizophrenia  
(Inpatients) 
 










All male Drug naive 1 night PSG ICD-10 Patients had a 
lower TST and 
lower stage 2 
duration than both 
control groups. 
Patients also 
reported lower stag 
3 latency, stage 4 
duration and stage 
1 and 4 TST.  
Sasidharan, 
2017 












Drug free for at 
least 3 months or 
drug naïve 
1 night PSG DSM-IV Patients had 








Schilling, 2017 Germany Cross-sectional N=17 Schizophrenia 
(inpatients) 





29.94 ( 10.60) 
33.31 ( 14.05) 
 





Medicated  2 nights PSG DSM-IV-TR Fast spindle density 
was reduced in 
patients and 
relatives and this 
was associated with 
decreased memory 
performance.  








All male Mixed:  
3 neuroleptic 
naïve 
2 no meds for 4 
weeks 
12 on stable med 
2 nights PSG DSM-IV No significant 
differences in sleep 
continuity.  
Patients reported 
more stage 2 and 
less stage 4 + 4 and 
also had lower total 
delta wave counts.  
Tekell,2005 USA Cross-sectional N=17 Schizophrenia 

















Med free for 4 
weeks 
2 Nights PSG DSM-III-R No diffs in sleep 
continuity. Patients 
had less S2 sleep v 
healthy controls, 
and   lower SE 
compared to both 
groups. 





30.7(5.2) All male Medicated with 
risperidone 




4 nights PSG- 2 
nights before 
clozapine and 2 
nights after 
clozapine. 
PANSS No significant 












All male Medication free 
for at least 9 
weeks before 
study 
4 Nights PSG RDC, BPRS Patient group had a 
longer SOL and 
lower SE. 
Differences in sleep 
architecture were 
also found including 
less stage 1 and 2 
and REM sleep in 
the patient group 
Van kammen, 
1994 
USA Cross-sectional N=28 Schizophrenia 
(Inpatients) 
33.9(6.4) All male Med free for 12 
days before the 
study 




with REM latency, 
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found in patient 
group. 
. 
Wyatt, 1970 Not 
reported 







Not on meds at 
time of admission 
3- 10 nights PSG  Patient  group had 
longer SOL and less 
NREM sleep and less 
REM activity 
Yang, 2006 Korea & 
USA 







All men Free from meds 2 
weeks prior to 





2 nights PSG- not 
all patients 
complied. 
DSM-IV Patient group had 
more TIB, WASO, 
longer SOL AND 
lower SE. 
There were also 
differences on sleep 
architecture.  
Zarcone, 1997 USA Cross-sectional N=20 Schizophrenia 
or schizo-affective 
inpatients 
33.9 (6.7) All male Free from meds 2 
weeks prior to 
study 
3 nights PSG RDC, BPRS SOL was correlated 
with thinking 
disturbance on the 
brief psychiatric 






Table 20: Sleep continuity in PSG studies 
Study SOL TST WASO SE 
Feinberg,1965- Longer in scz - - - 
Ferrarelli, 2010 Longer in SCZ n/s   
Ganguli, 1987 n/s - Higher in SCZ - 
Genzel,2015 - n/s - - 
Gillin, 1974 - - - - 
Goder, 2004 Longer SOL Shorter TST - Lower in SCZ 
Goder, 2015 n/s Longer TST - N/S 
Hudson, 1993 n/s Shorter TST - Lower in SCZ 
Kempeaners, 1988 Longer in SCZ N/S - n/s 
Keshavan, 1998 Longer in SCZ Shorter TST in 
SCZ 
Higher in SCZ Lower in SCZ 
Lauer, 1997 Longer in SCZ Shorter in SCZ Higher in SCZ Lower in SCZ 
Lee, 2001 N/S Shorter in SCZ Higher in SCZ Lower in SCZ 
Lusignan, 2010 - N/S - N/S 
Manoach, 2014 - N/S Higher in SCZ Lower in SCZ 
Oh, 2017 Longer in SCZ N/S N/S N/S 
Poulin, 2003 Longer in SCZ N/S - N/S 
Riemann, 1995 n/s - - Lower in scz 
Roschke, 1995 n/s n/s - n/s 
Rotenberg, 2000 Longer in SCZ N/s - n/s 
Sarkar, 2010 N/S Shorter in SCZ - N/S 
Sasidharan,2017 Longer in SCZ Longer in SCZ Longer in SCZ Lower in SCZ 
Schilling, 2017 N/S - - N/S 
Sekimoto, 2011 N/S N/S - N/S 
Tekell, 2005 n/s n/s - Lower in SCZ 
Van Cauter, 1991 Longer in SCZ N/S - Lower in scz 
Wamsley, 2012 - n/s n/s - 
Wyatt, 1970 Longer in SCZ - - - 
Yang, 2006 Longer in SCZ N/S Longer in SCZ Lower in SCZ 
 
 
Please note- for this table, only studies that compared sleep parameters to a control group are 










3: PSG 6: Power 7: Missing Data 8: Completion 
Rates 
9: Data Analysis 
Study        
Appelberg, 1997        
Bian, 2016        
Brambilla, 1983        
Chaparro- 
Vargras, 2016 
       
Feinberg,1965-        
Ferrarelli, 2010        
Ganguli, 1987        
Genzel ,2015        
Gillin, 1974        
Goder, 2004        
Goder, 2015        
Hinze- selch, 1997        




       
Kempeaners, 1988        
Keshavan, 1998        
Lauer, 1997        
Lee, 2001        
Lusignan, 2010        
Maixner, 1997 
 
       
Manoach, 2014        
Oh, 2017        
Ozone, 2013        
Poulin, 2003        
Ramakrishnan, 
2012 
       
Reich, 1975        
Riemann, 1995        




Rotenberg, 2000        
Salin Pascual, 
1999 
       
Sarkar, 2010 ` `      
Sasidharan,2017        
Schilling, 2017        
Sekimoto, 2011        
Tekell, 2005        
Tsekou, 2014        
Van Cauter, 199        
Van kammen, 
1994 
       
Wamsley, 2012*        
Wyatt, 1970        
Yang, 2006        





4.4 Discussion:  
Sleep disturbances are well documented in schizophrenia and a range of 
methods have been used to measure sleep in this population(Cohrs, 2008). The 
aim of our review was to critically evaluate the methods that have been used to 
measure sleep in NAP. We did this by conducting bias assessments of all of the 
included studies. We also sought to report what aspects of sleep are disrupted 
and consider these in the context of our bias assessments.  
Numerous reviews and studies have reported that sleep continuity is commonly 
disrupted in people with NAP, including increased SOL and a decreased TST 
(Chouinard et al., 2004; Cohrs, 2008). In our review we recorded 4 measures of 
sleep continuity- SOL, SE, WASO and TST. Our findings provide mixed support for 
disruption of sleep continuity. Firstly, there were numerous studies that did not 
report these measures, or did not have a control group to compare the measures 
to. Secondly, for each of our 4 outcomes, there were non-significant findings 
also reported. Thirdly, across methodologies, sleep continuity measures 
differed. For example, actigraphy had a trend towards increased TST, whilst PSG 
reported lowered TST in comparison to healthy controls, while no conclusions 
could be made from subjective studies. However, in line with previous research, 
the direction of the measures were more consistent. For example, for the 
studies that found significant differences in SOL, this was always in the direction 
increased SOL except for one study (Hofstetter, Lysaker, & Mayeda, 2005). 
Likewise, for WASO and SE, this was almost always in the direction of more 
severe disturbance in the NAP sample. Therefore, we can conclude that there is 
evidence for disruption of sleep continuity, but that this is not a consistent 
finding across all studies.  
Our review rated each study on risk of bias, and the components rated provide 
some insight into potential reasons for inconsistent results.  
Across all three of our methodologies, there were some common areas of bias 
that emerged. In the domains of patient selection, studies were rated as risk of 




as age, gender as well as inclusion/exclusion criteria or if they included 
unrepresentative samples. Likewise, numerous studies lacked control groups, or 
included unmatched groups. In future, studies should include clear information 
on the sample that includes inclusion/exclusion criteria, how samples were 
selected and important demographics such as age and gender. In terms of 
power, this was an area of bias across all three methodologies. Small samples 
make it difficult to exclude type 2 error, and can contribute to inconsistent 
results between studies. Power was especially an issue in PSG studies which 
were often conducted in small samples but the range in our studies was large- 
from 5 to 148 patients (Bian et al., 2016; Lee et al., 2001). The majority of 
studies were conducted in sample sizes of 20 participants or less. PSG is a costly 
and time consuming technique and this limits sample sizes. However, this makes 
it difficult to exclude type 2 error and can contribute to inconsistent results 
between studies. A potential area for future research may be conducting 
polysomnography at home in people with psychosis. This may be a more viable 
and ecologically valid way to measure sleep architecture.  
Our review also identified some method –specific areas of bias, and will be 
discussed in relation to each methodology next.  
4.4.1  Polysomnography 
Out of the 3 methods assessed in our review, PSG was the most commonly used 
method to assess sleep and the majority of the studies were conducted in 
inpatient samples. In our review, 42 studies used PSG. We found some evidence 
for disruption of sleep architecture, in the direction of lowered S1 sleep and 
reduced SWS, indicating more light sleep and less deep sleep. There were no 
consistent effects for REM sleep variables. These findings correspond with a 
recent review of PSG sleep studies who concluded that both sleep architecture 
and continuity were disturbed (Chan, Chung, Yung, & Yeung, 2017) as well as 
with a review that compared sleep across different mental disorders (Baglioni et 




Sleep microstructure has also been assessed with PSG, and in particular sleep 
spindles have been investigated. Sleep spindles are a hallmark of S2 sleep and 
are generated in the thalamus (Manoach, Pan, Purcell, & Stickgold, 2016). 
Various aspects of spindles have been assessed and studies find a reduction in 
spindles, lowered amplitude and lowered spindle duration (Ferrarelli et al., 
2010; Goder et al., 2015; Manoach et al., 2014; Sasidharan et al., 2017; Schilling 
et al., 2017; Wamsley et al., 2012). Other aspects of sleep also disrupted include 
delta waves and more sleep instability(Ganguli et al., 1987; Keshavan et al., 
1998; Sasidharan et al., 2017). These investigations are promising and have 
potential to highlight more fine grained sleep changes, which may help further 
our understanding of the relationship between sleep and its impact in psychosis. 
For example, spindle density has been linked to memory performance (Schilling 
et al., 2017).  
However, one of the most striking findings from the bias assessment was that 
69% of the studies were rated at risk of bias based on their PSG methodology. 
Using our bias tool, studies were rated at risk of bias if they did not include an 
adaptation night to rule out the first night effect  (Agnew, Webb, & Williams, 
1966) or if it was unclear if they restricted napping and caffeine on day of 
recording. Not including an adaptation night in PSG studies is problematic as it 
does not allow the participant to adapt to the unique environment of the sleep 
lab, and the sleep on the first night is unlikely to reflect their typical 
sleep(Agnew et al., 1966; Toussaint et al., 1995). Furthermore, night sleep can 
be affected by napping in the day (Borbély, 1982), as well caffeine use  which is 
an adenosine antagonist (Fisone, Borgkvist, & Usiello, 2004) and  has alerting 
effects and may influence sleep parameters. Based on this criteria, 69% of the 
PSG studies included in our review were rated at risk of bias. When interpreting 
findings from PSG studies, it is important to consider them in light these 
methodological limitations.  
4.4.2  Actigraphy   
Actigraphy studies revealed that people with NAP report more sleep during the 




indicative of circadian disruption. In terms of actigraphy methodology, studies 
were rated at risk of bias if they did not include at least a week or recording, or 
if there was no attempt to distinguish period of quiet rest from sleep, through 
use of sleep logs or diaries. Based on this criteria, 40% of the studies were rated 
at risk of bias. Looking at these studies in more detail, 3 were rated at risk of 
bias because they did not distinguish quiet rest from sleep and 1 because they 
only recorded 3 days. These criteria were selected as sleep is a variable 
experience, and in order to capture accurate estimate, multiple nights of 
recording are recommended (Aili, Astrom-Paulsson, Stoetzer, Svartengren, & 
Hillert, 2017; Ancoli-Israel et al., 2015; Briscoe et al., 2014). The use of detailed 
sleep logs and diaries that include information on times patients are resting, or 
have taken the actiwatch off is recommended to prevent over scoring of sleep 
time (Lichstein et al., 2006).  
4.4.3  Subjective assessment 
As with PSG and actigraphy, our coding revealed some areas of potential bias. 
Studies using subjective assessment were rated as risk of bias if they did not 
include validated measures of sleep. According to this criteria, 66% of studies 
were rated either at risk of bias, or unclear due to lack of information. The 
majority of studies used their own developed questions or did not clearly specify 
the questions used in the studies. A great number of validated questionnaires 
exist that should be used in future research. When using sleep diaries, we 
recommend the use of the validated Carney Sleep Diary (Carney et al., 2012). 
Without using validated questionnaires, the reliability and validity of questions 
becomes problematic.   
4.4.4  Limitations of the current review 
Meta-analysis could not be conducted due to inconsistent reporting of sleep 
parameters. We did not report on correlates of sleep disturbance in people with 
psychosis. But this has been covered extensively in previous reviews (Davies et 




area of bias within the methodologies, although our tool provides a good starting 
point. For example, within polysomnography blind scoring was not assessed.   
4.4.5  Strengths of the current review 
We have conducted a comprehensive review of sleep methods used in NAP.  Our 
review also went one step further in that we provided a comprehensive 
assessment of bias, and identified unique aspects that can be addressed in 
future research. 
4.4.6  Overall summary 
Sleep has been measured by a variety of methods and has helped revealed the 
sleep disturbances that are commonly reported in people with NAP. However, 
our review identified a number of important methodological weaknesses in study 
designs that call into question the strength of some of these findings. Our review 
also bought to the surface that many studies report non-significant results in 
relation to sleep disturbances. Addressing these methodological weaknesses will 
help tease out more clearly what aspects of sleep are disrupted in people with 
NAP, which in turn can help inform and better tailor sleep interventions.  
4.4.7  Recommendations for future studies 
 All studies should carefully and clearly report important demographic 
information about their patient samples, with inclusion and exclusion 
criteria.  
 Sample size should be justified e.g. through power calculations. 
 Missing data should be clearly stated and any strategies used to deal with 
missing data. 
 Completion rates should be reported/information on drop-outs provided 




 Studies using PSG should include an adaptation night to allow participants 
to accustom to the sleep lab, as well as eliminate napping and caffeine 
influences on recording days. 
 Studies using actigraphy should record at least 7 days to provide more 
reliable estimates, and include the addition of sleep logs/diaries when 
scoring actigraphy data. 
 Studies using subjective sleep measures should use the appropriate 
validated questionnaires for the aspect of sleep they are interested in. If 
using sleep diaries, we recommend using the Gold Standard Carney Sleep 




5 The role of sleep in predicting paranoia in non-
affective psychosis: an experience sampling 
study 
5.1 Introduction 
As many as 30-80% of people with a diagnosis of NAP conditions such as 
schizophrenia report sleep disturbances (Cohrs, 2008). Sleep disruption appears 
to be a persistent issue that is found in medicated, and non-medicated samples, 
as well as during acute and stable phases, (Poulin et al., 2003; Ruhrmann, 
Schultze-Lutter, Salokangas, & et al., 2010). Importantly, sleep disturbances are 
linked to a range of outcomes including severity of symptoms, mood, and quality 
of life (Cohrs, 2008; Mulligan et al., 2016) and patients report sleep is an 
important treatment target (Waite, Evans, et al., 2016). Together, this 
emphasises the importance of understanding the nature and correlates of sleep 
problems in people diagnosed with psychosis. 
5.1.1 What aspects of sleep are disrupted? 
Measured both subjectively and objectively, a range of sleep and circadian 
disturbances have been reported in people diagnosed with schizophrenia. For 
example, one study in a sample of 30 participants reported that over half the 
sample experienced moderate to severe levels of insomnia (Freeman et al., 
2009). Other studies have also reported elevated levels of insomnia, although 
the prevalence estimate varies (Palmese et al., 2011; Xiang et al., 
2009a).Nightmares are also prevalent. One study in a sample of 40 participants 
experiencing psychotic symptoms, reported that 55% reported weekly distressing 
nightmares (Sheaves et al., 2015). As well as nightmares and insomnia, circadian 
disruption in the form of sleep/wake pattern irregularity and alterations in 
circadian rhythms of melatonin are also found (Bromundt et al., 2011; Wulff et 
al., 2012). There is also some evidence for hypersomnia which is conceptualised 
as excessive daytime sleepiness. Estimates of excessive daytime sleepiness range 
from 32- 58% (Sharma, Dikshit, Shah, Karia, & De Sousa, 2016; Wichniak et al., 
2009). This evidence suggests that a range of sleep disturbances are common in 
people diagnosed with schizophrenia.  
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5.1.2 The relationship between sleep disturbances and paranoia 
Sleep disturbance has been linked to increased severity of symptoms (Cohrs, 
2008; Mulligan et al., 2016). In particular, strong relationships between sleep 
and paranoia have being found in both clinical and non-clinical samples 
(Freeman et al., 2012; Myers et al., 2011). In a longitudinal study, insomnia 
predicted the onset of paranoid thoughts in the general population (Freeman et 
al., 2012). In a clinical sample, improving sleep using cognitive behavioural 
therapy for insomnia (CBTi) was associated with reductions in both paranoia and 
insomnia (Myers et al., 2011).  Investigating mechanisms linking sleep to 
paranoia is the next step, with evidence being found for negative emotional 
states (Freeman et al., 2010; Scott, Rowse, & Webb, 2017) and levels of 
emotional awareness (Rehman, Gumley, & Biello, 2018). This research suggests 
that levels of negative emotions may be a key mediator in the relationship 
between sleep and paranoia. Our aims are to understand and further explore 
these relationships, taking into account limitations of prior work.  
5.1.3 Limitations of previous research 
In studies examining paranoia and sleep, paranoia is often measured in terms of 
frequency. This research excludes other important dimensional aspects of 
paranoid beliefs. For example, paranoia has dimensions of distress, pre-
occupation and conviction associated with it (Freeman & Garety, 2000; Freeman 
et al., 2005) and these aspects of paranoia could also be considered in relation 
to sleep. Another limitation of prior work is that it is cross-sectional in nature 
limiting inferences regarding causality (Mulligan et al., 2016). There is therefore 
a need to understand these relationships as they unfold in daily life. It has been 
shown that both sleep and psychotic symptoms show variability and are dynamic 
states. For example, paranoia fluctuates with changes in mood and self-esteem 
(Thewissen, Bentall, Lecomte, van Os, & Myin-Germeys, 2008). Sleep has also 
been found to show daily variation (Buysse et al., 2007). Another study found 
that next day mood was linked to prior night’s sleep in patients with depression 
suggesting a temporal relationship between sleep and mood (de Wild-Hartmann 
et al., 2013).  
113 
113 
5.1.4 Experience sampling method (ESM) 
To capture relationships at a daily level ESM requires participants to answer 
questions about mood, context and symptoms, several times a day for 
consecutive days, usually at random moments signalled on a smartphone (Myin-
Germeys et al., 2009).  ESM yields high levels of ecological validity, in 
comparison to retrospective techniques, as it allows experiences to be captured 
as they unfold in daily life. ESM has been used in a wide variety of psychiatric 
conditions including psychosis, borderline personality disorder, depression and 
eating disorders, with high levels of adherence and acceptability reported (Myin-
Germeys et al., 2009).  To date, there has only been one study using ESM to 
investigate relationships between sleep, symptoms and mood in people with 
NAP. This study found that both subjective and objective sleep predicted next 
day psychotic symptoms including paranoia and delusions of control (Mulligan et 
al., 2016). The study also found that the relationship between sleep and next 
day paranoia was mediated by negative affect, supporting studies conducted 
using retrospective measures. Our study differs from the Mulligan study in that 
they focused on a range of symptoms including delusions of grandeur, control 
and hallucinations. Furthermore, they also selected a sample of patients with 
experiencing insomnia symptoms, whereas in this study patients did not have to 
have a specific sleep complaint.    
5.1.5 Current study and aims 
We sought to investigate whether sleep predicts variation in frequency, distress, 
pre-occupation and conviction dimensions associated with paranoia. 
Furthermore, we sought to examine the temporal relationship between sleep 
and paranoia. We did this by investigating whether levels of state paranoia were 
predicted by levels of preceding state sleep, and whether this relationship was 




 Subjective sleep measured by a sleep diary will predict levels of paranoia, 
as well as distress, pre-occupation and conviction measured at the daily 
level.   
 Levels of sleep at one moment, will predict paranoia at the next moment, 




The study was reviewed and approved by the Greater Glasgow and Clyde 
National Health Service (NHS) Research Ethics Committee (REC) ref: 14/WS/0124 
and by local research and development offices. To be eligible for the study 
participants had a diagnosis of non-affective psychosis (schizophrenia, 
schizoaffective disorder, delusional disorder, schizophreniform disorder, 
psychotic disorder not otherwise specified) in accordance with International 
Classification of Diseases-10 (ICD-10; World Health Organization, 1992). 
Participants were aged between 18-65, had been on a stable medication regime 
for the past month and were able to give full informed and written consent. 
Exclusion criteria included alcohol or drug dependence, head injury, 
neurological illness, night shift work or having travelled across time zones in the 
past month. There were two routes for recruitment for participants- they could 
be referred to the study by their clinical team or they could self-refer through 
adverts that were put up in local centres about the study.  
5.2.2  Baseline questionnaire measures: 
A range of sleep questionnaires were select in the study to capture a range of 
sleep and circadian disturbances.  All questionnaires were administered face to 
face with patients and this allowed any confusion about wording or questions to 
be dealt with directly. All measures were administered by the first author (AR).  
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5.2.2.1  Wilson-Screening for Sleep Disorders  
This algorithm serves as a screening tool for sleep disorders including 
narcolepsy, sleep apnoea, parasomnias, restless legs and circadian rhythm sleep 
disorders. No one in our study met the criteria for any of the sleep disorders. 
The screening tool is published in (Wilson et al., 2010).  
5.2.2.2  Pittsburgh Sleep Quality Index (Buysse et al., 1989) 
The PSQI provides a reliable, valid, and standardized measure of sleep quality. 
Scores range from 0-21 with higher scores representing poorer sleep.  A PSQI 
global score >5 indicates that a participant is having severe difficulty in at least 
two areas, or moderate difficulty in more than three areas of sleep quality in 
the past month. Internal consistency of the PSQI is high α = .83 (Buysse et al., 
1989).   
5.2.2.3  Epworth Sleepiness Scale (M. W. Johns, 1991) 
The ESS provides an assessment of daytime sleepiness. Respondents are asked to 
rate, on a 4-point scale (0-3), their usual chances of dozing off or falling asleep 
while engaged in eight different activities. Most people engage in those 
activities at least occasionally, although not necessarily every day. The ESS score 
(the sum of 8 item scores, 0-3) can range from 0 to 24. The higher the ESS score, 
the higher that person’s ‘daytime sleepiness’. The questionnaire takes no more 
than 2 or 3 minutes to answer. Internal consistency in the study was α =0.75. 
5.2.2.4  Sleep Condition Indicator (Espie et al., 2014).  
The SCI is a screening measure for insomnia based on the DSM-V criteria for 
insomnia disorder. We used the short form which has 2 items. Internal 
consistency in the study was α=0.80. 
5.2.2.5  Nightmare Frequency:  
This was assessed by asking participants how often they experienced nightmares, 
with options ranging from never to more than once a day.  
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5.2.2.6  Nightmare Distress Questionnaire (Belicki, 1992) 
Includes 13 items rated on a five-point scale to assess the degree of self-
reported distress attributed to nightmares. Internal consistency in the study was 
α=0.80. 
5.2.2.7  Morning Eveningness Questionnaire: (Horne & Ostberg, 1976) 
The Horne-Ostberg Morningness Eveningness Scale is used to distinguish between 
chronotypes (whether one is a morning or an evening person). Scores range from 
16 to 86, corresponding to extreme eveningness (lower numbers) to extreme 
morningness (higher numbers). Questions focus on individual preferences for 
sleep and wake times. Internal consistency in the study was α=0.70. 
5.2.2.8 Toronto Alexithymia Scale (Bagby et al., 1994) 
The TAS -20 includes 20 items and measures 3 factors of alexithymia. Factor 1 
assesses difficulty in identifying feelings. Factor 2 assesses difficulty in 
describing feelings. Factor 3 assesses externally oriented thinking. Scores range 
from 20-100 with higher scores reflect higher alexithymia. Internal consistency 
in the study was α =0.85. 
5.2.2.9 Depression, Anxiety and Stress Scale (Lovibond & Lovibond, 1995)  
The DASS-21 is a self-report measure in which participants rate the frequency 
and severity of experiencing negative emotions over the previous week. 
Frequency/severity ratings are made on a series of 4-point scales (0 = did not 
apply to me at all, 3 = applied to me very much, or most of the time). Internal 
consistency in the study was α=0.96. 
5.2.2.10 Green Paranoid Thoughts Scale Part B (C. E. Green et al., 2008) 
The G-PTS is a 16-item measure of paranoia, assessing ideas of persecution over 
the past month. Scores range from 16-80 with higher scores indicating greater 
levels of paranoid thinking. The questionnaire includes subscales for conviction, 
preoccupation, and distress. The questionnaire has been psychometrically 
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evaluated in clinical and non-clinical populations. Internal consistency in the 
study was α=0.97. 
5.2.3  Daily measures and ESM 
5.2.4  Consensus Sleep Diary.  
The Consensus Sleep Diary (CSD; (Carney et al., 2012) was completed by 
participants each morning to measure subjective sleep parameters. The CSD has 
been credited as a gold-standard sleep diary (Carney et al., 2012). Participants 
filled out the sleep diary for 2 weeks. From the sleep diary, we extracted sleep 
a range of measures including sleep onset latency (SOL), total sleep time (TST), 
wake after sleep onset (WASO), sleep efficiency (SE), and time in bed (TIB) as 
predictors of paranoia.  
5.2.4.1  ESM sampling 
All participants completed the ESM procedure on smartphones (Galaxy Fame by 
Samsung) that they kept during the course of the study. Between the hours of 
10am and 10pm, participants were prompted 8 times a day to complete 
questions on mood, sleep, symptoms as well as their current context (See 
appendix for a full list of items). Participants received a beep notification in 
semi-random order within 90 min intervals, with a random beep occurring during 
that interval.  
Once beeped, the questionnaire was available for up to 15 minutes as research 
shows answers within 15 minutes are valid (Delespaul, deVries, & van Os, 2002). 
The questions took on average 2-3 minutes to complete. The ESM questions were 
administered on an app called PsyMate which can be downloaded from App 
stores. The phones only contained this App on it and patients were not able to 
use the phone to receive calls or send texts.  
5.2.4.2 ESM procedure  
All participants attended a pre-experimental meeting, where they were shown 
how to use the phone, access the questionnaire when prompted with a beep and 
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go over 2 practise questionnaires together. They then took the phone with them 
for 8 days and had access to the main researcher AR if they had any technical 
issues or problems with the phone. Following completion of the ESM period, 
participants were given a de-brief, and completed a comprehension 
questionnaire to ensure they understood the questions, the phone and that they 
followed the instructions correctly. Through the course of the study, two 
participants reported feeling paranoid about the phone and whether they were 
being recorded secretly. The researcher AR met with these patients to re-assure 
them. Following this, the participants went onto complete the study. All the 
phones were returned, and the procedure seemed acceptable to patients.  
5.2.4.3 ESM items: 
5.2.4.3.1 Paranoia 
Paranoia items were taken from a previous study that used these items to study 
variations in paranoia (Thewissen et al., 2008). The paranoia scale items 
included “I feel suspicious” and “I feel others may hurt me.” These two items 
formed the paranoia scale (α=0.72 over the subject mean scores). Following 
completion of paranoia items, patients were then asked to report their levels of 
distress, pre-occupation and conviction associated with the paranoid thoughts. 
Patients were asked: How much are the thoughts about others hurting causing 
you distress? How much are the thoughts about others hurting you pre-occupying 
your mind? How convincing are the thoughts about others hurting you? These 
items measured distress, pre-occupation and conviction. All the paranoia items 
were rated on a 6 point likert scale (1=not at all to 6=very). 
5.2.4.3.2 Other experiences 
While paranoia is the main symptom we are interested in, we also included 
measures of delusions of grandeur and reference, taken from a prior study (Ben-
Zeev, Morris, Swendsen, & Granholm, 2012) and taken from the comprehensive 
assessment of at risk mental states (CAARMS) (Yung et al., 2005). Items for visual 
and auditory hallucinations were taken from (Delespaul et al., 2002) and the 
CAARMS.  These items were included so patients did not guess the aims of the 
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study, and to reduce demand characteristics. The reliability of these items were 
also lower, and not included in our analyses.  
5.2.4.3.3 Emotion items  
To examine mood, 3 items were included to measure positive mood and 7 items 
were included to assess negative mood. Items were selected from other papers 
measuring mood using ESM. The items were rated on a 6 point likert scale (1=not 
at all to 6=very). The negative affect scale items included “I feel insecure, 
stressed, lonely, guilty, irritated, down and anxious”. These seven items formed 
the negative affect scale (α=0.83 over the subject mean scores). Positive mood 
wasn’t related to study hypotheses but was included alongside negative affect. 
The positive affect scale items included “I feel cheerful, relaxed and content”. 
These three items formed the positive affect scale (α=0.78 over the subject 
mean scores).  
5.2.4.3.4 Sleep items  
At every notification beep, participants completed questions on current levels of 
sleep. The items were rated on a 6 point likert scale (1=not at all to 6=very). 
Sleep items were taken from the Daytime Insomnia Symptom Scale (Buysse et 
al., 2007) which has been previously validated in an insomnia population. The 3 
sleep scale items included “I feel sleepy, fatigued and exhausted”. These three 
items formed the sleep scale (α=0.84 over the subject mean scores). 
5.2.4.3.5 Additional items 
Finally, a series of questions about context were asked. Whilst contextual items 
are not related to the current studies hypotheses, it has been suggested that 
additional information not related to the study be included to prevent subjects 
from predicting the aims of the study, which may lead to demand characteristics 
and introduce bias into the study. See appendix 3 for a full list of items.  
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5.2.5  ESM data analysis 
Multilevel modelling (MLM) techniques are an alternative of the more often used 
unilevel linear regression analyses and are ideally suited for the analysis of ESM 
data, in which repeated ESM observations (beep level) are nested within persons 
(subject level) (Myin-Germeys et al., 2003). As observations from the same 
subject are more similar than observations from different subjects, the residuals 
are not independent. Multilevel regression techniques take this into account. In 
the current data set we ran a two level model whereby observations at level 1, 
were nested within participants at level 2. Random effects were specified 
maximally, in accordance to (Barr, Levy, Scheepers, & Tily, 2013). All analyses 
were conducted in R using the lme4 and lmerTest packages (Bates, Mächler, 
Bolker, & Walker, 2014; Kuznetsova, Brockhoff, & Christensen, 2017; 
RCoreTeam, 2013). Level 1 and 2 variables were inspected for normality by 
inspection of histograms, which revealed skewness across most of the variables. 
Therefore, we ran the analysis with skewed predictors both log transformed, and 
untransformed data. The results remained consistent across both analyses. There 
is also debate on how to centre variables within MLM. Therefore, we ran our 
analysis centred (level 1 at group mean and level 2 at grand mean) as well as 
uncentred. Our results remained unchanged; therefore for ease of interpretation 
z scored and centred models are presented. See (https://osf.io/4e86c/) for data 
analysis code that includes both uncentred and centred models.  
5.3 Results 
Thirty-four potential participants expressed interest in taking part in the study, 
of which 23 met inclusion criteria. Eight were excluded because they did not 
meet diagnostic criteria, 1 was excluded because they moved out of area during 
the study and 2 declined to participate after receiving study information. In 
regards to recruitment, 16 were recruited via clinical teams, 3 self-referred and 
4 were recruited from charities or other organisations.  
121 
121 
5.3.1  Characteristics of the sample 
The mean age of patients was 46 (SD= 9.5) and there were 15 males and 8 
females. On average, patients had 11 years of education (range 2-20). In terms 
of employment, all but 2 were unemployed. All participants were in receipt of 
antipsychotic medication, with most on more than one type. For full list of 
medication and doses see appendix 4. We do not have patient info on duration of 
illness or info about previous hospitalisations. In our sample of 23 patients, 5 
were classed as good sleepers (PSQI score <5), 17 as poor sleepers (PSQI score 
>5) and for one person there was no PSQI score. See table 22 for descriptive 
statistics of the sample.  
Table 22: Characteristics of the sample 
 





9.2(4.19) 10 1-18 0-21 
Sleepiness  6.19(4.61) 6 0-17 0-24 
Insomnia  2.9(2.44) 2 0-8 0-8 
Chronotype  52.6(7.49) 54 37-65 16-86 
Nightmare 
distress 
25.8(13.60) 24 13-52 13- 65 
Mood (dass 
total score) 
29.5(17.6) 26.5 4-60 0-63 
Alexithymia 59.0(8.8) 59 40-77 20-100 
Paranoia 40.2(22.0) 33 16-80 16-80 
 
5.3.2  Retention and adherence  
In accordance with previous ESM schizophrenia studies (Delespaul et al., 2002; 
Myin-Germeys et al., 2003), participants had to complete at least 33% of the 
experience sampling activations in order for their data to be considered valid 
and included in the data analysis. Based on this, 20 participants were included in 
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the ESM data analysis. Two participants did not respond to enough beeps and 1 
participant could not complete the ESM as they had shaky hands, meaning that 
87% of the sample successfully completed the ESM procedure.  
5.3.3 Justification of using MLM  
The intraclass correlation co-efficient (ICC) explains the proportion of variation 
that is explained between subjects (level 2) and within subjects (level 1). The 
ICC value was 0.71 for paranoia, 0.66 for distress associated with paranoia, 0.67 
for pre-occupation associated with paranoia and 0.71 for conviction associated 
with paranoia. These values suggest that there is variance at both levels of 
analysis and MLM is suited for this data set.  
5.3.4  Main analysis:  
Hypothesis 1: Subjective sleep measured by a sleep diary will predict levels of 
paranoia, as well as distress, pre-occupation and conviction measured at the 
daily level.  Sleep diary measures were averaged over the 2-week period as 
there were missing data and individuals did not always write the date within 
their sleep diary. Therefore, sleep diary measures were treated as a level 2 
variable and used to predict paranoia measured at the daily level (level 1). 
Descriptive values for the variables are presented in table 23.  A random 
intercepts model was run with SOL, TST, WASO, TIB and SE as predictors and 
paranoia as the dependent variable. None of our sleep diary variables predicted 
paranoia. See table 24 for results for this model.  
Table 23: Values for sleep diary measures (n=20) 
Predictor 
Mean SD Range  
SOL 47.0 27.5 4-104 
TST 444.3 216.5 40-1105 
SE 73.2 16.5 43-97 
WASO 36.1 35.0 0-140 









Intercept 1.98 (0.29) 6.78(13) .280 
SOL -0.27 (0.31) -0.88(13) .394 
TST -0.10 (0.49) -0.20(13) .840 
SE -0.03 (0.42) -0.07(13) .945 
WASO 0.25 (0.42) 0.59(13) .560 





Do sleep diary variables predict distress associated with paranoia? 
None of our sleep diary variables predicted distress associated with paranoia. 
See table 25 for the results from this model. 
Table 25: The fixed effects for the model predicting whether sleep diary variables predict 
distress associated with paranoid thinking 
 Estimate (SE) Tvalue(do
f) 
p value 
Intercept 1.92 (0.28) 6.65(13) .555 
SOL -0.13 (0.30) -0.44(13) .665 
TST 0.07 (0.48) 0.15(13) .878 
SE 0.02 (0.42) 0.05(13) .960 
WASO 0.34 (0.41) 0.83(13) .419 





Do sleep diary variables predict preoccupation associated with paranoia? 
None of our sleep diary variables predicted pre-occupation associated with 
paranoia. See table 26 for results of this model. 
Table 26: The fixed effects for the model predicting whether sleep diary variables predict 
pre-occupation associated with paranoid thinking 
 Estimate (SE) Tvalue(dof
) 
p value 
Intercept 1.92 (0.28) 6.65(13) .555 
SOL -0.13 (0.30) -0.44(13) .665 
TST 0.07 (0.48) 0.15(13) .878 
SE 0.02 (0.42) 0.05(13) .960 
WASO 0.34 (0.41) 0.83(13) .419 





Do sleep diary variables predict conviction associated with paranoia? 
None of our sleep diary variables predicted conviction associated with paranoia. 
See table 27 for results of this model. 
 Table 27: The fixed effects for the model predicting whether sleep diary variables predict 
conviction associated with paranoid thinking 
 Estimate (SE) T 
value(dof) 
P Value 
Intercept 1.92 (0.29) 6.56(13) .799 
SOL -0.16 (0.31) -0.52(13) .610 
TST 0.06 (0.49) 0.13(13) .896 
SE 0.05 (0.43) 0.13(13) .899 
WASO 0.35 (0.42) 0.83(13) .422 
TIB 0.07 (0.54) 0.13(13) .896 
5.3.5 Time lagged analysis   
Hypothesis 2: Levels of sleep at one moment, will predict paranoia at the next 
moment, and this will be mediated by levels of negative affect (time- lagged 
analysis). 
To take advantage of the ESM design, we also tested whether paranoia measured 
at one timepoint (t) was predicted by sleep measured at the preceding 
timepoint (t – 1). Paranoia observations at the start of the day were excluded 
from analysis (as these observations had no preceding daily time point).  This 
model excluded one participant who showed no variation in their sleep and 
paranoia scores (all their responses were scored as 1). This model included sleep 
at t and t-1 as a Level-1 predictors, thereby controlling for sleep at t. Sleep at t-
1 did not predict paranoia at t, B = -0.01 (SE = 0.02), p = 0.687. Full time lagged 
results are presented in table 28.  
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Table 28: Time lagged analysis of whether sleep predicts paranoia at the daily level 
Predictor Estimate (SE) T value (DoF) P Value 
Sleep at current 
time 
0.05(0.04) 1.40(50) 0.15 
Sleep at T- 1 -0.01 (0.02) -0.40(79) 0.68 
 
5.3.6  Summary of results 
Our results did not support our hypotheses, sleep diary variables were not 
related to paranoia, or distress, pre-occupation and conviction associated with 
paranoia. Furthermore, there was no temporal or time lagged relationship 
between sleep and paranoia. However, inspection of individual plots of paranoia 
and sleep suggested that there may be there may be some patients, where there 
is a positive relationship between sleep and paranoia, some for whom it is 
negative, while others in our sample showed little or no variation. See figure 5.  
Figure 5 Individual relationships of paranoia and sleep measured at the daily level 
 
     
In this figure, each line represents an individual person, and the relationship between sleep and paranoia measured at 
the daily level (level 1). From the graph, it seems there are a sample of patients who have a positive relationship 
between sleep and paranoia and some who have a negative. Furthermore, there also appears to be a cluster of 
patients (bottom left of image) who showed very little variance during the ESM procedure. The solid blue line shows 
the overall regression line for all patients.  
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5.3.7  Post-hoc analyses 
5.3.7.1 Sensitivity analysis: 
As a check, we ran our analysis without patients who showed little or no 
variance. We defined lack of variance as having less than a one-point difference 
between the patient’s maximum and minimum score across all observations. This 
excluded 10 patients from the sample, leaving 10 in the analysis. Excluding 
these individuals did not change the pattern of results between sleep diary 
variables and paranoia, distress, pre-occupation or conviction. 
5.3.7.2  Moderation analysis: 
Our next approach was to examine whether the within person association 
between sleep and paranoia (level 1) varied as a function of level 2 
questionnaires (moderation analysis). For example, this would allow us to 
examine whether the relationship between sleep and paranoia varies as a 
function of PSQI score (level 2 variable), such that those with poorer sleep 
quality (higher PSQI) having a positive relationship between sleep and paranoia. 
This analysis may help us tease out whether there are some patients who do 
exhibit a relationship between sleep and paranoia. We conducted this analysis 
by including an interaction term between sleep (level 1) with sleep 
questionnaires measured at level 2. If the interaction term is significant, it 
suggests moderation exists, and results will be explored further. We ran a 
separate model for each of our questionnaires: PSQI, ESS, SCI, nightmare distress 
and MEQ. There was no significant moderation for PSQI, ESS, MEQ, nightmare 
distress or SCI. However, it was interesting to note a near significant interaction 
effect for ESS, B = -0.07 (SE = 0.03), p =0.06. This analysis is available here 
https://osf.io/4e86c/.  
5.3.7.3  Comprehension of method:  
Upon completion of the study, patients were asked 8 questions regarding the 
ESM procedure, which showed that they found the procedure acceptable, 
understood the instructions given to them, and could, read and understood the 
questions asked. It is unlikely that our results are a result of not following or 
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understanding the ESM procedure.  A list of all the items is included in appendix 
5.  
5.4  Discussion 
The aims of our study were to test whether subjective sleep measured by a sleep 
diary predicts frequency, distress, pre-occupation and conviction dimensions of 
paranoia. We also sought to test whether there was a temporal relationship 
between sleep and paranoia that was mediated by negative affect. We tested 
these relationships using ESM in a sample of people with non-affective psychosis. 
In our study, the key finding was that there was no clear relationship between 
sleep and paranoia.  
Against our hypotheses and the previous literature we did not find any 
relationship between sleep disturbance and paranoia (Freeman et al., 2010; 
Freeman et al., 2012; Rehman et al., 2018; Scott et al., 2017). We conducted 
two types of analysis. In the first we tested whether sleep diary measures 
predicted dimensions of paranoia such as frequency, distress, conviction and 
pre-occupation. None of our results were significant. However, we could not 
conduct more fine grained analysis such as looking at whether subjective sleep 
the previous night predicts next day paranoia due to missing data in our diary. 
This was an unfortunate limitation of our study. We had to aggregate our sleep 
diary measures and this may have limited variance and our ability to detect 
relationships.  In the second analysis, we tested whether there was a temporal 
association between sleep and paranoia, measured at the daily level. Again, we 
found no significant temporal relationship; levels of sleep at one time point, did 
not predict paranoia at the next time point. Therefore, we could not go on to 
test our mediation model of negative affect. One explanation for our results may 
be to do with our measure of sleep. Our items of sleep measured at the daily 
level included sleepiness, fatigue and exhaustion. These items may tap into a 
different aspect of sleep that is not related to paranoia. For example, fatigue is 
generally associated with depleted energy and weakness (Pigeon, Sateia, & 
Ferguson, 2003) whereas paranoia is associated with heightened arousal and 
alertness (Freeman et al., 2002). We may have measured aspects of sleep 
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associated with low arousal and deactivation that would not be related to 
paranoia. This could be a potential explanation for the lack of significance. 
However, when conducting moderation analysis, there was a near significant 
interaction for the ESS. In other words, the relationship between sleep and 
paranoia measured at the daily level may be moderated by levels of sleepiness. 
The relationship between sleepiness and paranoia has not been explored and 
requires further investigation.  
The findings suggest that the type of sleep disturbance related to paranoia is 
specific. Indeed, the majority of studies that have found a relationship between 
sleep disturbance and paranoia have been primarily measuring insomnia 
(Freeman et al., 2010; Freeman et al., 2012; Mulligan et al., 2016; Myers et al., 
2011). Insomnia and paranoia share a number of emotional factors that may 
drive the relationship, such as negative emotionality (Freeman et al., 2010; 
Mulligan et al., 2016).  
For example, it has been shown that when adding affective measures such as 
anxiety and depression, the relationship between insomnia and paranoia are 
reduced (Freeman et al., 2010). In our study, patients with and without sleep 
disturbance were eligible and our sample is likely to be more heterogeneous and 
non-specific. Even though sleep disturbances were common in our sample, a 
wide range of sleep disturbances were reported. It is unclear how prevalent or 
dominant insomnia difficulties were in our sample; our measure of insomnia was 
based on only two items. 
However, it is important to note that there are some sleep disturbances that do 
not have such a clear link to symptoms. For example, a study found profound 
sleep and circadian disturbances in people with schizophrenia, which was 
independent to their symptoms at the time (Wulff et al., 2012).  This finding has 
also been reported in other studies measuring circadian functioning (Bromundt 
et al., 2011; Martin et al., 2001). It may be also that there was a high level of 
circadian disturbance in our sample. Given that the majority of our sample was 
unemployed, they may have experienced lack of routine and this can cause body 
clocks to become out of sync with the environment (Boivin, 2000). As we did not 
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have any objective measure of sleep in our study, this is speculative. Including 
actigraphy would have helped to visualise whether they were circadian 
disturbances in our sample. Clearly, future research is required to closely 
examine whether aspects of sleep and circadian functioning are linked to 
paranoia. A recent review concluded that the relationship between various sleep 
disturbances and psychotic symptoms requires further work (Reeve et al., 2015).  
  
Another important finding in our study was that there was a sub-sample of 
patients who reported very little or no variation in their sleep, mood or 
symptoms over the course of the ESM framework. Sensitivity analyses with and 
without these 10 patients made no difference to the results. However, it is 
worthwhile to speculate why these patients showed such little variation. It is 
unlikely to be due to not engaging or understanding the ESM procedure, as all 
patients completed a questionnaire which showed that they had no issues with 
the procedure. One potential explanation may be alexithymia. Alexithymia is a 
trait whereby individuals have difficulties in understanding what they are 
feeling, or being able to verbalise how they feel (Bagby et al., 1994). Research 
has also shown that alexithymia is common in individuals with schizophrenia and 
found elevated in comparison to the general population (Kubota et al., 2012; van 
't Wout et al., 2007). It is possible that these individuals may struggle with the 
experience sampling procedure. Based on a cut off for alexithymia (TAS scores 
>61) 10 patients in our sample could be classed as alexithymic, of which 4 were 
from the low-variance group. This could potentially explain the low variance in 
some participants, but is not a full explanation. Another potential reason could 
be that the sampling procedure was not long enough to capture the full range of 
experiences for some of the patients and that we sampled some patients during 
a “good week”. To our knowledge, a sub-sample with lack of variation has not 
been reported before in ESM studies of people with NAP. Another potential 
explanation for lack of results in our study is the role of negative symptoms. 
Negative symptoms can be associated with lack of emotional expression, social 
withdrawal and inability to experience pleasure (Andreason, 1982). Individuals 
with elevated negative symptoms may have found it difficult to express their 
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feelings and experiences, and this could have contributed to some of the null 
findings reported. As we have no information to the levels of negative symptoms 
we cannot test this explanation. Finally, the potential effects of seasonality and 
circadian variability is worth noting. The recruitment process lasted between 
winter of 2014, and ended in spring of 2016, meaning that patients were 
recruited in all seasons. It has been shown that sleep shows a seasonal pattern, 
with sleep time being longer and sleep being delayed in the winter  (Kohsaka, 
Fukuda, Honma, Honma, & Morita, 1992; Oyane, Ursin, Pallesen, Holsten, & 
Bjorvatn, 2008), These effects have been partially attributed to lack of daylight 
(Friborg, BJORVATN, Amponsah, & Pallesen, 2012). Furthermore, mood has been 
shown to have both seasonal and circadian patterns, with positive mood peaking 
at noon and in the evening (Hasler, Mehl, Bootzin, & Vazire, 2008) and 
depressive symptoms being higher during winter months (Tonetti, Barbato, 
Fabbri, Adan, & Natale, 2007). Given these findings, perhaps there may be 
different relationships between variables such as sleep and mood depending on 
the season. As we did not have equal numbers of people across different 
seasons, we cannot test this.  
Finally, despite our lack of significant results, we note that sleep disturbances 
were present in our sample. There was evidence of disturbance of sleep 
continuity, with patients taking more than 30 minutes to fall asleep, and being 
awake during the night. The self- reported sleep disturbance values are similar 
to other samples of patients who were recruited on the basis of experiencing 
poor sleep (Freeman et al., 2005; Mulligan et al., 2016). Specific sleep 
disturbances were also common in our sample; only 5 of the patients in the 
sample could be classed as good sleepers. Furthermore, 6 of the patients 
reported excessive sleepiness (10 or more on ESS) and nightmares and insomnia 
were also reported. Previous research has found levels of insomnia; nightmares 
and circadian disruption to be elevated in people with a diagnosis of 
schizophrenia (Cohrs, 2008; Freeman et al., 2010; Freeman et al., 2012; Wulff et 
al., 2012) and our findings are in line with this. 
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5.4.1  Limitations  
Several limitations of our study should be considered when interpreting the 
results. Our study was fully subjective, and we did not have any objective 
measures of sleep. Both objective and subjective sleep are disrupted in people 
with schizophrenia and including actigraphy measures would have given deeper 
insight into sleep patterns. Furthermore, a recent study reported that the 
interaction between subjective and objective sleep was a stronger predictor of 
psychotic symptoms than using one method alone (Cosgrave et al., 2018). Due to 
the diverse medication profile patients were on, we could not test whether 
medication was linked to some of the results. Most patients being on multiple 
medications with some patients being on more than one anti-psychotic and many 
were on medications for other health conditions including high blood pressure, 
back pain and migraines (see appendix 4). The complex medication profiles of 
patients is likely to have an effect on mood, sleep and general well-being which 
could have influenced some of our results. However, this is representative of a 
typical outpatient sample. Moreover, in our study inferences about causality 
cannot be made. Although time-lagged data takes us closer to making causal 
inferences, the relationship could also exist in the opposite direction (e.g. 
paranoia predicting sleep). We ran this analysis as a check, and paranoia at t-1 
did not predict levels of sleepiness at the next time point  
5.4.2 Conclusions 
We did not replicate the relationship between sleep disturbance and paranoia in 
a sample of medicated outpatients with schizophrenia. However, sleep 
disturbance was present within our sample which supports the continued 
development of therapeutic interventions to improve sleep and circadian 




6 Clinician perceptions of sleep problems, and 
their treatment, in patients with non-affective 
psychosis. 
6.1 Introduction 
Sleep problems may well be a prominent concern for individuals with non-
affective psychosis diagnoses such as schizophrenia, with estimates of the 
prevalence of sleep disturbance ranging between 30 and 80% (Cohrs, 2008). A 
range of sleep disorder problems have been reported in this patient group 
including insomnia (Cohrs, 2008), circadian rhythm disruption (Wulff et al., 
2012) hypersomnia (Okruszek et al., 2014) and nightmares (Sheaves et al., 
2015). It is not clear yet what causes the sleep problems in people with 
psychosis, but a number of candidates have been proposed. A recent twin study 
found overlap in the genetic and environmental causes of both sleep disturbance 
and psychotic experiences such as paranoia (M. J. Taylor, Gregory, Freeman, & 
Ronald, 2015). Antipsychotic medications are known to interact with 
neurotransmitter systems that are involved in sleep/wake regulation and this 
may cause some sleep problems. For example, clozapine can increase sedation 
and aripiprazole has been linked to insomnia (Krystal, Goforth, & Roth, 2008). 
Another candidate is mood.  Elevated levels of depression and anxiety which are 
common in people with psychosis, also increase the risk for sleep problems such 
as insomnia (Baglioni et al., 2010). Psychotic experiences such as paranoia and 
voices may contribute to sleep disturbance (Jeppesen et al., 2015; Waite, Myers, 
et al., 2016). Finally, the high co-morbidity of physical health problems in 
people diagnosed with schizophrenia may also contribute to poor sleep (Kalucy, 
Grunstein, Lambert, & Glozier, 2013). The view now stated in DSM-5 is that 
sleep problems should be assessed and treated irrespective of other psychiatric 
difficulties (AmericanPsychiatricAssociation, 2013). Clinical guidelines 
recommend hypnotics for acute insomnia and cognitive behavioural therapy 
(CBT) for persistent insomnia (Morin & Benca, 2012). There is emerging evidence 
that CBT, suitably adapted, can improve sleep in people with psychosis and may 
also lower levels of delusions and hallucinations (Myers et al., 2011). A pilot 
randomised clinical control trial with 50 patients with current delusions and 
135 
135 
hallucinations in the context of non-affective psychosis found that an eight 
session CBT intervention led to very large improvements in sleep (Cohen’s effect 
size 1.9, CI=0.9, 2.9) (Freeman, Waite, et al., 2015). Adaptations for CBT in 
people with psychosis used in this trial have been described (Waite, Evans, et 
al., 2016) including a greater focus on circadian rhythm disruptions and the 
interaction with psychotic experiences. Furthermore, a recent qualitative study 
from this trial noted how highly valued the treatment of sleep problems is for 
this patient group (Waite, Myers, et al., 2016). However, the level of recognition 
in services of the extent of sleep problems in patients with psychosis and 
subsequent assessment and treatment in standard care has not been assessed. 
The aim of the current study was to address this gap. 
6.2 Methods 
A 16 item online survey was delivered using Qualitrics survey software 
(Qualtrics, Provo, UT). As there was no suitable questionnaire available to assess 
clinician perceptions, the authors generated questions based on their own 
research and clinical experience. We wished to devise a questionnaire that 
would generate descriptive data that could inform future knowledge exchange 
aimed at facilitating discussion and debate about research and clinical priorities 
for clinicians and other stakeholders. A process of discussion and refinement 
lead to questions that spanned 3 areas of sleep: the prevalence/types of sleep 
problems (e.g. What are the most common complaints patients with psychosis 
report about their sleep?), the impact/causes (e.g. In your view, what causes 
the sleep problems in people who experience psychosis?) and the 
assessment/treatment (e.g. What methods do you use to treat sleep problems in 
patients with psychosis?). Furthermore, to gain more insight into what barriers 
currently exist in clinical practise, two open ended questions were included: ‘In 
your view, are there any barriers to treating sleep problems in patients with 
psychosis?’ ‘Are there any other comments you wish to add about sleep in your 
patients with psychosis?’ The full list of questions is included in appendix 6. 
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6.2.1  Participants  
Emails containing the survey link were sent to clinical teams treating patients 
experiencing psychosis in 2 NHS localities: Glasgow Greater Glasgow & Clyde and 
Oxford Health NHS Foundation Trust. The survey was also advertised in staff 
newsletters and on posters in staff rooms. The study was reviewed and approved 
by the University of Glasgow ethics committee (reference: 200140033).  
The instructions displayed to clinicians on the survey included: 
“The questions in the survey ask about sleep in individuals with non-affective 
psychosis (e.g. schizophrenia, schizoaffective disorder and other non-affective 
psychotic disorders). Please answer the questions in relation to patients with 
non-affective psychosis.” 
6.2.2  Data analysis 
Descriptive statistics are presented for clinician responses to the questions. 
Reported percentages do not always add up to 100% because clinicians could 
select more than one answer for a number of the questions. The two open ended 
questions were analysed qualitatively using the Framework Analysis approach 
(Ritchie & Spencer, 2002), since the data were collected in accordance with our 
priori aims and objectives. Framework Analysis is a flexible approach to 
generating themes and organising different types of qualitative data (Pope, 
Ziebland, & Mays, 2000; Ritchie & Spencer, 2002). Analysis of clinician 
comments was conducted by AR, following the 5 steps outlined in Ritchie & 
Spencer (2002). Analysis of clinician comments was conducted by AR, following 
the 5 steps outlined in Ritchie & Spencer (2002). These 5 steps were 
familiarisation with the data (reading and re-reading comments), developing 
themes (identifying key issues and concepts within the comments), indexing 
(linking the themes to the data), charting (re-arranging data according to theme 
it fits with) and interpretation of the whole dataset (linking the findings to the 
original research question).  The credibility of the coding and thematic analysis 




6.3.1  Clinician characteristics and type of service: 
111 clinicians completed the online survey. A range of professions participated: 
psychiatric nurses (n=43, 39%), psychiatrists (n=38, 34%), psychologists (n=13, 
12%), occupational therapists (n=7, 6%), social workers (n=6, 5%) and other (n=4, 
4%). Almost half the clinicians were based in adult community mental health 
centres (CMHT’s) (n=52, 47%). Other service types included early intervention 
services (n=22, 20%), inpatient wards (n=20, 18%), crisis service teams (n=1, 1%), 
primary care teams (n=1, 1%) and other (n=15, 13%).  
6.3.2  Prevalence and types of sleep problems 
Sleep problems were considered as very common in patients with psychosis, with 
all clinicians reporting sleep problems in their patients. Difficulties falling asleep 
(insomnia) and oversleeping (hypersomnia) were the most commonly reported 
sleep complaints, followed by issues with the timing of sleep (circadian rhythm 
disturbance). See table 29 for full description of the questions and responses.  
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Table 29: Clinician reports of sleep disorder prevalence rates and types of sleep disorders in patients with psychosis. 
 0 1-20% 21-40% 41-60% 61-80% 81-100% Unsure  
What percentage of patients 
that you see with psychosis, 
also have sleep problems? N (%) 
0 N=8(7%) N=28, (25%) N=18, (16%) N=32, (29%) N=14, 
(13%) 
N=11, (10%)  









Narcolepsy Parasomnias Other  
What are the most common 
complaints patients with 
psychosis report about their 
sleep? (Select all that apply) 
N=97, 
(87%) 




6.3.3  Impact/causes of sleep problems: 
Sleep problems were viewed to have a negative impact in a wide range of domains 
with nearly all (n=104, 93%) clinicians reporting that sleep problems have a 
negative impact on daytime functioning. No clinician endorsed the item “there is 
no link between sleep and psychosis”. The majority of clinicians (n= 104, 93%) 
endorsed the option that the relationship between sleep problems and psychosis is 
bidirectional (i.e. that both sleep and psychotic symptoms influence each other). A 
small number of clinicians endorsed a unidirectional relationship, i.e. the view 
that sleep problems make psychotic experiences worse (n=2, 2%), or that psychotic 
experiences make sleep problems worse (n=3, 3%) and (n=2, 2%) were unsure.   
Various causes were reported to cause sleep problems in people with psychosis. 
Poor sleep hygiene was the most commonly reported cause of sleep problems and 
negative symptoms was the least commonly reported cause. A number of clinicians 
(n=18, 16%) stated other causal factors (e.g. lack of daytime activity, smoking and 
illicit drug use). See table 30 for full description of the questions and responses. 
6.3.4  Assessment/treatment: 
6.3.4.1  How often do you formally assess sleep problems in people with 
psychosis? 
Over half of clinicians (n=60, 54%) were unsure about how often they were 
formally assessing sleep problems. Twenty- three (21%) reported assessing sleep 
problems in the majority of their patients, 13 (12%) reported assessing sleep in 
around half of their patients, 11 (10%) reported assessing sleep in a minority of 
their patients and 4 (3%) reported assessing sleep rarely or never. 
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Table 30 Clinician reports of the impact and causes of sleep problems in patients with psychosis. 

















have a negative 
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the following 
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N=2, (2%) N=3, (3%) N=104, 
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In your view, 
what causes the 
sleep problems 
in people who 
experience 
psychosis? 















6.3.4.2 What methods do you use to assess sleep problems in people with 
psychosis?  
The majority of clinicians (n=92, 83%) reported assessing sleep by informally asking 
patients. This is followed by 18 (16%) using structured interviews, 4 (4%) using self-
report tools and 2 (2%) using objective methods (e.g. actigraphy). Twelve 
clinicians (11%) used ‘other’ methods of assessment which included observations in 
wards, sleep diaries and verification from family/friends. 
6.3.4.3 What methods do you use to treat sleep problems in patients with 
psychosis? 
A range of treatment methods were used by clinicians with the most common 
being sleep hygiene (n=104, 94%), and CBT was least frequently endorsed (n=13, 
12% delivering the intervention; n=19, 17% referring for CBT intervention). 
Medication was commonly used for treating sleep problems: hypnotics (n=64, 58%), 
antipsychotics (n=49, 44%), antidepressants (n=42, 38%) and anxiolytics (n=30, 
27%).  
6.3.4.4 What form of sleep treatment would you recommend for a patient with 
long-standing sleep difficulties and psychotic symptoms? 
Fifty-seven (51%) clinicians recommended multiple sleep treatments including 
medication, sleep hygiene, online self-help and CBT. A number of clinicians 
recommended a single treatment: 45 (40%) recommended sleep hygiene, 27 (24%) 
recommended medication, 24 (22%) recommended CBT and 16 (14%) recommended 
online self-help.  
6.3.5  Qualitative analysis  
From the qualitative analysis, 3 themes emerged regarding barriers to treating 
sleep problems in people with psychosis. The first theme was termed “Patient 
Related Factors” which could be further split into two subthemes i) “Lifestyle of 
the Patient” and ii) “Illness Related Factors”. “Lifestyle of the patient” included 
aspects of the patients life that can act as a barrier to treatment such as lack of 
routine, alcohol/drug dependence, lifestyle habits, social support, individual 
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differences and motivation levels. The second subtheme, “Illness Related Factors”, 
included severity of disorder, stage of illness, affective disturbance, capability of 
patient and medication and their side effects. The second theme was termed 
“Service Related Factors” which included lack of time, lack of awareness of sleep 
as a problem, resources, access to treatments, training needs, and acting as 
barriers. We also noted that a number of clinicians perceived there to be no 
barriers to treating sleep problems. The third and final theme was termed “Other 
Environmental Factors”, and this included barriers that are found on wards and in 
prisons. Example quotes from each theme are presented in table 31. 
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Table 31 Qualitative themes with example quotations 
Theme one: Patient 








Sub Theme 1 
Lifestyle of 
patient 
















































fearful of the 
process” 
“In an acute 
state I think 





about CBT for 
insomnia…” 
“Time pressure” 
“Lack of knowledge in 
staff” 
“Lack of knowledge 
and resources to treat 
sleep problems” 
“Clinicians may not 
assess complaints of 
sleep problems in 
sufficient detail” 
“It appears to me to be 
a significant issue that 
often seems neglected 
or viewed as a 
symptom of mental 
distress”  





wards are not 
conducive to good 
sleep” 




of its 'street value' 
amongst prisoners - 
makes treating sleep 
problems in the 
prison (a very big 
problem) difficult.” 






6.4  Discussion 
This is the first study to ask clinicians about their perceptions of sleep in people 
with non-affective psychosis. There was a clear disconnect: the importance of 
sleep in psychosis was well-recognised but assessment and treatment were 
limited. Clinicians also reported a number of barriers to treatment 
implementation. 
We found that clinicians were highly aware of the range of sleep problems that 
present in people with psychosis, particularly insomnia, hypersomnia and 
circadian rhythm disturbance. In the present study clinicians also identified a 
link between poor sleep and several domains of functioning including level of 
symptoms, mood and daytime activities. There is some support for these claims 
with poor sleep being associated with lower quality of life (Hofstetter et al., 
2005) increased positive symptoms (Afonso, Brissos, Figueira, & Paiva, 2011) and 
impaired cognitive functioning in people with psychosis (Bromundt et al., 2011). 
Other work in support of clinician opinions comes from research finding links 
between sleep disturbance and impaired physical health and mood disturbance 
(Cappuccio, Cooper, D'Elia, Strazzullo, & Miller, 2011; de Wild-Hartmann et al., 
2013; D. J. Taylor et al., 2007). These findings suggest that not only are sleep 
problems common and diverse, but that poor sleep may be negatively affecting 
many areas of functioning in people with psychosis. This emphasises the 
importance of treating sleep problems in this population. 
Clinicians also reported multiple causes of the sleep problems. Causal factors 
identified included poor sleep hygiene, positive symptoms, affective symptoms, 
followed by medications and negative symptoms. Work on the causes of sleep 
problems in people with psychosis is currently underway. There is growing 
evidence to suggest that sleep problems may precede the onset of psychosis, 
with a recent review concluding that sleep disturbance is very common in 
individuals at risk for psychosis (Davies et al., 2017). For example, in one 
longitudinal follow up study in people at risk for developing psychosis, sleep 
disturbance predicted transition to psychosis (Ruhrmann et al., 2010). Another 
line of work has examined the relationship between sleep disturbance and 
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individual psychotic experiences (Reeve et al., 2015). For example, in a large –
scale general population study conducted in 8,580 people, insomnia was 
associated with an approximately two to threefold increase in paranoid thinking 
(Freeman et al., 2010). A follow up study reported that insomnia was also a 
significant predictor of new incidences of paranoid thoughts, suggestive of 
insomnia having a causal role (Freeman et al., 2012). The Oxford Access for 
Students Improving Sleep (OASIS) trial is currently underway testing the 
potential causal relationship between insomnia, paranoia and hallucinations 
(Freeman, Sheaves, et al., 2015). Other additional causal factors identified by 
clinicians were also reported as barriers to treating sleep problems in people 
with psychosis such as lack of routine, low levels of daytime activity and 
drug/alcohol dependence. Another barrier recognised by some clinician’s 
concerned medications and their side effects. Although anti-psychotics are the 
recommended treatment for psychosis and such medications tend to improve 
sleep continuity, (Cohrs, 2008; Monti & Monti, 2004) their side effects such as 
sedation may cause further sleep problems. 
Clinicians mainly assessed sleep complaints in people with psychosis by 
informally asking them about their sleep. Few used objective (e.g. actigraphy) 
and subjective methods (questionnaires), although a number of clinicians (n=10, 
15%) used structured interviews to assess sleep. Patients own informal accounts 
of sleep problems are a quick and easy way to gain an impression of sleep 
problems when clinical time is limited. However, an in-depth and accurate 
assessment of sleep problems is critical in identifying the most appropriate 
treatment pathway that can target the specific sleep problem. Clinicians 
identified time as a barrier to treating sleep problems. This barrier could be 
addressed by making available brief and validated questionnaires that can assess 
the severity of the sleep problem and allow monitoring of sleep over time such 
as the Sleep Condition Indicator and the Epworth Sleepiness Scale (Espie et al., 
2014; M. W. Johns, 1991). The Sleep Condition Indicator has been developed 
specifically for clinicians to assess insomnia quickly and accurately. The short 
two-item version would be a particularly useful initial screening tool to assess 




It was also found in the study that clinicians were treating sleep problems but 
mainly by use of sleep hygiene techniques, despite the very limited 
effectiveness of such approaches (Morgenthaler et al., 2006). There was also a 
reliance on medications such as hypnotics, which should only be used only for 
short periods of acute insomnia (Morin & Benca, 2012). Critically, we found that 
even though clinicians would recommend a range of treatments including CBT, 
the numbers of clinicians actually referring people with psychosis to such 
services is much lower. According to recent guidelines, CBT is the recommended 
treatment for persistent insomnia and use of medications for other psychiatric 
disorders are not currently recommended (APA, 2013; Morin & Benca 2012).  
Some of the barriers identified by clinicians may explain the discrepancy 
between recommendation of CBT and low referral rates such as lack of access to 
sleep treatments. This barrier could be addressed by making CBT more widely 
accessible. Other barriers reported by clinicians include those specific to 
patients such as low motivation to change habits. These are barriers that can be 
addressed by highlighting the importance of good sleep, and empowering people 
with psychosis to gain control of their own sleep using evidence based 
techniques (Waite, Myers, et al., 2016).   
Finally, clinicians also noted that barriers to treating sleep problems exist in 
very specific environments such as inpatient wards and prisons. For example, 
assessing and treating sleep problems may be difficult in wards due to noise 
levels, night- time observations and limited resources to implement 
interventions. More work is required to address these barriers. 
The findings of our study should be viewed in light of some limitations. Firstly, 
clinicians who are interested in sleep would be more aware of sleep problems 
and may have been more motivated to complete the survey, and this may well 
have biased our sample. The survey was also completed mainly by psychiatrists 
and psychiatric nurses and completed from clinicians in only two NHS trusts, one 
of which was the site for an intervention study for sleep in patients with 
psychosis.  In spite of this, the results of the survey within the group are clear: 
sleep problems are considered very common in people with psychosis but 
services are currently limited in their responses to this issue.  
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6.4.1  Clinical implications and recommendations for future 
studies 
Sleep problems are very common in people with psychosis and this makes 
developing treatment pathways an important clinical aim (Waite, Evans, et al., 
2016). Greater awareness about the importance of sleep amongst both staff and 
people with psychosis is also required.  Training programmes would enable staff 
to identify, assess and treat sleep problems. We call for more research on 
understanding the causes of sleep problems in non-affective psychosis and 
testing the implementation of evidence- based sleep interventions in patients 
with non-affective psychosis. More work is also required to identify the impact 
of different medications on sleep.  
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7  General Discussion 
7.1 Summary of findings 
Chapter 3 described two studies that investigated the relationship between 
sleep quality and paranoia in healthy non-clinical samples. It was hypothesised 
that this relationship would be mediated by negative emotions, alexithymia and 
perceptual anomalies. These relationships were investigated on an online 
survey, which allowed for large samples.  In study 1 of chapter 3 we found 
perceptual anomalies, negative affect and alexithymia partially mediated the 
relationship between sleep and paranoia. This in line with other studies that 
have also found negative emotion to be a significant mediator (Freeman et al., 
2010; Scott et al., 2017). Our study was also novel, in that it was the first study 
to test another facet of emotion- levels of emotional awareness measured by 
alexithymia. Furthermore, this study provided a direct test of whether 
perceptual anomalies predicted paranoia. Together, the first study in this 
chapter highlighted that emotional and non-emotional factors play a role in the 
sleep- paranoia relationship. Study 2 was conducted to confirm and replicate the 
findings of study 1 and to test robustness of these findings. The addition of study 
2 however, painted a more complex picture. Firstly, instead of partial mediation 
there was full mediation. In other words, negative emotion, alexithymia and 
perceptual anomalies fully explained the relationship between sleep and 
paranoia. Secondly, the aspect of negative emotion differed. In study 1 it was 
negative affect, while in study 2 anxiety was the mediator. Reasons for 
discrepant results were explored by conducting linear regressions. It was 
revealed that in study 2, sleep quality was not a significant predictor of paranoid 
thoughts. Therefore, we could not fully replicate the results of study 1. Sample 
differences across studies were ruled out as a reason for discrepant results. 
Instead, it was hypothesised that the nature of sleep disturbance in the 
participants of sample 1 may differ from those in study 2 and this may explain 
the differences. For example, the relationship between sleep and paranoia is 
strongest for insomnia and there may have been more insomnia in participants of 
study 1. As we used a general measure of sleep quality, we could not directly 
test this.  
150 
150 
In chapter 4, a synthesis and systematic review of sleep disturbance in people 
with psychosis was conducted. The review was unique in that it looked at sleep 
in psychosis from a methodological viewpoint.  What methods have been used to 
investigate sleep in people with psychosis, and where are there methodological 
weaknesses in the studies? Main findings of this study included that a range of 
subjective and objective methods have been used and that a wide range of sleep 
disturbances have been reported. However, the review called into question 
some of the strength of these findings as there were areas of bias identified. 
Some of these biases were common across all methods such as power. Unique 
areas of bias were also identified, such as not including an adaptation night in 
PSG studies. There was also no one sleep parameter that was reliability 
disrupted in people with psychosis.  
Next in chapter 5, we sought to extend the findings of chapter 3 by looking at 
sleep and paranoia in a clinical sample of people diagnosed with NAP and we 
considered some of the limitations outlined in chapter 4. In chapter 5, a wide 
range of validated sleep questionnaires were used to quantify the levels of sleep 
disturbances found and to look at what aspects of sleep are disrupted. 
Furthermore, we also used ESM and sleep diaries to try and investigate the 
relationship between sleep and paranoia in more detail. The findings from this 
study were surprising as across two different types of analyses, we did not find 
significant relationships between sleep and paranoia. We also couldn’t test 
mediation models due to the lack of relationship between sleep and paranoia. 
On closer inspection, this may be partially due to the heterogeneous sample, 
and because of the measurement of sleep. However, sleep disturbances were 
common in the sample.  
Finally, in chapter 6 we investigated clinician perceptions of sleep to try and 
understand what is happening in clinical practise. Across two NHS trusts- 
Glasgow and Oxford, it was found that clinicians reported high levels of sleep 
disturbances in people with NAP and that they felt sleep was related to areas of 
functioning including symptoms, and mood. A key finding was that even though 
sleep problems were common, clinicians did not have the time and resources to 
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adequately assess and treat sleep problems. Table 32 presents a summary of the 
results from this thesis.  
7.2 Synthesis and discussion of findings  
Taking the findings of the chapters together paints a complex picture. Across 
clinical and non-clinical samples, there was no consistent relationship between 
sleep and paranoia. The systematic review also highlighted methodological 
weaknesses in sleep studies in people with NAP. However, in clinical practise, 
sleep disturbances are very common and clinicians are trying to treat them. The 
findings of the clinician survey are in line with qualitative studies of sleep in 
people with psychosis. In two separate qualitative studies it has been reported 
that people report poor sleep, and that they believe sleep has an impact on 
daily functioning including mood and symptoms (Faulkner & Bee, 2017; Waite, 
Evans, et al., 2016). The findings of the thesis can be summarised into two main 
findings: there was no clear link between sleep and paranoia, but that sleep 
disturbances are common in people with psychosis. These two findings will be 
discussed next in more detail. 
7.2.1  The relationship between sleep and paranoia.  
Sleep is a complex state, and can be measured and assessed on different levels, 
and in different ways, and this can contribute to mixed results across studies. 
The approach in this thesis has been to focus on one symptom common in 
psychosis: paranoia. However, sleep has been measured using a range of 
different questionnaires. This raises the question – which aspects of sleep should 
be measured and focused on? Currently, insomnia has been the most well 
studied sleep disturbance in psychosis and in relation to paranoia. The group led 
by Daniel Freeman has found that insomnia predicts paranoid thinking in both 
clinical and non-clinical samples (Freeman et al., 2010; Freeman et al., 2012; 
Myers et al., 2011) in both cross-sectional and longitudinal designs. Another form 
of evidence comes from treating sleep and examining the impact improving 
sleep has on paranoia. In a pilot trial of CBTi it was found that there were large 
effect size reductions in sleep, mood and paranoia. However, in a RCT of CBTi, 
there were large improvements in sleep, but only a small correlation of 
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improvements in sleep with levels of paranoia (Freeman, Waite, et al., 2015). It 
has also been shown that improving sleep via digital CBTi in a non-clinical 
sample who experience insomnia, is associated with an improvement in paranoia 
(Freeman et al., 2017). Given these findings then, why was there not a 
relationship of sleep and paranoia in the studies in this thesis? The most likely 
reason for this is that we did not include a specific measure of insomnia. For 
example, in chapter 3 I used the PSQI which is a measure of general sleep 
quality. Sleep quality can be influenced by numerous factors, and it is likely that 
insomnia was not the only factor contributing to poor sleep. In chapter 5 the 
short version of the SCI was used to assess insomnia, which may not have been 
extensive enough to capture insomnia in my sample. Another reason is also that 
previously mentioned studies that have examined sleep and paranoia, have used 
highly selected samples who report insomnia and paranoia. For example, criteria 
to be included in clinical trial that investigated if CBTi improved sleep and 
symptoms was evidence of persistent paranoia for at least 3 months and 
evidence of clinical insomnia (Freeman, Waite, et al., 2015). Therefore, these 
studies are more powered and able to capture the relationship. In contrast, in 
both chapter 3 (non-clinical sample) and 5 (clinical sample), to be included 
participants did not need to report insomnia or paranoia, creating more 
heterogeneous samples. This also suggests that there are people who have a 
diagnosis of psychosis who experience poor sleep, but this is not related to 
presence of paranoia. In other words, sleep disturbance can occur on its own, 
without it being linked to specific symptoms.  
7.2.2  Sleep disturbances are common in people with psychosis 
An important finding reported in chapter 5 is that a range of sleep disturbances 
were common in the sample of people with psychosis, with most participants 
being scored as poor sleepers. Sleepiness and nightmares were also common. 
This is also observed in clinical practise as outlined in chapter 6. Therefore, 
while the research on insomnia and paranoia is building up, the impact of other 
sleep disturbances on areas of functioning such as symptoms is yet to be 
explored. For example, in the clinician survey in chapter 6, hypersomnia was the 
second mostly commonly reported sleep complaint identified. Prevalence rates 
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for hypersomnia in psychosis range from 32-58% (Sharma et al., 2016; Wichniak 
et al., 2009) however the impact of hypersomnia in relation to symptoms has not 
be assessed. Whilst clinicians identified movement related disorders and 
breathing also being common, prevalence rates are not available. Their impact 
remains unknown. Regarding circadian disturbance, a number of studies have 
documented circadian disturbances in people with psychosis (Bromundt et al., 
2011; Wulff et al., 2012). In these studies, there was no relationship to 
symptoms, however they did not focus on specific symptoms such as paranoia. 
This highlights that there is a range of sleep disturbances that have not yet been 
systematically investigated in people with psychosis, and their impact has not 
been studied. 
7.2.3  Limitations of the thesis 
There are some limitations in this thesis that deserve comment. Firstly, the 
thesis has examined sleep throughout the chapters using subjective measures 
only. Although only validated measures have been used, the addition of 
objective measures would have helped complement the subjective data. It is to 
be noted that I did originally include actigraphy in chapter 5. However, the 
database this data was stored on became non-functional and the data was lost. 
In the case of chapter 3, it would not have made sense to use actigraphy due to 
the large sample sizes recruited. Another limitation is the lack of control sample 
in chapter 5. There are also limitations with the patient sample. There was no 
information on their symptom levels or previous hospitalisation information. This 
would have helped provide a fuller account and description of the patient 
sample. Furthermore, the medication profiles were diverse and most were on 
multiple medications. It is not clear how the combination of different 
medications may influence sleep. However, an unmedicated sample would not 
be representative of a psychosis outpatient sample. In terms of chapter 6, there 
may be a bias in the clinicians who completed the survey, as only those who 
were aware and dealing with sleep problems would be likely to complete it. This 
may have inflated the findings. Nonetheless, the findings still point to the fact 
that sleep problems are a common complaint in people with psychosis, and some 
clinicians are actively trying to treat sleep.  
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7.2.4  Directions for future research  
This thesis has documented that the relationship between sleep and paranoia is 
more complicated than first appears. This relationship may be specific only to 
patients who report clinically relevant levels of insomnia and persistent 
paranoia. This thesis also identified that a range of sleep problems are common 
in people with psychosis, and are commonly being reported by patients in 
clinical practise. Many unanswered questions remain. More specifically there is a 
need to a) Further understand the relationship between insomnia symptoms and 
paranoia and to understand the mechanisms underlying the relationship, b) 
understand the nature and impact of sleep disturbances in people with psychosis 
and c) refine and further develop sleep interventions that address the range of 
sleep disturbances experienced in people with psychosis. Each of these points 
will be expanded on in the next section.  
7.2.4.1 Further understand the relationship between insomnia and paranoia 
It is clear now that a relationship between insomnia symptoms and paranoia 
exists, which is partially mediated by negative affect (Freeman et al., 2010). 
There is a need to refine this model further and test other theoretically relevant 
mediators.  In chapter 1, perceptual anomalies and emotional awareness were 
also meditators. As we focused on sleep quality and not insomnia symptoms, it 
would be of interest to test whether these factors also mediate insomnia and 
paranoia. Furthermore, cognitive factors have not been investigated in the 
insomnia-paranoia relationship. It has been shown that the reasoning bias 
jumping to conclusions is associated with delusional thinking, and may be 
relevant for paranoia (Freeman, Pugh, & Garety, 2008; Moritz & Woodward, 
2005). As poor sleep is also associated with lowered cognitive functioning (Alhola 
& Polo-Kantola, 2007) this could be a potential target of study. Furthermore, in 
chapter 5, we also measured dimensions of paranoia- distress, pre-occupation 
and conviction. Research examining how insomnia symptoms relate to these 
dimensions would also be important. For example, are insomnia symptoms 
related to distress associated with paranoia, as well as frequency? Distress is 
often associated with negative emotions, so this could be a potential route to 
explore. Insomnia symptoms are multi-faceted, and can be defined by 
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difficulties in initiating sleep, maintaining sleep or early morning awakening 
(APA, 2013). One study found that perceived problems in initiating sleep was 
related to paranoia, but not problems maintaining sleep (Scott et al., 2017). This 
study was conducted in a non-clinical sample and requires replication in a 
patient sample. By identifying more closely which dimensions of insomnia and 
paranoia are linked, and how they are mediated, provides useful targets that 
can be used to refine sleep interventions that are currently being used 
(Freeman, Waite, et al., 2015).For example, if sleep initiation problems are 
most relevant for paranoia, CBTi elements that address this can be used in 
treatment. This also gives more options to people with psychosis on what’s 
aspects of insomnia they may want to improve on and promotes more autonomy 
in their treatment.  
7.2.4.2 Understand the nature and impact of sleep disturbances in people 
with psychosis 
Given the wide range of sleep disturbances reported in psychosis, there is a need 
to document and understand their impact on areas of functioning. This is a 
difficult feat and made more complicated by factors such as medication status 
and co-morbid health problems. Longitudinal studies that follow people at risk 
for psychosis can help document changes in sleep, and how this might relate to 
symptoms. Such a study would be able to tease out if there is a threshold of 
sleep disturbance that must be reached before an individual develops psychosis 




Table 32 Summary of thesis findings 
Chapter 3 Chapter 4 Chapter 5 
 
Chapter 6 
No consistent link 
between sleep 
quality and paranoid 
thinking. 
Study was conducted 
in non-clinical 
sample. 
Effects were small.  
A systematic review was 
conducted in 58 studies 
that have investigated 
sleep in people with 
psychosis. 
Key methodological areas 
of bias were outlined. 
The review calls into 
strength some of the 
sleep-psychosis findings.  
A novel experience 
sampling study was 
conducted investigating 
sleep in people with 
psychosis.  
Subjective sleep was 
investigated. 
Sleep diary variables did 
not predict paranoia. 
There was no time-
lagged temporal 
relationship between 
sleepiness and paranoia. 
A sub-group of 
participants showed no 
variation in their 
responses  
An online survey in 111 clinicians was conducted 
to investigate their perceptions of sleep.  
All clinicians believed there is a relationship 
between psychosis and sleep. 
Framework analysis was conducted on open 
ended clinician responses to investigate barriers 
to assessment and treatment of sleep.  
Barriers related to patients (lifestyles), service 
facilities (lack of time) and environmental 
factors.   
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Great gains have been made in understanding the relationship between insomnia 
and paranoia, but other psychotic symptoms also deserve attention. For 
example, the relationships between sleep and grandiosity, hallucinatory 
experiences remain relatively unexplored (Reeve et al., 2015). In study 5 we 
included delusions of reference, grandiosity as well as hallucinations as 
additional measures. But these were not reliable (as indicated by low cronbach 
alphas) and were endorsed at low levels and therefore exploratory analysis could 
not be done. An ESM study of sleep and psychotic symptoms found relationships 
between sleep and next day auditory hallucinations and delusions of control 
(Mulligan et al., 2016). Furthermore, the focus on specific symptoms, also 
applies to specific sleep parameters. Using the ICSD can serve as a useful 
framework for classifying different sleep conditions. Within this, sleep is split 
into- insomnia, hypersomnia, circadian disturbance, parasomnias, sleep related 
movement and sleep related breathing. Each type of sleep disturbance has 
specific treatment strategies associated with it. For example, disorders of 
circadian timing are caused by mis-alignments of internal and external time, and 
treatment involves reducing the mis-alignment via behavioural techniques such 
as chronotherapy and light therapy (Wilson et al., 2010). There is evidence for 
increased prevalence of circadian rhythm disruptions in people with psychosis 
(Wulff et al., 2012), but circadian treatments have not been trialled yet.  
There is also a need to document how sleep impacts other areas of functioning 
apart from symptoms as sleep disturbance persists even after symptoms are 
treated (Baandrup, Jennum, Lublin, & Glenthoj, 2013). In chapter 6, clinicians 
identified domains of functioning that they believe sleep to effect, including 
cognition, social functioning, and physical health. The impact of sleep upon 
these areas of functioning are well documented. Poor sleep has negative effects 
on a range of cognitive variables including memory and attention (J. Lim & 
Dinges, 2010), and sleep effects socio-emotional functioning including emotion 
perception (Beattie, Kyle, Espie, & Biello, 2015) and insomnia has been linked to 
physical health problems and inactivity (Sutton, Moldofsky, & Badley, 2001). 
However, these relationships have not been investigated yet in people with 
psychosis. One route that might be promising is the investigation of sleep in 
relation to negative symptoms. Negative symptoms are common and prevalent in 
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people with psychosis and are linked to cognitive disturbance (Bobes et al., 
2010; Myin-Germeys & van Os, 2007). Some evidence exists of a relationship 
between sleep and negative symptoms (Kato et al., 1999; Tandon et al., 1992). 
However, these studies have been conducted using PSG methods and may be at 
risk of bias as outlined in chapter 4. Therefore, a systematic investigation of 
sleep and negative symptoms is required. 
In chapter 4, the systematic review identified potential areas of bias that may 
occur including those specific to different sleep methodologies. These factors 
should be considered in the design of studies to produce more rigorous and 
reliable results. Furthermore, in addition to this, the field of sleep and psychosis 
would be further advanced by adhering to the principles of open science. In 
chapter 5, our ESM data and code were freely made available and is accessible 
here (https://osf.io/4e86c/). This is an important step in increasing clarity and 
promoting replication in psychology.  
7.2.4.3 Refine and further develop sleep interventions that address the 
range of sleep disturbances experienced in people with psychosis. 
Sleep has been identified as a potential causal factor in the development and 
maintenance of psychotic symptoms (Freeman et al., 2012) and a few studies 
have shown that improving sleep can improve symptoms. In people with 
insomnia, CBTi is the recommended treatment (Morin & Benca, 2012) and this 
has been adapted and tested in people with psychosis. In a pilot trial of 15 
people with persistent insomnia and paranoid delusions, four sessions of CBTi 
were administered that covered sleep hygiene, psycho-education and stimulus 
control (Myers et al., 2011).This study found there were large improvements in 
sleep and paranoia. There were also improvements in mood and perceptual 
anomalies, which may be mechanisms that mediated the change. In a large scale 
RCT, effectiveness of CBTi was compared to standard care. Again, there were 
large improvements in sleep, although the effects on symptoms were 
inconclusive (Freeman, Waite, et al., 2015). However, one explanation for the 
small effects on symptoms is that large improvements in sleep, leads to a 
reduction in emotional distress. Given that emotional distress is strongly 
associated with paranoia, by targeting this mediating variable, there may not be 
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changes in paranoia detected. In a more recent study, the effectiveness of CBTi 
was tested in a sample of people who are at risk for psychosis, again finding 
large improvements in sleep. There were also improvements in mood and 
symptoms including paranoia (Bradley et al., 2018). These are promising results. 
However, in order to take this research further, we still need to understand 
what components of CBTi are effective, and treatments need to be refined to 
adapt to more specialised populations. For example, in chapter 6, clinicians 
identified sleep disturbances in psychiatric wards and in prisons. These unique 
environments pose some challenges. In wards, noise and light levels which would 
be covered in sleep hygiene modules cannot be easily modified. There has also 
been some research to suggest that short sleep on inpatient wards is associated 
with next day aggression in people with psychosis (Langsrud et al., 2018). In a 
pilot study, CBTi was administered to people on an inpatient ward who were 
experiencing an acute episode of psychosis or bipolar disorder. The CBTi was 
adapted to meet the needs of the ward environment. For example, enhanced 
light exposure was administered via light boxes and encouraging walks outside. 
The sleep treatment was associated with improvements in sleep, wellbeing and 
being discharged earlier (Sheaves et al., 2017). This provides some preliminary 
evidence that sleep can be treated on wards. 
So far CBTi has been delivered in patient samples face to face (Freeman, Waite, 
et al., 2015; Myers et al., 2011). However, online treatment methods could be 
another option. In the OASIS trial, sleep treatment was administered online 
(Freeman, Sheaves, et al., 2015). Could this be another mode of treatment for 
people diagnosed with psychosis? Research suggests that people with psychosis 
are open to using the internet and smartphones for mental health treatment  
(Lal & Malla, 2015; Palmier-Claus et al., 2013).The “Early signs Monitoring to 
Prevent relapse in psychosis and prOmote Wellbeing, Engagement and Recovery” 
(EMPOWER) study is using technology- an app on a smartphone that allows 
individuals to self- monitor a variety of experiences such as self -esteem and 
symptoms.  When individuals start to experience problems, they can be 
contacted directly and supported (https://empowerstudy.net/). Sleep lends 
itself to be treated online and this form of treatment has yet to be investigated 
in a clinical population. This would fit in with a stepped care approach where 
160 
160 
online CBTi could be administered when people report sleep problems as this 
would be more cost-effective and less intensive than face to face (Espie, 2009).  
7.2.5 Conclusions 
In this thesis, in both a clinical and non-clinical sample, we did not find a 
consistent relationship between sleep and paranoia, which contradicted a body 
of research (Freeman et al., 2010). One main reason for this was likely to be 
because we did not include specific measures of insomnia. In this thesis we also 
found that sleep disturbances are varied in people with psychosis and a common 
complaint in clinical practise. Therefore, the need to understand the nature and 
impact of sleep in this population is critical. A set of suggestions for future 
research was outlined. 
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Appendix 1: Bias assessment tool piloting 
We chose to include the 5 components (patient selection, confounding variables, 
power and missing data and statistical analysis) because these are most 
commonly reported in other checklists and assessment tools (Crowe & Sheppard, 
2011; Sanderson, Tatt, & Higgins, 2007).  
For the methodological component we developed a component that allows us to 
rate bias for each type of sleep methodology (actigraphy, subjective sleep 
assessment and polysomnography). In actigraphy for example, some have 
questioned its validity in clinical samples, as it has a tendency to score quiet 
rest as sleep (Paquet et al., 2007). Therefore, actigraphy may be less accurate 
in populations with sedentary lifestyles such as in schizophrenia. Studies that do 
not include any methods to distinguish quiet rest from sleep, are likely to have 
biased estimates of sleep, such as over-scoring total sleep time. Likewise, for 
accurate sleep parameter estimates, at least 7 days of recording are 
recommended (Aili et al., 2017). Studies with less than 7 days, could be at risk 
for bias.  
In regards to polysomnography, bias may occur if an adaptation night is not 
included to allow individuals to accustom themselves to the strange sleeping 
environment of the sleep lab. This phenomenon is known as the first night 
effect, whereby individuals sleep worse on the first night in a new environment 
than they would at home (Agnew et al., 1966; Toussaint et al., 1995). Therefore, 
PSG studies without an adaptation night may be at risk for bias. The second area 
is the use of caffeine and presence of napping. Caffeine has alerting effects, and 
may influence sleep estimates (Van Dongen et al., 2001). Likewise, napping in 
the daytime may also effect sleep at night (Dinges, 1992). Therefore, PSG 
studies that do not limit the use of napping and caffeine on sleep recording days 
may be at risk for producing biased sleep estimates.  
Finally, for subjective sleep studies, those that do not use validated 
questionnaires or who do not present psychometric data for their own developed 
questionnaires may be at risk for producing biased sleep estimates.  
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To assess reliability 3 people (AR, and two individuals not involved in the 
systematic review) completed the tool for 6 studies. Agreement was relatively 
high ( >70% agreement) for all domains except missing data (50%) agreement, 
and most inconsistencies concerned rating studies at high risk of bias or unclear. 
Thus the tool was edited and modified with clearer instructions. Therefore, in 





Domain Description Bias Assessment (low (0), high (1), 
unclear). 
Patient Selection: Component 1 
 
Criteria for high risk of bias (1):  
Patients are not representative OR if 
inclusion/exclusion criteria isn’t stated 
OR criteria is inappropriate OR if 
important information on patients is 
missing e.g. medication info, or age. 
 
 
Criteria for low risk of bias (0):   
If there is appropriate 
inclusion/exclusion criteria stated, and 
enough information about patients is 
provided and if patients are 
representative. 
 
Rate studies as unclear if study doesn’t 
meet criteria for low or high bias.  
Describe methods of Patient Selection 





Did the study have appropriate 
inclusion/exclusion criteria (Y/N/U) 
Was there enough information on 
patients selected? (Y/N/U) 
Were the patients representative 
(Y/N/U) 
 








Baseline characteristics component 2 
  
Criteria for high risk of bias (1):  
There is no control group OR if patient 
and control groups differ on important 
variables e.g. age, gender, and these 
factors are not controlled for in any 
statistical analysis. 
 
Criteria for low risk of bias (0):   
There is a control group, if the groups 
are well matched or if differences 
between groups are controlled for in 
analysis.  
 
Rate study as unclear if it doesn’t meet 
criteria for low or high bias.  
 
Describe patient and Control group  
 
 
Is there a control group? (Y/N) 
Are there differences between the two 
groups e.g. on demographic 
variables(Y/N/U/NA) 
Are differences controlled for in 
analysis?(Y/N/U/NA) 
 
Could differences between the groups 








Criteria for high risk of bias (1):  
If there is no explicit statement about 
distinguishing quiet restfulness from 
sleep e.g. through sleep logs OR if there 




Describe actigraphy methodology e.g. 







Did the study record sleep at least 7 
days?(Y/N/U) 
Could actigraphy methodology have 
biased the study? 
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Criteria for low risk of bias (0) 
If there is an attempt to distinguish quiet 
restfulness from sleep e.g. through sleep 
logs AND if the recording period is 7 days 
or more.  
 
Rate study as unclear if it doesn’t meet 
criteria for low or high bias 
Was there an attempt to distinguish quiet 
rest from sleep?(Y/N/U) 
Sleep Methodology: Polysomnography  
component 4 
 
Criteria for high risk of bias (1):  
If sleep is only recorded for one night, 
i.e. no reference to first night effect, or 
no adaptation night OR if there are no  
instructions to participants e.g. 
refraining from caffeine, that may 
produce biased sleep estimates 
 
Criteria for low risk of bias (0): 
If more than one night of recording is 
conducted, AND there are instructions on 
days of sleep recordings are stated e.g. 
participants were asked to refrain from 
caffeine. 
 
Rate study as unclear if it doesn’t meet 
criteria for low or high bias 
Describe PSG methodology  e.g. 




Did the study take into account the first 
night effect(Y/N/U) 
Was there pre- sleep lab recording 
instructions to participants e.g. avoid 
caffeine(Y/N/U) 
Could polysomnography methodology 






Sleep Methodology: Subjective Sleep 
Assessment  component 5 
 
Criteria for high risk of bias (1):  
If non-validated measures of sleep are 
used OR if there is no 
psychometric/reliability data for authors 
own questionnaire 
 
Criteria for low risk of bias (0): 
Study at low risk of bias if validated 
measures of sleep are used or if authors 
present psychometric data to validate 
their questions.  
 
Rate study as unclear if it doesn’t meet 
criteria for high or low bias  




Did study use validated measures of 
sleep?(Y/N/U) 
If not, is psychometric data available for 
their questionnaire/diary?(Y/N/U/NA) 
Could sleep measurement have biased 
the study? 
Power:  component 6 
 
Criteria for high risk of bias (1):  
If the sample size is too small (e.g. <10) 
or if the study has no justification for the 
sample size (e.g. through power analysis) 
 
Criteria for low risk of bias (0): 
If sample size is large, if it is justified or 
power calculations are conducted. 
Describe how sample size was chosen 
e.g. power calculations 
 
 
Did study conduct power analysis 
(Y/N/U) 











Rate study as unclear if it doesn’t meet 
criteria for high or low bias 
 
 
Missing Data component 7 
 
Criteria for high risk of bias (1):  
If there is data missing, if there is no 
explicit mention of missing data and 
results suggest there may be or if there 
are no strategies to deal with missing 
data or if no degrees of freedom are 
presented to calculate missing data 
  
Criteria for low risk of bias (0): 
If missing data is stated and the number 
is low, or strategies to deal with missing 
data are used or degrees of freedom or 
other data is presented that suggests 
no/little missing data.  
 
Rate study as unclear if it doesn’t meet 
criteria for high or low bias.   
 
Describe any missing data reported, 




Did study report missing data?(Y/N/U) 
Was missing data handled appropriately? 
(Y/N/U/NA) 
 




Completion Rates component 8 
 
Criteria for high risk of bias (1):  
Describe completion rates or numbers 








If dropout rate not reported or if there is 
a high dropout rate or if drop outs differ 
from completers on important variables  
 
Criteria for low risk of bias (0): 
If there are very few or no drop outs, If 
dropouts do not differ from completers 
or if completion rates are explicitly 




Rate studies as unclear if  it doesn’t 
meet criteria for high or low bias 
Did the study report completion rates? 
(Y/N/U) 
Did study report why individuals dropped 
out? (Y/N/U) 
Were completers and non-completers 
compared on main variables e.g. age 
(Y/N/U) 
 
Data Analysis: component 9 
 
Criteria for high risk of bias (1):  
 
If inappropriate statistics are used or if 
important variables between groups e.g. 
age or gender are not controlled for in 
analysis. 
 
Criteria for low risk of bias (0): 
If appropriate statistics are used and any 
important co-variates and any group 
differences are controlled in analysis. 
 
 
Describe data analysis methods e.g. 




Did the study use the appropriate 
statistics for the data(Y/N/U) 
Did the study control for baseline 
differences (if any) in statistical 
analysis?(Y/N/U/NA) 
 
Could methods of data analysis have 
biased the study? 
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Rate studies as unclear if  it doesn’t 
meet criteria for high or low bias 





Describe any other areas in the study 








Appendix 2: Search terms for systematic review  
 
Ovid MEDLINE R and In-Process & Other Non-
Indexed Citations.   
 
1. Sleep 
2. Schizophrenia  
3. 1 and 2     
4. Psychosis 
5. 1 and 4  
6. Psychotic disorder or psychotic disorders/      
7. 1 and 6    
8. sleep disorders or Sleep Wake Disorders 
9.           8 and 2 
10.         8 and 4 
11.         8 and 6 
12.         Circadian rhythms.mp. or Circadian 
Rhythm/ 
13.         12 and 2 
14.         12 and 4 
15.         12 and 6 
16.         actigraphy.mp. or Circadian Rhythm/ or 
Actigraphy/ or Monitoring, Physiologic/ 
17.         16 and 2 
18.         16 and 4 
19.         16 and 6 
20.          Polysomnography.mp. or 
Polysomnography/ 
21.          20 and 2 
22,          20 and 4 
23.          20 and 6 
24.          Polysomnography/ or Sleep/ or Sleep, 
REM/ or sleep EEG.mp. or Sleep Stages/ 
25.           24 and 2 
26.           24 and 4 
27.           24 and 6 
Limit all to (Full text, English language, year = 1953 
and Humans). 















Appendix 3: ESM items 
Item type 
Items Scale 
   
Sleep I feel sleepy, fatigued, 
exhausted 
1-6 point likert scale(not at all to very) 
Paranoia I feel suspicious, I feel 
that others may hurt 
me 
1-6 point likert scale(not at all to very 
Reference I feel that someone is 
communicating with 
me through the TV or 
radio 
 
I feel that things 
happening around me 
have special meaning 
1-6 point likert scale(not at all to very) 
Grandeur I feel I have special 
powers to do things 
that nobody else can 
 
I feel like I am 
especially important 
1-6 point likert scale(not at all to very) 
Delusional dimensions 
Each type of delusion 




with it.  
How much are the 
thoughts about (X) 
causing you distress? 
 
How much are the 




How convincing are 
the thoughts about 
(X)? 
1-6 point likert scale(not at all to very) 
Hallucinations 
(auditory and visual) 
I hear things 






I see phenomena 
I see things that others 






I feel: Insecure, 
lonely, anxious, 
irritated, down, guilty, 
stressed 
 
I feel cheerful, 
relaxed, and content. 
1-6 point likert scale(not at all to very) 
Context Who are you with at 
the present moment?  
 
What are you doing at 
this moment?  
 
 
Did this beep disturb 
you?  
 
Since the last beep 
have you taken any 
other substances?  
 
Since the last beep 
have you had any 
caffeine?  
 
Since the last beep 
have you had anything 
























Appendix 5: Comprehension of ESM procedure 
Question Average score (1= 
strongly disagree, 
7= strongly agree) 
Could you read the text on 
the phone screen clearly? 
6.5 
Did you find it awkward to 
operate the phone? 
1.6 
Were the verbal instructions 
you received about using the 
phone clear? 
6.6 
Were the questions that you 
answered on the phone 
difficult or unclear? 
1.7 
Did you find it aggravating or 
stressful to use the phone? 
2.1 
Were the number of beeps 
acceptable? 
6.6 
Was the time taken to 
complete the questions 
acceptable to you? 
6.6 
Were there any technical or 
other problems that meant 
you had problems answering 






Appendix 6: Clinician survey questions for chapter 
6. 
Question(s) Answer options 
 What is your job title? Choice from: Psychiatrist, Psychiatric 
Nurse, Psychologist, OT, Social Worker, 
Primary Care Team, or Other.  
 What type of service are you 
based in? 
Choice from: Inpatient Ward, Adult 
Community Health Team, Early 
Intervention Services, Crisis Resolution 
Team, Primary Care Team or Other.  
Where are you based? Choice from: Oxford, Glasgow, 
Birmingham, Manchester, Edinburgh, 
Liverpool.  
 What percentage of patients 
that you see with psychosis, also 
have sleep problems? 







What are the most common 
complaints patients with 
psychosis report about their 
sleep? (Select all that apply) 
(More than one option can be selected) 
 
-Insomnia (difficulties getting to sleep or 
staying asleep) 
-Sleep related movement disorders (e.g. 
restless legs syndrome, periodic limb 
movements) 
-Sleep related breathing problems (e.g. 
sleep apnoea)- ---  
-Hypersomnia (sleeping for very long 
periods, feeling tired in the day) 
-Circadian Rhythm disruption (e.g. 
mistimed sleep: going to bed too early, or 
very late) 
-Narcolepsy 




In your view, do the sleeping 
problems that patients with 
psychosis experience have a 
negative impact in any of the 
following domains? (Select all 
that apply) 
(More than one option can be selected) 
- Mood (e.g. anxiety) 
- Positive symptoms (e.g. paranoia) 
- Negative symptoms (e.g. 
anhedonia)  




- Physical health (e.g. feeling 
unwell) 
- Social functioning (e.g. 
relationships) 
- Daytime activities (e.g. attending 
appointments) 
In your view, what causes the 
sleep problems in people who 





(More than one option can be selected) 
- The sleep problems are a 
consequence of medication 
- The sleep problems are a result of 
poor sleep hygiene (e.g. too much 
caffeine, napping) 
- The sleep problems are a 
consequence of affective 
symptoms (e.g. Low mood, 
anxiety) 
- The sleep problems are a 
consequence of positive psychotic 
symptoms 
- The sleep problems are a 




What is your understanding of 
the relationship between sleep 
and psychosis? 
-Sleep problems are one factor that can 
make psychotic symptoms (positive 
and/or negative) worse 
-Psychotic Symptoms (positive and/or 
negative) are one factor that can make 
sleep worse 
-Both of the above are true ( it works 
both ways) 
-Unsure 
-Sleep and Psychosis are not related  
How often do you formally assess 
sleep problems in people with 
psychosis? 
-Rarely/Never 
-In a minority of cases 
-In around a half of cases 
-In the majority of cases (75%) 
-In nearly all or all patients with 
psychotic symptoms 
 
What methods do you use to 
assess sleep problems in people 
with psychosis? (Select all that 
apply) 
-Informally ask patient 
-Objectively assess sleep (e.g. EEG, Neck 
Circumference) 
-Psychometric self-report (e.g. 
Administer the Insomnia Severity Index 
Questionnaire) 





How often are you treating sleep 





-In a minority of cases 
-In around a half of cases 
-In the majority of cases (75%) 




What methods do you use to 
treat sleep problems in patients 







-Refer for Cognitive Behavioral Therapy 
for Insomnia 
-Deliver Cognitive Behavioral Therapy for 
Insomnia 
-Sleep Hygiene Tips 
-Offer Psychoeducation materials 
-There are no effective treatments for 
sleep problems in people with psychosis 
-Other  
 
In your view, are there any 
barriers to treating sleep 
problems in patients with 
psychosis? 
Open ended answer  
What do you think could be the 
benefits of improving sleep in 
people who experience 
psychosis? (select all that apply) 
 
-None 
-Improved psychotic symptoms 
-Improved affective symptoms 
-Increased energy 
-Increased engagement in activities 
-Improved physical health 
-Other  
What form of sleep treatment 
would you recommend for a 
patient with long-standing sleep 
difficulties and psychotic 
symptoms? (Select all that apply) 
-Medication 
-Sleep Hygiene Tips ( from a leaflet or 
website) 
-Online self-help 
-Cognitive Behavioral Therapy for 
Insomnia  
-All of the above 
Are there any other comments 
you wish to add about sleep in 
your patients with psychosis? 
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